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ABSTRACT I 
This thesis describes the design and synthetic approach to a potential transition state 
inhibitor 26 of an a(1,3)-fucosyltransferase - an important enzyme involved in the 
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Chapter 1 reviews the literature of potential inhibitors of both glycosyltransferases and 
glycosidases and outlines the aim of the project. Chapter 2 reveals the retrosynthetic 
strategy adopted for the trisubstrate analogue 26 and of the core azasugar portion 
which is a bis-hydroxymethylpiperidine 27. The synthetic challenge in this project 
resided in the synthesis of this unit and initially, an asymmetric synthesis of the known 
azasugar L-deoxyfuconojirimycin (DFJ) 7, which contains four of the required 
stereogenic centres of the core azasugar 27 was investigated. Chapter 3 describes the 
sucessful synthesis of 7 in 14 steps commencing from the readily available amino acid 
N-Boc-L-alanine 51. 
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It was envisaged that the route to DFJ could subsequently be elaborated to the bis-
hydroxymethylpiperidine 27, but due to unforeseen problems a revised approach to 
the prime target from N-Boc-L-alanine 51 was adopted. Chapter 4 outlines 10 steps 
that have been completed en route to an appropriately functionalised acyclic system 
which is anticipated to undergo a Lewis acid catalysed 6-exo-tet cyclisation of an 
amine function onto a gem-disubstituted epoxide to furnish a cydised precursor to the 
target azasugar 27. 
ix 
1. INTRODUCTION 
1.1 GLYc0BI0LOGY:- THE ROLE OF CARBOHYDRATES IN 
BIOLOGICAL PROCESSES 
Carbohydrates are very important compounds in a wide range of biological processes 
and the emerging field of glycobiology is enabling an understanding of the interactions 
and mechanisms involved in the many different processes of the complex 
carbohydrates which are present on cell surfaces. The majority of carbohydrates of 
biological relevance are attached to proteins or lipids and can be highly branched 
molecules connected by many different linkages. These protein or lipid bound 
carbohydrates are referred to as glycoconjugates and can be classified as 
glycoproteins, glycolipids and proteoglycans, and differ by their characteristic 
carbohydrate tethers. 
The carbohydrate residues of the glycoprotein and glycolipids act as binding sites for 
other large molecules such as proteins, bacterial toxins and antibodies. Both are 
complex glycoconjugates and are fundamental to a wide range of processes including 
fertilisation, immune defence, viral infection, cell growth, cell-cell adhesion and 
inflammation. Figure 1 highlights an example of known carbohydrates that are 
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Through the understanding of complex carbohydrate structures a number of 
carbohydrate based drugs have been developed for a range of therapeutic applications 
including anti-inflammatories, cancer chemotherapy, diabetes, anti-virals and 
infectives and also neurological therapies, several of which are shown in Figure 2. 
Carbohydrates such as sialyl Lewis-X and GM2 have also been synthesised and used 
as potential drug candidates.1'2 
Figure 2 
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These carbohydrate drugs exert their potency by either mimicking the cell-bound 
carbohydrate, thereby blocking the corresponding interaction, or by inhibiting the 
specific enzymes which create the active carbohydrate hence decreasing or increasing 
the amount of active compound that is causing the disease state. 
The area of interest in this project is the carbohydrate mediated cell-cell adhesion 
process that occurs as a result of tissue injury or infection. 
2 
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1.2 CELL-CELL ADHESION AND THE INFLAMMATORY 
RESPONSE 
Carbohydrate mediated cell adhesion is a basic cellular mechanism that is required for 
many functions including pathogen infectivity and cellular immune responses and has 
also been implicated in metastasis of tumours.3  
Cells are completely covered with glycocalyx, a layer of carbohydrates arising from 
glycoproteins, glycolipids or glycosaminoglycans, and as these carbohydrates 
dominate the exterior of the cell membrane they are in ideal positions to mediate initial 
contacts between two cells. 
The LECCAMS or selectins are a family of cell adhesion molecules which mediate 
adhesive interactions between circulating leukocytes (white blood cells) and the 
vascular endothelium. One of the three members of this family is E-selectin (formally 
known as ELAM-1, endothelium leukocyte adhesion molecule-1) and is displayed on 
the surface of the endothelial cells when inflammation occurs. It promotes adhesion of 
neutrophils, monocytes, and a sub-population of lymphocytes (the 3 main types of 
leukocytes) to the endovascular wall adjacent to the site of inflammation.48  
The recruitment of leukocytes to the injured tissue is illustrated in the simplified 
diagram shown in Figure 3. When tissue injury occurs (a) small peptides called 
cytokines are released to signal E-selectin synthesis on the endothelial cells which also 
change shape (b). The leukocytes then roll along the surface of the endothelial cells via 
protein-protein interactions mediated by proteins called integrins (displayed on the 
leukocytes) and a protein ligand (on the endothelial cells) called ICAM- i (intracellular 
adhesion molecule-1), (c). The leukocytes are then able to squeeze through the gaps 
between the endothelial cells and enter the adjacent tissue to help repair injury.9 
Unfortunately, there is a series of acute and chronic diseases which result from the 
misdirected or excessive migration of too many leukocytes to the area of infection such 
as cardiogenic shock, stroke, rheumatism, psoriasis and bacterial meningitis. It is also 
thought that certain cancer cells may exploit this phenomenon of adhesion to spread 
throughout the body, hence compounds that alter cell-cell interactions may have many 
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The oligosaccharide which has been found to interact with E-selectin in the above 
process is a tetrasaccharide called sialyl Lewis-X (sLex) 1 and is found at the terminus 
of glycolipids displayed on the surface of the leukocyte membrane, Figure 4•4,5,10 
Through a series of inhibition studies using sLex  and analogues, it was proposed that 
the interaction between E-selectin and sLex  was multivalent and the active binding 
domain of sLex  arises from the carboxylate of the N-acetyl-neuraminic acid (NeuAc), 
the 4 and 6-hydroxyl groups of the galactose residue and the three hydroxyl groups of 
the fucose. The methyl group of fucose is not essential, as this residue can be 
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1.2.1 Control of cell-cell adhesion 
The development of therapeutic agents for treatment of inflammation related diseases 
and cancers requires the need to prevent healthy tissue damage, i.e. to control the rate 
of flow of leukocytes through the endothelium wall. Two main approaches to this are 
as follows:- 
To synthesise sLe' and analogues as competitive inhibitors of the binding 
interaction between the sLe'-containing leukocytes and E-selectin. 
To inhibit the glycosyltransferase enzymes that are involved in the 
biosynthesis of the intracellular sLe'. One of the enzymes that has been targeted for 
inhibition is the a( 1 ,3)-fucosyltransferase [cz( 1 ,3)-FucT]. 
There is literature precedent for the synthesis (both chemical and enzymatic) of sLe' 
and analogues as inhibitors, 12-14  but very little information on the inhibition of the 




1.2.2 The role and mechanism of the cc(1,3)-Fudf 
The two families of enzymes that assemble and shape the carbohydrates of bioactive 
glycoprotein and glycolipid conjugates are the glycosidases and glycosyltransferases. 
Glycosidases catalyse the hydrolysis of glycosidic linkages and are involved in the 
trimming of oligosaccharides. Glycosyltransferases catalyse the transfer of 
monosaccharides from sugar-nucleotide donors (e.g. GDP-fucose) to suitable 
acceptors resulting in lengthening of oligosaccharides. 
The final enzyme involved in the biosynthesis of sLex  is an a(1,3)-FucT which 
catalyses the transfer of the L-fucose moiety from guanosine diphosphate f3-L-fucose 
(GDP-fucose) to the 3-OH of N-acetyl glucosamine (G1cNAc) resulting in inversion of 
configuration at the anomeric carbon of the fucose residue (Figure 5). 
Glycosyltransferases also require metal cofactors, typically calcium or manganese (II) 
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There is little known about the mechanism of glycosyltransferase catalysed reactions. 
However, it has been proposed that there are similarities with the mechanism of 
glycosidase catalysed hydrolysis which has been well studied, which can result in 
inversion or retention of the configuration at the anomeric centre dependent on the 
enzyme involved.8-20 The mechanism for enzymes that hydrolyse with retention of 
configuration (illustrated using fucose as an example in Figure 6) is proposed to go via 
a transient glycosyl cation after department of the R-OH aglycon. This is then 
stabilised by a carboxylate side chain of the enzyme producing a glycosyl-enzyme 
intermediate that will then undergo hydrolysis at the active site. 
Figure 6 
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The glycosyltransferase catalysed reaction may proceed through a similar glycosyl 
cation which then undergoes nucleophilic attack from another sugar residue resulting 
in the glycosylated product. The divalent metal co-factor e.g. manganese (II), which is 
essential for glycosyltransferase activity is thought to form a 6-membered ring 
complex with the diphosphate group of the GDP moiety. 17 
7 
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Several years ago, Palcic et al.,21 postulated that the enzymatic fucosyl transfer from 
GDP-fucose to the 2-OH group of 3-D-ga1actopyranoside catalysed by an a( 1,2)-
FucT, proceeded via an ion-pair mechanism involving a flattened half-chair glycosyl 
cation intermediate (Figure 7). This implies that GDP-fucose and the acceptor sugar 
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This proposed transition state has been used extensively as a basis in the search for 
new inhibitors of glycosyltransferases in general, and recently Wong and co- 
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workers17'22 have studied a(1,3)-FucT-V (one of the 5 human (x(1,3)-FucT's that 
have been cloned to date) and have found that the enzyme has an ordered, sequential 
mechanism with GDP-fucose binding first and the product GDP released last. Results 
also suggest that significant glycosidic cleavage of the GDP-fucose bond occurs prior 
to the nucleophilic attack by the acceptor sugar - an overall process between SN1  and 
SN2 proceeding via the glycosyl cation intermediate. 
1.3 GLYCOSIDASE AND GLYCOSYLTRANSFERASE INHIBITORS 
1.3.1 Early glycosidase inhibitors 
Some of the first glycosidase inhibitors were families of monosaccharides derived 
from -aldonolactones (e.g. D-gluconolactone 2) and glycosylamines (e.g. D-
glucosamine 3), (Figure 8). 
Figure 8 
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These families of compounds displayed competitive inhibition against glycosidases 
whose substrates they most resemble, however they lacked long term stability in 
aqueous solution. 
1.3.2 Azasugar based inhibitors 
In recent years it has been discovered that several types of polyhydroxylated piperidine 
and pyrrolidine alkaloids (from plants and microorganisms) are naturally occurring 
glycosidase inhibitors. For example nojirimycin 4 and mannojirimycin 5 are regarded 
as simple analogues of D-glucose and D-mannose respectively, and in the pyrrolidine 
series, 2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine 6 represents the analogue of 
Introduction 
f3-D-fructofuranose. These compounds are given the term 'azasugars' due to the 
replacement of the ring oxygen with a basic nitrogen atom, (Figure 9). 
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Such compounds and their 1-deoxy derivatives exert their biological activity by 
competitive inhibition of specific glycosidic enzymes.23 Protonation of the azasugars 
at physiological pH mimics the charge distribution of the glycosyl cation developed in 
the transition state of the glycosidase catalysed reaction. 
1.3.2. 1 Five-membered azasugars as inhibitors 
Polyhydroxylated pyrrolidines have a similar conformation and charge distribution to 
the half-chair glycosyl cation and have been found to be potent inhibitors of a wide 
range of glycosidases. The five azasugars shown in Figure 10 were found to be good 
inhibitors of various glucosidases including mannosidases and galactosidases, 
however none showed any inhibition of an a-L-fUcosidase.24 
Figure 10 
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1.3.2.2 Six-membered azasugars as inhibitors. 
Azasugars including (-)-deoxyfuconojirimycin (DFJ) 7 and its derivatives have been 
found to be potent inhibitors of a-L-fucosidases.25-27 To investigate the effects on 
stereochemical and functional group changes on the core structure of DFJ, a number of 
derivatives 8-11 were synthesised and assayed as inhibitors of several glycosidases 
(Figure 11, the K values shown are those obtained from an assay against a human 
liver (X-L-fucosidase). DFJ 7 was not only found to be a very potent inhibitor of the 
human liver a-L-fucosidase but also very specific as the other 11 glycosidases assayed 
were not inhibited to any extent. N-Methylation to give the analogue 8 had very little 
effect on competitive inhibition of the a-L-fucosidase, however it did broaden the 
specificity by showing inhibition of other glycosidases. -Homofuconojirimycin (3-
HFJ) 9 (one of the class of azasugars characterised by a hydroxymethyl group at the 
a-position of the sugar) retained inhibitory activity. (-)-Deoxymannojirimycin (DMJ) 
10 showed poor fucosidase inhibition but was the only derivative to show 
mannosidase inhibition suggesting that mannosidases are sensitive to substituents at 
C1. Finally, 6-epi-a-homofuconojirimycin, 11 (the C1-05 epimer of 9) showed a 
considerable loss in activity. 
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These azasugars exist in a 6-membered chair conformation and as a result are very 
specific for the enzymes whose natural substrate they inhibit. Substituents and 
stereochemistry of the azasugar can have a dramatic effect on the enzyme inhibition, 
and the results above outline the neccessity for preparation of various analogues as 
potential inhibitors. 
A bisubstrate analogue was successfully synthesised by Liu28 as a potent glucosidase 
inhibitor, (Figure 12). The transition state analogue consisted of nojirimycin to 
facilitate polar-polar interactions, glucose attached by a f3-linkage, and also a 
methylene unit inserted between the two saccharide rings to mimic the lengthening of 
the severing glycoside linkage and to enhance its stability towards enzymatic 
hydrolysis. The analogue was found to be a competitive inhibitor of several 
glucosidases. 
Figure 12 
1.3.2.3 The synergistic inhibition of a( 1 ,3)-FucT 
Two known potent a-L-fucosidase azasugar inhibitors have been tested12'15 against an 
a(1,3)-FucT and were found to be moderate inhibitors for the enzyme with IC50 
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Interestingly, in the presence of GDP at the IC50 of the individual inhibitors, more than 
80% of the enzyme was inhibited. This suggests that a possible interaction between 
GDP and the azasugar in the active site of the enzyme is mimicking the transition state 
structure of the fucosyl transfer reaction as illustrated in Figure 14. (This effect is 
known as synergistic inhibition). 
Figure 14 
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On the basis of this synergism, Wong and co-workers17 designed a potential inhibitor 
of an a(1,3)-FucT-V consisting of f3-L-homonojirimycin covalently linked to an 
acceptor substrate (LacNAc). The azatrisaccharide 12 was anticipated to form a 
complex with GDP (of which a relatively high concentration is found in the cells) in 
the enzyme active site, and was found to be responsible for a 77-fold reduction (to 31 







HO 	 -------- 
OH 
------------ .ethylenespacer 








Spacer = -CH2CH2CH2- 
-CH2CH2CH2CH2 
0  -CH2 
Introduction 
A similar approach by Jefferies and Bowen29 to a transition state mimic involved 
tethering the azasugar DFJ 7 to a D-galactose residue by a spacer to give the analogues 
13, (Figure 16). These azasugar analogues showed potent inhibition (IC50 81-500 
tM) of an a( 1 ,3)-FucT-IV enzyme relative to DFJ (3.5 mM). A synergistic effect was 
also noted for the derivative containing the aromatic spacer where at a concentration of 
2 IIM of GDP, an IC50 of 50 j.LM was observed (IC50 81 .tM in absence of GDP). 
Figure 16 
1.3.3 Non azasugar based inhibitors 
1.3.3.1 Bisubstrate analogue as an cz(1,2)-FucT inhibitor 
One of the first examples of a bisubstrate analogue was designed and synthesised by 
Palcic et al.,21 on the basis of their proposed transition state (Figure 7) of an a(1,2)-
FucT. The analogue 14 contained structural elements of both donor (GDP) and 
acceptor sugar (phenyl-[3-D-galactopyranoside) covalently attached through the 
acceptor hydroxyl (normally used by the enzyme). This bisubstrate analogue was 
found to have a K value of 2.3 pM with respect to the acceptor substrate, which 
unfortunately showed only a slight increase in inhibitory activity to GDP (K1 8.7 pM), 
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1. 3.3.2 Trisubstrate analogues as inhibitors of a( 1 ,3)-FucTs 
Recently, van Boom and co-workers16 embarked on the synthesis of two fucose 
containing trisubstrate analogues as potential inhibitors of the postulated ion-pair 
transition state. The proposed inhibitors 15 and 16 (Figure 18) contained a 
malondiamido instead of a pyrophosphate linkage between the guanosine and L-fucose 
moieties. It was anticipated that the non-charged amide bonds would aid membrane 
transport. 
Synthesis of the potential inhibitor 15 was unsuccessful due to the acid lability of the 
target compound. A route to the second analogue 16 was reported, although no 
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Other trisubstrate analogues have been synthesised for use as inhibitors of different. 
glycosyltransferases, for example, the trisubstrate analogue 17 (Figure 19) has shown 












1.3.3.3 Carbocyclic analogues of GDP-fucose 
The approach to inhibitors of fucosyltransferases by Toyokuni et al.,31 involved 
replacement of the glycosyl moiety of the sugar nucleotide donors by a more stable 
carba-sugar. They reported the synthesis of two novel carbocycic analogues 18 and 











Preliminary inhibition assays carried out against a(1,3/4)-FucTs showed both 18 and 
19 exhibited inhibitory activity greater than that for GDP. 
1.3.3.4 Potential inhibitors using pyrophosphate mimics 
Recently, Wong and co-workers32 have investigated the development of 
glycosyltransferase inhibitors using -( 1 ,4)-galactosyltransferase (GalT) as a model 
system. This enzyme catalyses the transfer of galactose from UDP-galactose to an 
acceptor sugar and is proposed to proceed via a transition state analogous to that of the 
FucT in Figure 7. 
Attention was focused on the development of pyrophosphate analogues that would be 
capable of mimicking the pyrophosphate-metal ion cofactor interaction thought to form 
a 6-membered ring complex as depicted in Figure 21. Malonate, tartrate and 
monosaccharide linkages were chosen as pyrophosphate mimics on the basis of other 
galactosyltransferase inhibitors, and it was proposed that the malonate and tartrate 
esters could form a 6-membered complex with Mn2 , and that the monosaccharide unit 
could mimic the 6-membered ring conformation. The compounds shown in Figure 21 
were synthesised and their inhibitory activities assessed. 
The malonate analogues 20 and 22 showed no inhibition of the GaiT, however 
analogue 21 did show some inhibition (I( 1 mlvi) but was much less effective than 
UDP (K 460 jiM). Compounds 21 and 22 were expected to show better activity due 
16 
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to protonation of the azasugar at physiological pH which would mimic the half-chair 
conformation of the glycosyl cation developed in the proposed transition state. Despite 
this, the results suggested that the malonic ester moiety was a very poor 
pyrophosphate substitute. An interesting factor in the difference in activity of 21 and 
22 (the only difference in structure being the configuration at C-3 in the azasugar) is 
paralleled in the inhibition of galactosidase where the azasugar portion of 21 is a better 
inhibitor than that of compound 22, strengthening the concept that glycosyltransferase 
reactions possess a similar donor transition state structure to the corresponding 
glycosidase reactions. 
Figure 21 
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Compound 23 also showed no inhibition towards the GaiT, and 24 was also found to 
be a poor inhibitor (K 1 mM). Interestingly, analogue 25 was a moderate inhibitor (K1 
120 jiM) suggesting the pyrophosphate-metal ion complex may be mimicked by the 
glucose residue and that this conformation may be crucial for transferase recognition. 
Other work has been reported into the synthesis of pyrophosphate mimics 
incorporating a (1,1-difluoromethylene)phosphate group at the C-2 position of a 
hydroxylated piperidine but no inhibition assays were given.33  
18 
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1.4 PROJECT AIM AND INHIBITOR DESIGN 
The aim of the project was to design and synthesise compounds as potential inhibitors 
of human a(1,3)-FucTs which are involved in the biosynthesis of sialyl Lewis-X, 1. 
This may enable control of the flow of leukocytes to the site of injury in the 
inflammatory response and result in the development of potential therapeutic agents. 
The inhibitor design was based on a combination of known inhibitors of a-L-
fucosidases and a(1,3)-FucTs (and related enzymes) and also on the postulated 
transition state of the latter.21 As a result a novel trisubstrate analogue 26 was 
designed consisting of an azasugar, a GDP unit and a sugar residue. 
It was anticipated that the azasugar, based on deoxyfuconojirimycin which contains all 
the peripheral orientation and stereochemistry of fucose, would be protonated on the 
nitrogen in vivo and hence mimic the glycosyl cation generated in the transition state of 
the enzymatic fucose transfer. It was also reasoned that the 0-linked GDP and sugar 
unit would mimic the presence of the corresponding groups in the transition state. 
Insertion of the methylene units between these residues and the azasugar is expected to 
prevent hydrolytic cleavage of the substituents whilst mimicking the lengthening of the 














Sugar =Glu, G1cNAc, Gal. 
A retrosynthetic disconnection of the trisubstrate analogue 26 as indicated in Figure 23 
reveals three fragments- a bis-hydroxymethylpiperidine 27, a sugar and the GDP 
residue. The synthetic challenge of the trisubstrate 26 lies in the ability to prepare the 
azasugar unit 27 and the following section details some of the previous syntheses of 




















15 PREVIOUS AZASUGAR SYNTHESES 
1.5.1 Carbohydrates as starting materials 
Due to the presence of 3 or 4 contiguous chiral centres, the majority of syntheses of 
homochiral azasugars have begun with carbohydrates from the chiral pool. This 
approach enables the retention of some of the existing sugar stereochemistry and 
functionality in the azasugar product. 
Utilising carbohydrates requires the introduction of nitrogen and the formation of the 
piperidine ring between C-i and C-5, or pyrrolidine between C-i and C-4. Common 
methods of achieving this rely on:- 1) introduction of the nitrogen by 5N2  displacement 
of a good leaving group by azide followed by hydrogenation; or 2) by oxidation of an 
appropriate 2° hydroxyl group, followed by oxime formation and stereoselective 
reduction (reductive animation). 
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Outlined below, are some selected syntheses of several key azasugars from 
carbohydrates. 
(+)-Nojirimvcin 
The first synthesis of (+)-nojirimycin 4 was achieved by Inouye et al., from D-
glucose,34 and involved oxidation of the secondary hydroxyl to give the ketone 28. 
Oxime formation followed by reduction and deprotection yielded the amine 29 which 
























Reagents and conditions: (a) 4 steps, 46%, (b) DMSO, Ac20, 73%. (c) i. NH20H.HC1, 
MeOH, crude. ii. Raney Ni, MeOH, NH3(l), 94%. (d) i. Li/NH3(l), -70°C, 74%. ii. SO2, 
H20, 40°C, 96%. iii. Dowex 1X2 (OH) resin, quantitative. 
(-)-Deoxvmannojirimvcin 
A ten step synthesis from diacetone glucose has been developed for the synthesis of 
(-)-deoxymannojirimycin 10, in an overall yield of 35% and on a moderate scale.35  
Piperidine ring formation was achieved by an intramolecular nucleophilic displacement 
of a triflate at C-2 in compound 30 by an amine at C-6 (generated in situ) to give the 





























Reagents and conditions: (a) i. aq. acetic acid. ii. TsC1, pyridine, -14°C, 92% (2 steps). iii. 
NaN3, DMF, 40°C, 92%. iv. NaH, BnBr, Bu4NI, THF, 68%. (b) i. acidic methanol, 96%. ii. 
triflic anhydride, DCM, pyridine, 97%. (c) i. Ph3P, DCM, then K2CO3-  ii. PhCH2CO2C11  
ether, 82% (2 steps). (d) i. aq. TFA, 85%. ii. NaBH4, aq. EtOH, 94%. (e) H2, Pd-C, acetic 
acid 95%. 
(iii) (-)-Deoxvfuconojirimvcin 
The first synthesis of DFJ 7, required connection of C-i and C-5 of methyl a-D-
glucopyranoside with nitrogen, inversion of configuration at C-2 and C-3 and 
deoxygenation of C-6.26 Introduction of the nitrogen proceeded via an SN2 
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Reagents and conditions: (a) i. acetic acid:water (4:1). ii. TsC1, pyridine, -20°C, 75% (2 
steps). (b) i. LiA1H4, THE ii. BnBr, Na}1, Bu4NI, THF, 64% (2 steps). (c) i. TFA:H20 
(4:1). ii. NaBH4, EtOH, 85% (2 steps). iii. 3 eq. MsC1, pyridine, 0°C. (d) Bu4NN3, DMF, 
60% (2 steps). (e) i. sodium hydrogen telluride, 75%, ii. H2, Pd-C, EtOH, quantitative. 
Several years later, a more practical and efficient synthesis was reported.36 This 
synthesis utilised only one isopropylidene protecting group, was completed in 5 steps 
























Reagents and conditions: (a) anhydrous CuSO4, acetone, 60%. (b) i. Tf20, DCM. ii, NaN31  
DMF, 0°C, 89% (2 steps). (c) MeLi, THF, -78°C, 97%. (d) H2, Pd-C, EtOH, 83%. (e) aq. 
TFA, quantitative. 
1.5.2 Chemoenzymatic syntheses 
As illustrated above, many of the chemical syntheses of azasugars have required 
multiple protection and deprotection steps resulting in multi-step routes and low yields 
of products. Several chemoenzymatic syntheses have been employed as practical 
routes to azasugars due to their high regio- and stereoselectivity with less emphasis on 
a protecting group strategy. Outlined below are some of the literature reports of 
azasugar synthesis utilising enzymes. 
1.5.2.1 Chemical-microbial synthetic approach 
An enzyme mediated step has been utilised in the synthesis of (+)-deoxynojinmycin 
(DNJ) 32, resulting in a 4-step synthesis of the azasugar from D-glucose.37  
Conversion of glucose to the benzyloxycarbonyl protected amine was performed and 
the product subjected to treatment with Gluconobacter oxydans which selectively 
oxidised the secondary hydroxyl function adjacent to the primary hydroxy group in the 
presence of the other hydroxyls. Subsequent intramolecular reductive amination gave 
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Reagents and conditions: (a) i. Raney Ni, NH3(1), MeOH, H2. ii. PhCH2000C1, H20, pH 8-
10. (b) Gluconobacter oxydans, 02, quantitative. (c) H2, Pd-C, MeOHIH20, 75%. 
1.5.2.2 Use of aldolases 
Aldolases are enzymes capable of catalyzing an aldol condensation and have been used 
in the preparation of azasugars to introduce more than one stereogenic centre.38'39 The 
example given in Scheme 6 employs fructose 1 ,6-diphosphate aldolase (FDP-aldolase) 
to generate 2 chiral centres in one step with control of relative and absolute 
configuration.40 The triols 33 and 34 are then dephosphorylated using a phosphatase 





























Reagents and conditions: (a) Escherichia coli Zn2 FDP-aldolase. (b) i. acid phosphatase. 
ii. H2, Pd-C. 
Introduction 
1. 5.2.3 Manipulation of cyclohexadiene-cis-diols 
Another short synthesis of mannojirimycin 5, was achieved via enzymatic 
hydroxylation of chlorobenzene followed by a stereoselective amination and oxidative 
cleavage,41'42 (Scheme 7). 
Scheme 7 
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Reagents and conditions: (a) Pseudomonas putida (39D). (b) i, 2,2-DMP, pTSA, DCM. 
ii. mCPBA, DCM. (c) i. LiC1, MeCOCH2CO2Et, ii. NaN3, DMF. (d) 03 -78°C, MeOH; 
NaBH4. (e) i. PMe3, THF-H20. ii. 90% aq. TFA. 
1.5.3 Alternative asymmetric syntheses 
Recently, a considerable amount of attention has been focused on the asymmetric 
synthesis of homochiral azasugars by utilising different precursors and asymmetric 
techniques. Outlined below are just a few of the approaches that have been developed. 
1.5.3. 1 Utilising hetero-Diels-Alder cycloadditions 
The hetero-Diels-Alder reaction has been employed as the key step in the synthesis of 
azasugars,43 for example (+)-fuconojirimycin, (+)-allonojirimycin and their 1-deoxy 
derivatives.44 Scheme 8 illustrates the synthetic route to (+)-DFJ. Reaction of the 
diene acetal 35 with the chioronitroso dienophile 36 gave the cycloadduct 37 after N-




























Reagents and conditions: (a) i. MeOH, HC(OMe)3. (b) i. PhCH2CO2C1, ii. 0s0, NMO, 
acetone:H20, 35% (2 steps) (c), i. Tf20, pyridine, 95%. ii. BuNOBz, toluene. iii. Na2CO3, 
MeOH, 58% (2 steps). (d) i. H2, Pd-C. ii. SO2, H20, 42% (2 steps). iii. Ba(OH)2, H20. iv. 
H2, Pd-C, H20, quantitative. 
A similar approach to potent glycosidase inhibitors 5-methyltrihydroxypyrrolidines has 
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1.5.3.2 Use of kinetic resolution to afford a flexible building block 
An efficient method for the kinetic resolution of ct-furfuryl amide using a modified 
Sharpless asymmetric epoxidation reagent has been used to afford chiral building 
blocks suitable for the synthesis of many types of alkaloids4648 and is illustrated for 
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Reagents and conditions: (a) i. Ti(O'Pr)4, L-(+)-DIPT, TBHP, silica gel, CaH2, DCM. (b) i. 
HC(OEt)3, BF3.OEt2, THF, 0°C. 76%. ii. NaBH4, CeC13.7H20, MeOH, -30°C, 72%. iii. 
DEAD-TPP, PhCO2H, THF, 92%. (c) NaBH4, HCO2H, 0°C, 87%. (d) i. (DHQ)2-PHAL, 
0s04, K3Fe(CN)61  K2CO3, tBuOH-H20, 85%. ii. Ac20, DMAP, pyridine, 100%. (e) BBr3, 
DCM, -78°C, 72%. (f) Na-naphthalene, DME, -60°C, 51%. 
1.5.3.3 Fromaminoacids 
There are surprisingly few syntheses of azasugars which employ natural amino acids 
as starting materials. Examples of the main strategies are outlined below. 
i. From serine 
Dondoni et al. ,495 1 have synthesised several azasugars from L-serine, including (-)-
nojirimycin via a thiazole intermediate acting as a protected aldehyde, (Scheme 10). 
Addition of the stabilised carbonylphosphorane 38 to the aldehyde derived from L-
serine, gave the E-enone which underwent cis-dihydroxylation to gave a mixture of 
diols (86:14, anti:syn) separable by column chromatography. Stereochemically 
controlled reduction of the carbonyl gave the required diastereomer (ds >95%) 
followed by a one pot thiazoyl-to-formyl unmasking procedure to reveal the aldehyde 
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Reagents and conditions: (a) i. Boc2O, 1,4-dioxane, 0°C, pH 10. ii. CH2N2, ether, 0°C, 80-
90% (2 steps). iii. 2,2-DMP, pTSA, benzene, reflux. iv. DIBAL, toluene, -78°C, 76%. (b) 
i. 38, toluene, reflux, 90%. (c) 0s04, NMO, 'BuOH, 1120, 60%. (d) 2,2-DMP, pTSA, 
benzene, reflux, 94%. (e) i. NaBH4, MeOH, 60°C, 96%. ii. TBSC1, imidazole, DMF, -80°C, 
85%. iii. Mel, MeCN, reflux, 82%. iv. NaBH4, MeOH. v. HgC12, MeCN, 1120,82% (2 
steps). (f) aq. TFA, 80%. 
Altenbach and Himmeldirk52 also utilised L-serine to synthesise a dihydropyridine 
derivative 40 as a key intermediate for use as a building block for the synthesis of 
azasugars, the strategy is outlined in Scheme 11. 
Finally, Dalton et al.,53 also applied L- and D-serine as precursors for the synthesis of 
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40 	 1 -deoxy-allonojirimycin 
Reagents and conditions: (a) i. HCCCO2Et, nBuLi, THE, HMDT, -90--35°C. ii. BzC1, - 
50°C. (b) Lindlar catalyst, EtOAc, quinoline. (c) i. Ether/H20/TFA (1:1:3). ii. EtOAc, sat. 
aq. NaHCO3. (d) 6 steps. 
ii. From vinyl glycine methyl ester 
A strategy for the synthesis of 2-hydroxymethyl-3-hydroxypyrrolidines was 
developed using a ruthenium catalysed olefin methathesis as key step for ring 
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Reagents and conditions: (a) i. PhCH2000C1, NaHCO3, H20, DCM, 45%. ii. LiBHI, 
MeOH, ether, 81%. (b) NaH, DME, then BrCH2CH=CH2, 92%. (c) i. NaOH, H20, EtOH, 
reflux. ii. Boc20, Et3N, DCM, 82%. (d) C12(PCy3)2Ru=CH-CH=CPh2 (4 mol%), benzene, 
95%. (e) i. Ph3CC1, DMAP, Et3N, DCM, 93%. ii. mCPBA, ether, 75%. (0 i. LiBH4, MeOH, 
diglyme, 150°C, 85%. ii. HCL, MeOH, 90%. 
iii. From L-alanine 
Polt and Sames55 synthesised (-)-deoxyfuconojirimycin 7, utilising a Schiff base 
protection of the chiral a-amino ester derived from L-alanine. Stereoselective C-C 
bond formation with chelation control followed by further functionalisation gave (-)-
DFJ in 20% yield in 8 steps from the alanine Schiff base 42, (Scheme 13). 
Scheme 13 




























Reagents and conditions: (a) Ph2C=NH, DCM, 93%. (b) i. 'Bu5Al2H, ii. Li-CH=CH-
CH2OTBS, 70%, (2 steps). (c) i. Pivolyl protection, (no details given). ii. K2OsO2(OH)4, 
K3Fe(CN)61 K2C031 tBuOHJH20, 70%. iii. TBAF, THF, 99%. (d) TEMPO, NaOC1, 
DCMIH20. (e) NaBH3CN, HOAc, H201 pH 5, 75-80% (2 steps). (1) i. nBu4NOH, 1,4-













1. 5.3.4 Additional non-carbohydrate based precursors 
Asymmetric synthesis of azasugars have been successfully developed utilising 
precursors other than those mentioned above, for example diethyl tartrate5658, myo-
inositol,59'60 and very recently from achiral building blocks such as dihydropyran.61  
Other groups have proceeded via ring opening operations on bis-aziridines62 and also 










2.1 RETROSYNTHETIC ANALYSIS OF THE TRISUBSTRATE 
ANALOGUE 26 
An initial disconnection in the retrosynthetic analysis of the target molecule 26 is 
illustrated in Scheme 14. Disconnection of the C-O and P-O bonds connecting the 
sugar and GDP moieties reveals an azasugar with a bis-hydroxymethyl unit, a sugar 
and a GDP residue. 
Scheme 14 
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It was envisaged that formation of the glycoside-azasugar bond could be achieved by 
SN2 displacement by the primary hydroxyl function of 27 of an appropriate leaving 
group on the glycoside donor, sugar-X.64 
33 
Retrosynthes:is 
Assembly of the GDP moiety is well established and can be achieved by initial 
phosphitylation of the primary hydroxyl function at C-2 (using a suitable hydroxyl 
protected derivative of 27) with dibenzyl, NN-diisopropyl phosphoramidite and 1H 
tetrazole, followed by oxidation with meta-chloroperbenzoic acid.65 Birch reduction to 
remove the benzyl groups would then allow coupling to GMP-morpholidate under 
standard conditions. 66,67 
A further disconnection of the bis-hydroxymethyl piperidine 27 at the N-C2 bond 
reveals an acyclic system 43 containing 5 contiguous stereocentres, whereby ring 
formation may result from attack of a nucleophilic amine onto an electrophilic carbon, 
(Scheme 15). 
Scheme 15 
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Previous work within the group involved a study of the ring closing ability of an 
acyclic unfunctionalised amine onto an electrophilic carbon species as a potential route 
to piperidiné formation.68 Initially, a 6-exo-trig cyclisation was investigated utilising 
different nitrogen protecting groups, (Scheme 16a). Mercury (II) metal cation mediated 
cyclisation was attempted using mercuric acetate and mercuric trifluoroacetate but none 
of the desired piperidine was observed (X = HgOAc or HgOCOCF3). Intramolecular 
cyclisation of the N-Tosyl protected amino alkene was effected smoothly by treatment 
with the organoselenium reagent N-phenylselenophthalimide (N-PSP) to give the 
cyclised product (X = SePh) in excellent yield (92%). Unfortunately, oxidation of the 
C-Se bond to a C-O bond proved problematic and only proceeded in 27% over 2 
steps. 
An intramolecular 6-exo-tet cyclisation of an amine onto a gem-disubstituted epoxide 
was also investigated, (Scheme 16b). Cyclisation was effected only in the presence of 
the Lewis acid, boron trifluoride etherate (BF3.OEt2) and only with the N-Tosyl 
protected amine in a yield of 56%. Use of other Lewis acids (TiC14) and bases (NaH, 
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P = COEt, CO2But, CO2Bn, COMe, COCF3, S02Bn, Ts. 
From these model studies it was proposed that a route to the fünctionalised piperidine 
27 could be developed by an intramolecular 6-exo-tet cyclisation of an N-Tosyl 
protected amine onto a disubstituted epoxide 44, (Scheme 17). 
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Due to the complexity of the functionalised azasugar 27, a simplified azasugar 
(-)-deoxyfuconojirimycin 7 was the target for initial synthesis. (-)-DFJ contains four 
of the required stereocentres of 27 and it was envisaged that development of a 













Despite the previous syntheses of DFJ26'36 the project aim was to devise a route to the 
azasugar from simple acyclic starting materials and incorporate the stereochemistry in 
the synthesis. This strategy not only allows extension of the synthesis to the key target 
molecule 27 but also allows analogues of key intermediates and products to be 
synthesised with minor manipulation of the synthetic strategy, thereby providing a 
wide range of substrates for assay as potential inhibitors of cx( 1 ,3)-FucTs. 
2.2 RETROSYNTHESIS OF DE0xYFuc0N0JI1UMYcIN 
The presence of the amino functionality and the absolute configuration of the adjacent 
methyl group in both the simplified azasugar 7, and the ultimate target 27, suggested 
the use of the natural amino acid L-alanine 50 as a precursor. A retrosynthetic analysis 
of 7 is illustrated in Scheme 18. 
The initial disconnection of the N-C6 bond reveals an amino aldehyde 46 which is 
anticipated to undergo nucleophilic attack by the nitrogen followed by reduction to 
produce the piperidine ring 7. Three functional group interconversions from the 
aldehyde 46 leads to the acetylene 49 via a triol 47 and allylic alcohol 48. 
Disconnection of the C3-C4 bond in 49 reveals two fragments, an cc-amino aldehyde 
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K SYNTHESIS OF 
DE0xYFuc0N0JIRIMYcIN 
Work on the approach to DFJ from an acyclic precursor had commenced68 in the latter 
months of doctorate research by Richard Cameron at the University of Exeter. As 
illustrated in section 3. 1, despite success with the initial steps, problems were 
encountered later on and the route was not completed. The initial task in this body of 
research was to repeat and scale up the steps already implemented and continue with 
the synthesis of DFJ. 
3.1 CONTINUATION OF ONGOING RESEARCH 
3.1.1 Chiral induction of the second stereocentre 
The precursor used for this synthesis was the readily available N-tert-butoxycarbonyl-
L-alanine (N-Boc-L-alanine) 51 and the strategy is outlined in Scheme 19. 
Scheme 19 
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Reagents and conditions: (a) MeONHMe.HC1, N-methyl piperidine, MeOCOC1, DCM, - 
42°C—*r.t., 78%. (b) LiA1H4, THF, ether, -65°C, 82%. (c) 54, MeMgI, ether, -78°C, 62%. 
(d) 2,2-DMP, BF3.OEt2, acetone, 68% 
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The aldehyde N-Boc-L-alaninal 53 was prepared by adaptation of a literature method 
by Goel et al.69 This procedure involved formation of the N-methyl-N-methoxy amide 
52 (known as a Weinreb amide) by initial activation of the amino acid 51 with methyl 
chloroformate followed by displacement of the mixed anhydride with N,O-
dimethyihydroxylamine. Reduction of the Weinreb amide 52 to the a-amino aldehyde 
53 was effected using lithium aluminium hydride in TI{F/ether in 82% yield and both 
compounds 51 and 52 were consistent with reported literature.70 
Preparation of the tert-butyldimethylsilyl ether 54 was achieved by treatment of the 
readily available propargyl alcohol 50 with tert-butyldimethylsilyl chloride and 
catalytic imidazole in pyridine. The addition of the acetylene 54 to the a-amino 
aldehyde 53 was adapted from a procedure by Hanson and Lindberg7' who reported 
the addition of vinylmagnesium bromide to N-Boc-L-phenylalaninal resulting in a 














At -78°C in THF, a mixture of syn- and anti~ were obtained in a ratio 56:44 
respectively and in a yield of 66%. An improvement in selectivity was observed in 
favour of the Cram-chelation controlled product (syn) on performing the reaction at 
room temperature. At the higher temperature it was proposed that a higher proportion 
of NH protons would be removed to form the Cram-transition state as shown in 
Figure 27 prior to the aldehyde carbonyl addition, resulting in preferential formation of 






Results and Discussion 
Application of this methodology to favour formation of the desired amino alcohol 55a 
was implemented. Initially the corresponding Grignard reagent of the acetylene 54 
was prepared (MeMgI, ether, reflux) and 2 equivalents added to N-Boc-L-alaninal 53 
at low temperature resulting in an inseparable mixture of n-amino alcohols 55a1b 
(62%). The ratio of diastereomers was relatively low (2:1) as determined by the ratio 
of the a-methyl signals in the 'H nmr spectrum and very little difference in selectivity 
was observed by repeating the reaction at room temperature. As a consequence, the 
reaction was subsequently performed at low temperature to avoid any possible 
racemisation and unwanted side products. In addition, the reaction was carried out in 
ether rather than THF due to the insolubility of the in situ generated Grignard reagent 
of 54 in THF. 
Previous attempts to improve this ratio of diastereomers in favour of the amino alcohol 
55a by using other acetylene additions or asymmetric reductions of a chiral a4-
acetylenic ketone failed to provide an improved system.68  
Separation of the f3-amino alcohols 55a1b was achieved by formation of the 
corresponding oxazolidines 56 and 57 (2,2-DMP, BF3.OEt2, acetone72) and column 
chromatography. 'H nmr nOe experiments were performed on both the oxazolidines to 
verify the stereochemistry of the newly formed stereocentres and the results are 
















The nOe enhancements, which result from through space interactions, suggest that the 
protons Ha  and Hb  in the oxazolidine 56 are anti- to each other due to the small 
percentage enhancement (2%) observed compared to that in oxazolidine 57 (10%). 
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Further evidence for the anti- relationship in 56 is depicted between Ha  and Me where 
an enhancement of 6% was observed while in the diastereomer 57 no enhancement 
was recorded due to the distance between the relative groups. 
Using the methodology developed by Cameron68 the above reactions were performed 
with the yields quoted. A considerable amount of time was spent in the early months 
of this project scaling up these initial 4 steps and as a result, all have been performed 
successfully on a large scale ranging from 15-25g of substrate in acceptable yields. 
The only obstacle encountered in the scale up was the time consuming separation of 
the oxazolidine diastereomers 56 and 57, which required several column 
chromatography steps in order to obtain pure product. 
3.1.2 Introduction of the hydroxyl functionality 
The next steps in the proposed route to DFJ 7 required the introduction of two 
hydroxyl groups into the major oxazolidine 56 which already contained two of the 
required four stereocentres. This route was still that initially performed by Cameron 
and it was along this pathway that problems were encountered. 
Reduction of the acetylene function of 56 to the Z-alkene was achieved under 
hydrogenation conditions in the presence of the Lindlar catalyst. Although Cameron 
reported the need for quinoline as a poison to prevent any over reduction, it was found 
that there was no need for this additive as the reaction proceeded in excellent yields 
(>90%) with no observed side products. Removal of the silyl protecting group was 
achieved under standard conditions of tetrabutylammonium fluoride in TI-IF to give the 
Z-allylic alcohol 58, (Scheme 20). 
It was envisaged that epoxidation of the Z-alkene and epoxide ring opening would 
allow the two hydroxyl groups to be introduced but initial attempts by Cameron to 
epoxidise the Z-alkene 58 asymmetrically utilising the Sharpless epoxidation 
conditions failed to give any significant amount of desired product 59 after 3 weeks 
(10-20%). Further attempts using meta-chloroperbenzoic acid gave epoxides 59 and 
60 in an overall yield of 78% after 6 days but with no selectivity of epoxide 
formation.68 It was evident from an attempt at this same reaction in this project, that 
the epoxidation was indeed slow due to the slow depletion of the starting material 
when monitored by tic after 3 days, hence the reaction was abandoned. This slow rate 
of reaction was attributed to the electron deficient nature of the alkene. 
41 
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Scheme 20 
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Reagents and conditions: (a) i. Lindlar catalyst (Pd on CaCO3), H2, hexane, 94%. ii, 
TBAF, THF, 77%. (b) mCPBA, DCM. 
3.1.3 Conclusion 
Although this route to DFJ showed potential in the early stages, the low selectivity and 
yield of the epoxidation prevented continuation of this synthetic pathway. As a result a 
new route was undertaken to introduce the remaining stereochemistry. 
3.2 REVISED APPROACH To DE0xYFuc0N0JI1UMYCIN 
To utilise some of the methodology already developed in the previous synthesis, it was 
anticipated that introduction of the two remaining stereocentres could be effected via 
formation of the E-alkene from the oxazolidine 56, which would then align the system 
for a syn-dihydroxylation. The product from this strategy would include all the 
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functionality required and ring cyclisation could then be effected to produce DFJ 7. 
Scheme 21 illustrates the proposed route. 
Scheme 21 
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3.2.1 Acetylene reduction to an E-allylic alcohol 
There are several ways of reducing acetylenes to E-alkenes73 among which are 
dissolving metal reductions-sodium/liquid ammonia,74 use of low valent transition 
metal ions such as chromium sulfate75 and use of hydride reducing agents. 
The mechanism of hydride reduction of simple propargylic alcohols has been reported 
by Grant and Djerassi using lithium aluminium hydride.76 These results illustrated that 
reduction of the propargyl alcohols in THF gave essentially products due to E-
reduction, but in ether a second product was often isolated and identified as the Z-
alkene. Grant and Djerassi proposed a mechanism for the two solvent dependent 
pathways for the reduction under these conditions and this is shown in Figure 29. 
After formation of the 0-Al bond, intramolecular hydrogen transfer occurs resulting in 
the formation of the transition states 61a or 61b. In weak Lewis basic solvents like 
ether, the lithium counter ion is readily available to stabilise the developing anionic 
charge in the transition state 61a. In the strong Lewis basic solvent THF, the 
developing anionic centre would not be stabilised by the lithium counter ions due to 
solvation and would result in an energetically favoured configuration with the greatest 
charge separation, as depicted in 61b. Hydrolysis of these transition states would then 
occur with retention of configuration to give the Z- and E-isomers, respectively. 
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Figure 29 
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To apply this methodology, the silyl protecting group in the oxazolidine 56 was 
cleaved under standard conditions (TBAF, THF) and the resulting propargylic alcohol 
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Reagents and conditions: (a) TBAF, THF, 90%. (b) LiA1H4, THF, -78°C, 90%. 
Verification of E-alkene formation was obtained from the 'H nmr spectrum which 
revealed the alkene protons in the region 65-6 with characteristic coupling patterns and 
vicinal coupling of J 15.5 Hz. As initially predicted no Z-alkene was observed and in 
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addition no products resulting from attack of the hydride reagent at the carbonyl of the 
N-Boc group was observed. 
3.2.2 Syn-dihydroxylation 
A stereoselective syn-dihydroxylation of the E-alkene was envisaged to introduce the 
two remaining hydroxyl groups as illustrated in Scheme 23. 
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Top face attack of the reagent on the E-alkene 62 or 63 is required to give the diol 
with the appropriate stereochemistry for DFJ (64 or 65). Several attempts at this step 
were performed and the outcome is outlined below. 
3.2.2. 1 Use of catalytic osmium tetraoxide 
The reaction of osmium tetraoxide (0s04) with an alkene is undoubtedly the most 
reliable method for a syn-dihydroxylation of the double bond and has been used 
extensively throughout organic chemistry for many years. At the turn of the century it 
was discovered that osmium tetraoxide could be used catalytically in the presence of a 
secondary oxygen donor such as sodium chlorite avoiding the use of osmium 
tetraoxide in stoichiometric quantities which is impractical due to its high cost and 
toxicity. Since then several other oxidising agents have been used in conjunction with 
osmium tetraoxide for the catalytic oxidation of alkenes, and these include hydrogen 
peroxide, sodium hypochlorite, and one of the most used to date, N-methyl-
morpholine-N-oxide77 (NMO). 
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The overall result of 0s04 addition to an alkene in the presence of NMO is shown in 
Figure 30. The osmium tetraoxide adds to the alkene to form an osmate ester species 
which then undergoes hydrolytic cleavage of the Os-0 bonds to yield the syn-diol. 
Regeneration of the osmium tetraoxide occurs by oxidation of the osmic acid formed in 
the hydrolysis, by the co-oxidant. Due to the large steric requirements of the osmium, 
reactions take place predominately from the least hindered side of the double bond. 
Figure 30 
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Osmylation of the allvlic alcohol 62 
Treatment of the E-allylic alcohol 62 under the conditions of catalytic osmylation in 
acetone/water with NMO gave a mixture of diastereomers 64 and 66 in a combined 
yield of 84%. The ratio of diastereomers was determined by comparison of the integral 
intensities of the oxazolidine methyl doublets (ö 1.3) in the 'H nmr spectrum, and 
suggested a ratio of 3:1. Separation by column chromatography gave the diastereomers 
64 and 66 in a similar ratio. 
Two key factors allowed tentative assignment of the major triol. The initial factor takes 
into consideration the bulky osmium reagent which with the alkene 62 adds to the top 
face of the alkene due to steric crowding of the lower face, and the second factor is 
based on studies performed by Kishi and co-workers78 One of the conclusions 
resulting from Kishi' s research stated that "the relative stereochemistiy between the 
pre-existing hydroxyl or alkoxy group and the adjacent newly introduced hydroxyl 
group of the major product in all cases is ervthro ". Consequently, it was predicted that 
the major diastereomer formed from osmylation of the alkene 62 is the triol 64. 
Although the ratio of diastereomers 64:66 was low, it was not unexpected and 
correlated well to experimental results reported by Kishi. On the basis of these same 
results by Kishi it was anticipated that an improvement in the ratio may have been 
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possible through use of stoichiometric osmylation conditions, however the high 
toxicity and cost of this reagent far outweighed its use for a slight improvement in 
diastereomer ratio. 
Osmvlation of the E-alkene 63 
An attempt to improve on the selectivity produced in the osmylation of alkene 62 was 
undertaken after a recently published report by Sames and Polt55 illustrated two 
dihydroxylation procedures en route to DFJ 7, both of which are outlined in Figure 
31. The stereochemical outcome was as that predicted by Kishi78, however the 
diastereoselectivity of the products looked very promising with reported ratios ranging 
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Reagents and conditions: (a) K20s02(OH)4, K3Fe(CN)6, K2CO3, tBuOH, H2O. (b) Ac20, 
pyridine or MOMC1, pyridine. 
Hence, the allylic alcohol 62 was initially protected by treatment with tert-
butyldimethylsilyl chloride and imidazole/DMF to furnish the TB S-ether 63 and then 
subjected to the conditions used by Polt. Unfortunately, both the diastereomers 65 and 
67 were again obtained in a ratio of 3:1 and combined yield of 77%, therefore 
showing no improvement from osymlation of the allylic alcohol 62. 
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3.2.2.2 Osmium catalysed asymmetric dihydroxylation (AD) 
An attempt to asymetrically dihydroxylate the E-alkene 62 was undertaken using the 
Sharpless asymmetric dihydroxylation procedure involving the use of AD-mixes.79-81  
These pre-mixed formulations contain 0.2 mol% K20s02(OH)4 as a non-volatile 
source of 0504, 3 mole equivalent of co-oxidant K3Fe(CN)6 and K2CO3,  and 1 mol% 
of the chiral ligand. The two mixes known as AD-mix-a and AD-mix-P differ in 
















A mnemonic device for predicting the enantiofacial selectivity in the reaction has been 
derived from extensive studies and is shown in Figure 33a. In this mnemonic device, 
the southeast quadrant and northwest (to a lesser extent) present steric barriers but the 
northeast is relatively open for olefin substituents of moderate size. The southwest 
quadrant is regarded as being an 'attractive' site - well suited to accommodate flat, 
aromatic substituents or large aliphatic groups. 
Asymmetric dihydroxylation of the E-alkene 62 represents a 'double asymmetric 
synthesis' which concerns the interaction of two homochiral reactants, the substrate 
and reagent. For olefins with an allylic heteroatom it can be predicted which 
combination of reagents will constitute a "matched" or "mismatched" pair by 
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employing the mnemonic device in conjunction with the Kishi78 rules. As a result, it 
was predicted that use of the AD-mix-[3 containing the (DHQD)2-PHAL as chiral 
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A representative example of a double diastereoselection of an olefin reported by 
Morikawa and Sharpless82 is shown in Figure 34. In the matched case, the phthalazine 
ligand (DHQD)2-PHAL gave the diastereomers 72 and 73 in a ratio of 39:1 
respectively, and in the mismatched case with ligand (DHQ)2-PHAL a ratio of 1:1.3 
respectively was obtained. Both these results were obtained with use of the standard 
AD-mix conditions, hence these conditions were applied to the E-alkene 62 in the 





Alkene 62 was treated with the AD-mix-P81 and 1 mole equivalent of methane 
sulfonamide in tert-butanol/water at 0°C for 10 hours then at room temperature for a 
further 24 hours. Monitoring the reaction by tic gave early indications of product 
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formation but little difference after 34 hours. Work up followed by column 
chromatography gave recovered starting material and product 64/66 (20%), and 'H 
nmr spectrum unfortunately suggested a ratio of the diastereomers (3:1) similar to that 
achieved by the catalytic osmylation conditions without the ligand. 
This was disappointing due to above literature precedent, but it was noted that other 
examples of double diastereoselectivity79'80 used quantities of potassium osmate and 
chiral ligand exceeding that in the commercial AD-mix. It was suggested that chelation 
of substrate substituents to the osmate (VI) ester may cause suppression of the 
reaction, but an increase in both reagent concentrations alleviated this problem. This 
increase in ligand and osmium concentration is referred to as the "Super AD-mix". 
Despite this literature precedent the super AD-mix was not utilised on the E-alkene 62 
as it was anticipated that only the rate of reaction would be increased and not 
necessarily the diastereoselection due to a possible incompatibility of the substrate and 
the chiral osmium species in the reaction. 
3.2.2.3 Use of catalytic ruthenium tetraoxide 
Ruthenium tetraoxide (Ru04) has been used as an oxidant for many organic 
transformations such as oxidative fissions of olefins to give carbonyl compounds, 
acetylenes to give 1 ,2-diketones and for the oxidation of primary alcohols. 
Dihydroxylation of olefins to syn-diols with catalytic ruthenium tetraoxide was 
observed to proceed in a biphasic solvent system of ethyl acetate, acetonitrile and water 
(ratio 3:3:1). In the presence of 0.07 mole equivalent RuC13.(H20)3 and 1.5 mole 
equivalent of sodium periodate (in situ generation of Ru04) syn-dihydroxylation 
occurred within minutes with only minor products due to oxidative fission of the 
alkene.83'84 Treatment of the E-alkene 62 under the conditions reported by Shing, 
followed by rapid quenching of the reaction mixture after 3 minutes gave recovered 
starting material and product (30%). 'H nmr analysis of the diastereomeric triol 
mixture again suggested a ratio of 64 and 66 of 3:1, hence showing no improvement. 
A minor product was also isolated from the reaction mixture and this indicated that 
oxidation of the primary alcohol in 62 had occurred resulting in an a-13-unsaturated 
aldehyde. 
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3.2.2.4 Summary of the 5yn-dihydroxylation 
The best overall process of the syn-dihydroxylation of the E-alkene 62 resulted from 
the use of catalytic osmium tetraoxide with NMO as co-oxidant in acetone and water. 
This reaction has been performed on a scale ranging from 0. 1  - 2.6g of alkene with 
very little difference in the yield obtained, and in most cases more than the required 1 
mol% of osmium tetraoxide was used due to the difficulties in handling and weighing 
such small quantities of the reagent. 
The osmylation reaction on the silyl protected alcohol 63 by in situ generation of the 
osmium tetraoxide with the use of the co-oxidant potassium ferricyanide showed no 
advantage over that of the above case, and use of ruthenium tetraoxide on alkene 62 
gave low yield of product with no increase in selectivity and also indicated the 
presence of undesired side products. 
Improvements on the asymmetric dihydroxylation using the AD-mixes could have 
been attempted by employing different temperature or allylic alcohol protecting groups, 
and also by repeating the reaction with the AD-mix-(x for comparison. However, due 
to the amount of time spent on this reaction step as a whole it was decided not to 
implement these but to continue the synthesis. 
Additional points 
The high field 1H nmr spectrum of the major triol diastereomer 64 was improved by 
simply changing from deuterated chloroform (CDC13) to deuterated methanol 
(CD30D). Broad signals observed in CDC13 were much sharper in CD30D and 
coupling patterns were very clear. As a result full assignment of all signals was 
achieved aided by a 1H-'3C correlation spectrum. Attempts to improve the broad and 
complex spectra of the minor triol 66 in a similar manner failed due to insolubility of 
the isomer in CD30D, and also decomposition of the isomer when left at room 
temperature overnight or after being dissolved in solvent for any period of time. 
Significantly less decomposition was observed for the major diastereomer 64 under 
similar conditions. 
The major diastereomer 64 was also subjected to acetylation conditions (Ac20, 
pyridine) to verify triol formation and aid in the characterisation of the compound, 
(Scheme 24). 
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Clean formation of the acetylated triol 74 was achieved and full data analysis obtained. 
3.2.3 Selective oxidation of a primary alcohol 
There are very few efficient methods for the selective oxidation of primary alcohols 
over secondary alcohols.85'86 
TEMPO (2,2,6,6-tetramethylpiperidinyl- 1 -oxy, 77a) a nitroxyl radical species, has 
emerged as a mild oxidant used catalytically with bleach as co-oxidant. Semmelhack87 
proposed that the oxoammonium salt 75 reacts with alcohols forming the 
corresponding carbonyl compound and hydroxylamine 76. Syn-proportionation 
between 75 and 76 affords two molecules of nitroxyl 77a, which is then oxidised 
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Results and Discussion 
Figure 36 
The basic reaction conditions consist of 1 mol% TEMPO 77a, 10 mol% potassium 
bromide and 5 mol% of a phase transfer catalyst in a bi-phasic mixture of DCM-sat.aq. 
NaHCO3, followed by addition of sodium hypochiorite (30% excess) buffered at —pH 
8. The acidic conditions use para-toluenesulfonic acid in DCM with 2 equivalents of 
(acetylamino)-TEMPO 77b as preferred oxidant due to the precipitate of the resultant 
hydroxylaniine salt and therefore ease of work up. 
There is some inconsistency in the use of TEMPO as oxidant due to the observation of 
some over-oxidation to the carboxylic acid, but it seems to depend highly on the 
reaction conditions and substrate used. Secondary alcohols can also be oxidised using 
TEMPO but may require longer reaction times and is also dependent on the sterical 
demand of the alcohol, for example in a substrate containing both a primary and 
secondary alcohol, the primary should be oxidised more readily unless steric factors 
are involved. A TEMPO mediated oxidation of such a case proved successful in the 
synthesis of DFJ by Sames and Polt55 and is illustrated in Chapter 1, Scheme 13. The 
basic conditions used were adapted from a earlier report by Skarzewski and co-
workers.90 Under these conditions, no over-oxidation of the substrates was observed. 
The selective oxidation of the primary alcohol in the triol 64 (Scheme 25) was 
therefore attempted using these conditions. Benzyltrimethylammonium chloride 
(BTAC) was used as the phase transfer catalyst and sodium bromide replaced 
potassium bromide. 
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After slow addition of the buffered bleach to a vigorously stirred mixture at 0°C and 
continued stirring for a further 30 minutes, the bi-phasic mixture was warmed to room 
temperature extracted with DCM and washed with sat. aq. NaHCO3. Optimised 
reaction conditions gave a crude product which was isolated as a solid in yields 
ranging from 80%-quantitative. Tlc analysis was of little use in detecting product 
purity due to streaking on the plate, and the 'H nmr spectrum was unclear due to broad 
signals. The '3C nmr spectrum was also difficult to assign due to presence of various 
contaminants but it was noted that the CH2 signal of the precursor triol 64 had 
disappeared as would be expected. In addition, no aldehydic signal was observed but 
this is not uncommon in aldehydes due to oligomerisation and hydration of the 
carbonyl. 
It was assumed aldehyde 78 resulted from the TEMPO oxidation after repetitions 
produced consistent results, hence the crude product was used directly in the next 
sequence of reactions to obtain a cyclised product. 
3.2.4 Piperidine ring formation 
It was anticipated that removal of the nitrogen protecting group in aldehyde 78 to give 
the free amine, would allow ring closure by nucleophilic attack to occur (Scheme 26). 
Several deprotection conditions were attempted with unexpected results. 
Initially, it was proposed that a selective deprotection of the acetonide leaving the Boc 
protecting group intact would result in formation of the piperidine 79a, but treatment 
of the crude aldehyde 78 with Amberlyst 120H in aqueous methanol72 failed to give 
little more than starting material after 7 days. 
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Scheme 26 
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Treatment with aqueous trifluoroacetic acid at room temperature for 30 minutes to 
effect cleavage of both the Boc and acetal protecting groups gave base line material 
with loss of starting material when monitored by tic. The 'H nmr spectrum of the 
freeze dried residue was complex although there was evidence of some coupling 
patterns. Acetylation of this residue with acetic anhydride, DMAP and pyridine to 
simplify the spectra and aid characterisation of the piperidine as 79b gave a product 
albeit in very little quantity (2 mg). 'H nmr analysis initially looked promising with 
sharp coupling patterns typical of a cyclised product, but one major drawback was the 
observation of only three acetate signals instead of the predicted four, and a coupling 
pattern different to that expected for the per-acetylated fuconojirimycin 79b. Repetition 
of this procedure was performed and an acetylated product similar to that previously 
obtained was isolated but again in small yield (6 mg after use of 100 mg of precursor 
64). 
Full nmr data was obtained on this isolated product including COSY and decoupling 
spectra. Nominal and accurate mass spectra and infra-red data were also collected to 
try and assign a structure to this product which was obviously not the piperidine 79b. 
As mentioned previously, only three acetate signals were present in the proton nmr, 
but on accumulation of the '3C nmr spectrum it was noted that four carbonyl signals 
were present in the region 8 168-170. This was confirmed by a unidentified carbonyl 
stretch at 1800 cm' in the infra-red spectrum in addition to a stretch at 1752 cm' 
which is due to the acetate carbonyl groups. 
Taking into consideration all the above factors and after thorough analysis of the 
COSY and decoupling spectra, it was suggested that the isolated product was the 
lactone 80. The structure was consistent with the accurate mass of the molcular ion 
(C.I.) which gave a MH ion with m/z 288.10832 (calculated 288.10830). 
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This lactone formation was unexpected due to the literature precedent on the 
trifluoroacetic acid deprotection and ring closure to azasugars like nojirimycin and 
mannojirimycin from aldehydes,50 hence it was proposed that the lactone may result 
from problems in the TEMPO-mediated oxidation. A proposed mechanism to justify 
lactone formation is outlined in Figure 37. The mechanism suggests that initial 
oxidation of the primary alcohol does occur in the TEMPO reaction but is then 
followed by a rearrangement resulting in the intermediate lactol 81 which contains an 
imine functionality which is subsequently trapped out by the secondary alcohol as 
indicated to give a 5-6 membered ring system. Further oxidation of this lactol produces 
the lactone which undergoes deprotection of the Boc and acetonide functions in 
trifluoroacetic acid, and acetylation to give the isolated lactone 80. 
Figure 37 
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Suggestions that over-oxidation of the aldehyde 78 to produce the carboxylic acid may 
occur in the TEMPO oxidation of triol 64 were dismissed due to several factors. 
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Firstly, the basic aqueous work up following the TEMPO reaction would remove any 
acid formed; secondly, tic analysis did not indicate any acid formation when developed 
using a bromocresol blue stain which is characteristic of carboxylic acids; finally, no 
over oxidation was observed by Polt who utilised identical conditions, albeit on a 
different substrate. 
3.2.5 Route modification 
From the problems encountered in the previous route due to oxidation of the primary 
alcohol and subsequent rearrangement involving a free secondary hydroxy group, it 
was anticipated that protection of the secondary hydroxyl functionality would prevent 
this sequence of events and result in preferential formation of the piperidine product. 
3.2.5. 1 Hydroxyl protection strategy 
Protection of the primary alcohol functionality in triol 64 with tert-butyldimethylsilyi 
chloride in DMAP/pyridine or in imidazolefDMF failed to give the TBS-ether 65 in 
yields greater then 36%, however treatment with the more reactive tert-
butyidimethyisilyl triflate and 2,6-lutidine in DCM gave 65 in good yield (75%), 
(Scheme 27). 
Scheme 27 
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Reagents and conditions: (a) TBS-triflate, 2,6-lutidine, DCM, -10°C, 75%. (b) 2,2-DMP, 
BF3.OEt2, acetone, 85%. (c) TBAF, THF, 80%. 
Protection of the two secondary alcohols as the acetonide using catalytic para-toluene 
sulfonic acid in DCM gave very little product 82, but was effected by treatment with 
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the previously used conditions for oxazolidine formation (2,2-DMP, BF3.OEt2, 
acetone72) in excellent yield. Cleavage of the silyl protecting group was achieved by 
use of tetrabutylanimonium fluoride in THF to give the alcohol 83, with the 
appropriate hydroxyl functions protected. 
3.2.5.2 Alcohol oxidation and ring closure 
Oxidation 
Oxidation of the unprotected alcohol in the substrate 83 to the corresponding aldehyde 
84 was now targeted as a precursor to a cyclised product, (Scheme 28). Several 
reagents were utilised in order to effect this oxidation and are outlined below. 
Scheme 28 
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The first reagent of choice was tetra-n-propylammonium perruthenate (TPAP) and was 
selected due to successful oxidation of alcohols by colleagues. TPAP9192 is a mild 
catalytic oxidant used in conjunction with NMO as co-oxidant and gives the 
corresponding carbonyls from a wide range of primary and secondary alcohols 
without racemisation of adjacent chiral centres. Treatment of the alcohol 83 with 5 
mol% TPAP, 1.5 equivalent NMO in DCM and crushed molecular sieves gave 2 
products, both very complex especially in the high field region ö 1-2 of the 'H nmr 
spectrum and in very low yields. 
An attempt using Swern oxidation conditions93 (DMSO, oxalyl chloride, Et3N) 
surprisingly gave only recovered starting material, but it was later suspected that the 
reagents used were of poor quality. 
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The third reagent to be used was the precursor to the Dess-Martin reagent, o-




Alcohol 83 in DMSO was added to a solution of IBX in DMSO and stirred at room 
temperature for 48 hours before work-up. Tic analysis indicated streaking on the plate 
and a crude 'H nmr spectrum of the residue revealed a complex spectrum although an 
aldehydic proton in the low field region was observed. It also illustrated some 
similarities to one of the fractions obtained in the TPAP oxidation. 
The oxidant that finally proved successful was the nitroxyl radical TEMPO 77a 
(section 3.2.3) in which the alcohol 83 was subjected to the basic reaction conditions 
as employed earlier in the synthesis,90 and monitored by tic. Early indications showed 
starting material diminishing as the bleach solution was added, and after complete 
addition no starting material was observed. Isolation of the crude mixture was 
performed and subjected to nmr and mass spectral analysis. The 'H nmr spectrum 
although complex, did show an aldehyde proton at 8 9.6 and coupling patterns in the 
region 8 3.5-4.5 resulting from the methine protons. The high field region 8 1-2 was 
complicated and indicated a high number of proton signals with respect to the lower 
field signals, an effect due to possible oligermerisation of the aldehyde. The '3C nmr 
spectrum was surprisingly clear and all signals were fully assigned, including a 
carbonyl signal at ö 199. Aldehyde formation was also verified by infra-red spectra 
which showed a characteristic carbonyl stretch at 1735 cm' alongside the tert-
butoxycarbonyl stretch at 1688 cm'. 
Comparison of this 'H nmr spectrum to those obtained in the TPAP and IBX 
oxidations showed similarities in all, but the TEMPO mediated oxidation product was 
significantly cleaner and higher yielding than the previous oxidations. 
Derivitisation of the aldehyde 84 as the diethyl acetal 85 was achieved albeit in low 
yield (40%), (Scheme 29). Sufficient characterisation was obtained to reinforce the 
assumption that the aldehyde was formed in the TEMPO oxidation and optimisation of 
the conditions was not required. 
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With conclusive evidence that aldehyde 84 had been formed, the following steps 
involved removal of the nitrogen protecting groups to allow the nucleophilic attack to 
commence. 
Subjection of aldehyde 84 to 90% aqueous trifluororacetic acid50 for 30 minutes 
followed by removal of the solvent under reduced pressure, was expected to give the 
cyclised piperidine 79c as the free base after ion exchange chromatography. To aid 
identification of the product the residue was taken up in pyridine and acetylated using 
acetic anhydride to yield 79b. On inspection of the 1H nmr spectrum it was evident 
that the expected piperidine 79b had not been formed, but a compound with proton 
signals resembling that of the lactone 80. Other impurities were also present which 
were difficult to remove by column chromatography due to insufficient separation and 
streaking and as a result this compound was not characterised. 
Other acidic deprotections which also were unsuccessful included para-toluene 
sulfonic acid in methanol51 at 50°C in an attempt to form the piperidine 79d, but 
resulted in a multispot mixture when monitored by tic. Use of 1M and 3M 
hydrochloric acid in EtOAc in an attempt to produce 79c resulted in crude residues that 
exhibited complex 1H nmr spectra although did suggest cleavage of the Boc and acetal 
protecting groups due to the absence of these peaks. Attempts to isolate an acetylated 
product 79b from one of these residues by treatment with acetic anhydride in pyridine 
gave a multispot mixture by tic and as a result was not purified. 
Unsuccessful formation of azasugars 79b-d by use of the above acidic conditions 
resulted in an attempt to form a bisulfite adduct of the azasugar from the aldehyde 84. 
There is a significant amount of literature on the formation of the bisulfite adducts en 
route to azasugars such as nojirimycin, deoxynojirimycin and mannojirimycin,59'95-97 
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and it was hoped that application of this methodology to the aldehyde 84 would prove 
successful. 
Sulfur dioxide in water produces sulfurous acid (H2S03) which was predicted to 
cleave the Boc and acetal groups in the aldehyde 84 to give the bisulfite adduct 87 via 
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The procedure was adapted from a report by Dondoni and Perrone51 and involved 
saturation of an ice-cold solution of the aldehyde 84 in water with sulfur dioxide gas 
and continued stirring at 40°C for 2 days. In the first trial, dilution of the mixture after 
2 days with methanol and re-saturation with sulfur dioxide at 0°C failed to give any 
precipitate as anticipated. Removal of the solvent under reduced pressure did result in a 
off white solid, but the yield was very high (>100%) and the presence of more than 
one product was evident in the complex nmr spectra. 
This procedure was repeated on the diethyl acetal 85 which would give in situ 
generation of the aldehyde under the acidic conditions. Addition of methanol again 
gave no precipitate and a crude 'H nmr spectrum of the residue after removal of the 
solvent was similar to that obtained in the first case. Attempts to precipitate the bisulfite 
adduct were tedious but ultimately successful when a solid (6 mg, 25% from 85) was 
collected after addition of methanol to the crude mixture in water at 0°C. 
High field (600 MHz) 'H nmr illustrated detailed coupling patterns and NOESY and 
decoupling experiments gave conformational information which is summarised in 
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Figure 38. It must be stressed that only one diastereomer of the bisulfite adduct 87 
was formed in the reaction and is confirmed to be that shown in Figure 38 due to the 
observed large coupling constant J 10.5 Hz between the two protons depicted as H1 
and H2  - a characteristic value for axial-axial proton interactions. 1D-NOESY 
experiments performed on the adduct 87 also suggested the molecule to be in the chair 
conformation shown i.e. 'C4 in which the majority of substituents are equatorial as 
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Further data such as 13C nmr and infra-red spectra were collated and found to correlate 
well to the literature values for the bisulfite adduct of D-fuconojirimycin.44 Optical 
rotation could not be performed due to insufficient material. 
Although a route to a cyclic precursor of deoxyfuconojirimycin had now been 
established, the yield was low due to isolation problems. After several further attempts 
using the crude aldehyde 84 as substrate, optimum conditions were achieved resulting 
in precipitation of the bisulfite adduct after 2 days at 40°C. Filtration of the solid 
followed by treatment of the mother liquors with methanol and sulfur dioxide resulting 
in a second batch of solid, gave the bisulfite adduct 87 in an overall yield of 66% from 
the aldehyde 84. It was concluded that precipitation of the product was highly 
dependent on the concentration of the aldehyde in water at the beginning of the reaction 
and also the amount of methanol added to the mother liquors may have been crucial for 
maximum isolation of product. 
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An optical rotation was now attempted due to the availability of sufficient material but 
to no avail due to a possible contaminant which would not allow the machine to 
register a value. This was unexpected due to the observed purity in the nmr spectra, 
but CHN analysis of the same material also failed to give results within the excepted 
limits. 
Deoxvfuconojirimvcin 
It is well documented that hydrolysis of bisulfite adducts using Dowex ion-exchange 
resin produce the corresponding azasugars with an anomeric hydroxyl group, whereas 
saponification with barium hydroxide followed by hydrogenation (H21  Pd-C, H20) 
yields the deoxy-azasugars. Application of this latter procedure59 to the bisulfite 
adduct 87 (Scheme 31) gave a product in 86% yield after cation exchange resin. 'H 
and '3C nmr spectra were exceptionally clear and exhibited sharp coupling patterns 















Reagents and conditions: (a) Ba(OH)2.8H20, H2O. (b) Pd-C, H2, H20, 86% (2 steps). 
The 250 MHz 'H nmr spectrum of the product L-deoxyfuconojirimycin 7 is shown in 
Figure 39. The spectrum highlights the sharp coupling patterns characteristic of the 
azasugar but also indicates the presence of an impurity with a small coupling pattern in 
the region 1.3-1.5, and an attempt to separate this impurity from the product by 
performing a second purification step through the ion exchange resin failed. 
Despite this impurity, unequivocal assignment of this isolated product as L-
deoxyfuconojirimycin 7 was obtained by polarimetry whereby the recorded optical 
rotation was consistent with the literature value, [aID
21  -48.3 (c 0.46, H2O), lit. [aI20 D - 
48.8 (c 0.64, H20).26 
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Figure 39 
Is 4.0 	 3.6 	 PPM 	
2.5 	 20 	 i0 
Formation of DFJ provided conclusive evidence that the tentative assignment of 
stereochemistry during the synthetic pathway was accurate, and also confirmed that no 
epimerisation of the a-methyl group had occurred under any of the conditions utilised 
in the synthesis. 
3.2.5.3 Alternative ring closure via an SN2  displacement 
A simultaneous ring closing sequence that was implemented alongside the above route 
involved the replacement of the primary alcohol in 83 with a halogen in order to align 
the system for an SN2  displacement to effect cyclisation as illustrated in Scheme 32. 
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This was effected by formation of the alkyl iodide 88 by treatment of the alcohol 83 
with triphenyiphosphine, iodine, and imidazole in ether/acetonitrile.98 The mechanism 
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The iodo compound 88 was isolated in 45% yield along with recovered starting 
material on the first and only attempt at this reaction. Addition of this electron 
withdrawing group into the molecule was evident in the 'H nmr spectrum where a 
dramatic separation of the low field proton signals now illustrated an ABX system of 
the CH2 signal, and sharp coupling patterns of the methine protons. The '3C nmr 
spectrum also confirmed product formation due to a characteristic high field methylene 
signal at 8 7.8. 
An attempt to convert this iodo-compound 88 to DFJ 7 by removal of the protecting 
groups was implemented by treatment with aqueous trifluoroacetic acid at room 
temperature. Analysis by tic after 4 hours indicated starting material, but after 24 hours 
only baseline material was observed. The trifluoroacetic acid was removed under 
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reduced pressure and the crude mixture subjected to 'H nmr spectroscopy. The 
resulting spectrum showed no evidence of a cycised product and very little 
information was available from the spectrum to assess the actual outcome of the 
reaction. No other data was collected due to the small scale on which the reaction was 
performed and due to the sucessful formation of DFJ 7 by the approach via the 
bisulfite adduct 88. 
33 SUMMARY OF THE SYNTHESIS OF DFJ 
A synthesis of L-deoxyfuconojirimycin 7 has been completed in 14 steps from the 
commercially available N-Boc-L-alanine 51. Scheme 33 outlines the pathway that was 
developed for the synthesis. 
Scheme 33 
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Reagents and conditions: (a) i. MeONHMe.HC1, N-methyl piperidine, MeOCOC1, DCM, - 
420C—r.t., 78%. ii. LiA1H4, THF, ether, -60°C, 82%. (b) i. 54, MeMgI, ether, -78°C, 62%. 
ii. 2,2-DMP, BF3.OEt2, acetone, 68%. (c) i. TBAF, THF, 90%. ii. LiA1H41 THF, -78°C, 
90%. (d) 0s04, NMO, acetone, H20, 84%. (e) i. TBS-triflate, 2,6-lutidine, DCM, -10°C, 
75%. ii. 2,2-DMP, BF3.OEt2, acetone, 85%. iii. TBAF, THF, 80%. (f) i. TEMPO, NaOC1, 
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DCM, 0°C. ii. SO2, H20, 40°C, 66% (2 steps). (g) i. Ba(OH)2.8H20, H20. ii. H21  Pd-C, H201  
86% (2 steps). 
Inhibitory activity of bisulfite adducts of nojirimycin and mannojirimycin and the 
corresponding deoxyazasugars have been determined against several glycosidases 
although they possess different activities with respect to their parent deoxyazasugar.59 
Thus, both the bisulfite adduct 87 and DFJ 7 were synthesised in sufficient quantities 
to be assayed for inhibition of an a(1,3)-FucT-Vll by Genzyme Ltd., to observe any 
similar activity pattern. Unfortunately, at a concentration of 200 j.tM no inhibition of 
the enzyme was observed by either substrate suggesting an IC50 value well out of 
useful potency range and no further studies were performed. 
3.4 SYNTHESIS OF DEOXYFUCONOJIRIMYCIN ANALOGUES 
An initial proposal in the design of a synthetic pathway to DFJ was the potential 
extension and manipulation of the route for the preparation of a range of analogues. 
Outlined below is a synthesis that was undertaken using a minor diastereomer from the 
DFJ synthesis, and also some proposed manipulations that could be effective in 
producing a wide range of synthetic azasugars. 
3.4.1 Attempted synthesis of a DFJ azasugar analogue 
The synthesis of an azasugar analogue of DFJ was attempted by extension of the 
minor triol diastereomer 66 resulting from the osmylation of the E-alkene 62 (Scheme 
23). The synthetic pathway paralleled that used in the route to DFJ and exhibited 
promising results in the early stages as illustrated in Scheme 34. 
The triol 66 was converted to the protected primary alcohol 90 under similar 
conditions as in the previous synthesis, and oxidation to the aldehyde 91 proved 
successful. Treatment of the aldehyde 91 with sulfur dioxide gas in water for 2 days 
failed to result in a precipitate, and addition of methanol also had no effect. Removal of 
the solvent gave a residue which exhibited a complex 'H nmr with no evidence of the 
bisulfite adduct 92. Several attempts to precipitate the product failed hence the residue 
was subjected to saponification with barium hydroxide followed by catalytic 
hydrogenation in an attempt to give the azasugar 93. The 1H nmr spectrum of the 
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Reagents and conditions: (a) i. TBS-triflate, 2,6-lutidine, -10°C, DCM. ii. 2,2-DMP, 
BF3.OEt2, acetone, 62% (2 steps). (b) TBAF, THE, 80%. (c) TEMPO, NaOC1, DCM, 0°C, 
83%. (d) SO2, H2O, 40°C. (e) i. Ba(OH)2.8H20, H201  ii. Pd-C, H2O. 
As reported in the previous synthesis of DFJ, precipitation of the bisulfite adduct 87 
was crucial for isolation of pure product. Problems in the precipitation of the adduct 
92 may be due to two factors; 1) the concentration of the substrate 92 in the solvent 
was too dilute; and 2) the difference in stereochemistry of this adduct may result in a 
difference in properties. Taking into consideration this second factor a comparison 
between the two bisulfite adducts 87 and 92 is depicted in Figure 41. 
If the conformation of the bisulfite adduct 92 is depicted in the 'C4 conformation, as in 
the case for 87 it will contain 3 axial hydroxyl groups which will result in a higher 
energy conformer than 87, however if positioned in the 4C1 conformation- the bulky 
methyl and sulfur groups are then axial and will pose large steric interactions. This 
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energy barrier and steric interactions may have a significant effect on the properties of 
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This synthesis of the azasugar 93 was not repeated due to time constraints and the lack 
of the diastereomer 66 due to the significant decomposition of this triol diastereomer. 
3.4.2 Potential manipulations for analogue generation 
Although time did not permit the manipulation and extended syntheses of other L-
deoxyazasugar analogues, Figure 42 illustrates some possible transformations that 
could be performed from intermediates or minor diastereomers from the above 
methodology. Some of the azasugars shown overleaf have been previously 
synthesised by Streith and Defoin43 in both the racemic form and asymmetrically to 
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Additionally, by utilising the D-alanine amino acid precursor N-Boc-D-alaninal, an 
asymmetric synthesis of a range of D-azasugars could be performed via a similar 
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I: 1 ,5 -imino- 1 ,5,6-trideoxyglucitol, (glucose derivative); II: (talose derivative); ifi: 
(gulose derivative) 
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4.1 EXTENSION OF THE ROUTE USED IN THE SYNTHESIS OF 
DFJ 
4.1.1 Proposed route 
The aim of the project after the deoxyfuconojirimycin synthesis was to extend and 
elaborate the synthetic pathway to allow further functionalisation to yield the key target 
molecule 1,1 -bis-hydroxymethyl- 1 ,5-dideoxy- 1 ,5-imino-L-fucitol, 27. 
A proposed route to the polyhydroxylated piperidine 27 utilising some of the 
methodology from the synthesis of DFJ is outlined in Scheme 35 and illustrates the 
extension of the synthesis from the oxazolidine 56. 
The initial synthetic challenge involved removal of the N-Boc protecting group in the 
oxazolidine 56 and N-sulfonation to give the N-Tosyl amide 94. The N-Tosyl 
protecting group is necessary for a 6-exo-tet cyclisation to be implemented later in the 
pathway for piperidine ring formation as described in section 2.1. It was anticipated 
that introduction of the hydroxyl groups could be achieved by initial formation of the 
E-alkene followed by a syn-dihydroxylation to give the trio! 96 using conditions 
optimised in the previous synthesis. The first of the two hydroxymethyl groups was 
anticipated to be introduced by treatment of aldehyde 97 with [(methoxymethyl) 
methyl]lithium generated in situ from [(methoxymethyl)methyl]tributylstannane and n-
butyllithium.99101 The second hydroxymethyl group would be generated after 
cyclisation of the tosylated nitrogen group onto the epoxide 99 to give the 
polyhydroxylated piperidine 100. 
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Scheme 35 
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4.1.2 Nitrogen protecting group manipulation 
Removal of the N-Boc protecting group was required to enable reprotection of the 
nitrogen with the tosyl group. Standard acidic deprotection conditions of 3M 
hydrochloric acid in EtOAc or trifluoroacetic acid were implemented on the minor 
oxazolidine diastereomer 57 to achieve optimum conditions and to avoid unnecessary 
depletion of stocks of the major diastereomer 56, (Scheme 36). Attempts using 3M 
hydrochloric acid in EtOAc and subjecting the crude residue to tosyl chloride with 
catalytic DMAP in pyridine failed to give any product due to the low solubility of the 
residue in the solvent. Repetition of the reaction using different tosylation conditions 
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(TsC1, Et3N, DCM) did give a white solid as product albeit in moderate yield (56%). 
Nmr spectroscopy of the isolated product was performed in deuterated DMSO and the 
'H nmr spectrum illustrated sharp coupling patterns with characteristic coupling 











Reagents and conditions: i. 3M HC1, EtOAc, ii. TsC1, Et3N, DCM (56% 2 steps); or i. 
TFA, 0°C. ii. TsC1, Et3N, DCM, 1,4-dioxane, (51% 2 steps). 
An attempt to cleave the Boc group using trifluoroacetic acid followed by tosylation 
(TsC1, Et3N, DCM) gave 101 but in low yield (25%), until it was noted that addition 
of 4 equivalents of triethylamine in the second step improved the yield of product to 
44%. Use of 1,4-dioxane as co-solvent in a repeat of tosylation conditions improved 
the yield of isolated product to 51% with only 2 equivalents of triethylamine due to 
increased solubility of the substrate in the mixed solvent. 
Two attempts to form the corresponding oxazolidine 102 by treatment of 101 with. 
2,2-dimethoxypropane and boron trifluoride etherate in acetone (Scheme 37) only 
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Reagents and conditions: 2,2-DMP, BF3.OEt2, acetone. 
Conclusion 
As a result of obtaining the tosylated product 101 in low-moderate yields and difficult 
formation of the corresponding oxazolidine 102, this route to the poiyhydroxylated 
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piperidine 27 was abandoned without application of the methodology to the major 
diastereomer 56. The low yield of tosylated product could be due to the polar nature of 
the resulting amine which under the conditions used also cleaves the silyl protecting 
group to reveal the free hydroxyl group. Continuation of the synthesis at this stage 
seemed impractical when considering the number of steps ahead. 
Thus, a novel route to the target molecule 27 was developed to enable a more 
convergent synthesis to be performed whilst incorporating some of the methodology 
so far developed. 
4.2 REVISED ROUTE To 1,1-BIs-HYDR0xYMETHYL-1,5-
DmEoxY- 1,5-IMINO-L-FucIToL 
4.2.1 Proposed route 
A retrosynthetic analysis of the target molecule 27 is outlined in Scheme 38 and 
highlights the key disconnections and functional group interconversions that could be 
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Disconnection of the N-C and C-C bonds reveals two fragments - the u.-amino 
aldehyde 53 which is available from N-Boc-L-alanine 51, and a polyhydroxylated 
fragment 103. Functional group interconversions of 103 yields the epoxy-acetylene 
104 which in turn can be derived from the a,-acety1enic ketone 105. A further 
disconnection of 105 gives two synthons 106 and 107 as shown. 
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A synthetic pathway proposed from this retrosynthetic analysis is descibed in Scheme 
39 and involves the construction of the acetylene unit containing one of the 
hydroxymethyl substituents required, before addition to N-Boc-L-alaninal 53. 
Although a protecting group strategy is required to enable orthogonal deprotection, 
further functionalisation will then be possible utilising methodology from the synthesis 
of DFJ. This pathway fulfils the aim of the project by retaining the flexibility to allow 
preparation of analogues en route to the target molecule 27 by minor manipulations of 
the synthetic route. 
Scheme 39 
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4.2.2 Synthesis of the acetylene unit 
The readily available and inexpensive precursor for the assembly of the acetylene unit 
is ethyl glycolate 108. Protection of the free hydroxyl group in ethyl glycolate as the 
benzyl ether 109 was effected by treatment with benzyl bromide and silver (I) oxide in 
refluxing ether102 (Scheme 40). Attempts using benzyl bromide under various other 
conditions such as sodium hydride/tetrabutylammonium iodide/THF, sodium 
hydridefDMF, potassium carbonate/acetone gave little or no desired product. 
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Reagents and conditions: i. BnBr, A920, ether, reflux, 82%. ii. DIBAL (1M in toluene), 
DCM, -78°C, 60%. iii. Bis-trimethylsilyl acetylene, MeLi:LiBr, THF, 0°C, 75%. 
Reduction of the ester 109 to the aldehyde 110 was then attempted using di-
isobutylaluminium hydride (1M solution in toluene) in DCM.103 On small scale (<ig) 
the aldehyde was isolated after column chromatography in excellent yields of 80-90% 
with no evidence of any over reduction to the corresponding alcohol. Scale up of the 
reaction led to problematic work ups due to formation of a thick emulsion which 
required tedious separations and resulted in slightly reduced yields. Use of di-
isobutylaluminium hydride as a molar solution in DCM on small scale proceeded well 
however a significant impurity was present when visualised by tic and was difficult to 
separate from the product resulting in contamination of the aldehyde 110. 
Introduction of the silylacetylene unit to the aldehyde 110 was effected by initial 
displacement of a single trimethylsilyl group from bis-trimethylsilylacetylene using 
methyllithium in THF according to the procedure of Holmes et al. 104  Addition of 1.6-
1.8 equivalents of the mono-lithiated TMS-acetylene to the aldehyde 110 resulted in 
the racemic propargyl alcohol105 111 in good yields (70-80%). Use of 1.2-1.5 
equivalents of the lithiated acetylene resulted in lower yields (11-57%) of the propargyl 
alcohol 111. 
Hydroxyl protection 
Protection of the hydroxyl function in 111 was required before attachment of the 
acetylene unit to N-Boc-L-alaninal 53 to avoid any potential side reactions occurring at 
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the hydroxyl group. The tetrahydropyranyl ether (THP) was chosen as protecting 
group due to its stability towards basic reaction conditions and organometallic reagents 
yet potential cleavage under mild acidic conditions which prove ideal for the proposed 
pathway. The THP ether 112 was formed by treatment of the propargyl alcohol 111 
with 3,4-dihydro-2H-pyran and para-toluenesulfonic acid in DCM106 in 84% yield. 
The 1H nmr spectrum was complex due to the resultant diastereomers but in 
conjunction with the '3C nmr spectrum it was evident that the THP ether had formed. 
Treatment of the THP ether 112 with methanolic potassium carbonate105 cleaved the 
trimethylsilyl group to give the terminal acetylene 113 in 90% yield. 
Scheme 41 
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Reagents and conditions: i. 3,4 dihydro-2H-pyran, pTSA, DCM, 84%. ii. K2CO3, MeOH, 
90%. iii. N-Boc-L-alaninal 53, nBuLi, THF, -100°C, 56%. 
Two equivalents of the terminal acetylene 113 were then treated with n-butyllithium in 
THF at low temperature to form the corresponding lithium acetylide, and N-Boc-L-
alaninal 53 added dropwise in THE After several minutes the reaction was quenched 
and extracted at room temperature to yield, after chromatography, the recovered 
terminal acetylene 113 and 3-amino alcohol 114 (56%). Unfortunately, due to the 
presence of 4 stereogenic centres in the isolated product 114 the 1H and 13C nmr 
spectra were complex and although the product was verified as that expected, the ratio 
of the diastereomers formed in this step could not be deduced due to the complexity of 
the spectra. 
This route showed promise in that the two units, the acetylene 113 and the a-amino 
aldehyde 53 could be combined by the acetylide addition, however the poor choice of 
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hydroxyl protecting group was evident and the resulting products 114 could not be 
characterised fully by nmr due to the high number of stereocentres. As a result of this 
it was anticipated that a different protecting group strategy which would simplify the 
spectra would allow the synthesis to continue. 
Carbonyl protection 
The stereocentre in the racemic propargyl alcohol 111 was removed by oxidation to 
the a,3-acetylenic ketone 115 utilising the TEMPO-mediated oxidative procedure,90 
(Scheme 42). Protection of the ketone as the 1,3-dioxolane was chosen due to its 
stability under basic conditions and cleavabiity under acidic conditions which were 
again ideal for the proposed synthetic route. The ketal 116 was obtained in favourable 
yields after treatment of the aj3-acetylenic ketone 115 with ethylene glycol and 
trimethylsilyl chloride in DCM.107  
Scheme 42 
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Reagents and conditions: i. TEMPO, NaOC1, BTAC, NaBr, sat. aq. NaHC031  sat. aq. NaCl, 
DCM, 0°C, 97%. ii. HOCH2CH20H, TMSCI, DCM, 88%. iii. K2CO3, MeOH, 93%. 
Removal of the trimethylsilyl group of 116 in methanolic potassium carbonate gave 
the terminal acetylene 117 in excellent yields, use of tetrabutylammonium fluoride in 
THF also gave the acetylene 117 albeit in lower yields. 
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4.2.3 Acetylide addition to N-Boc-L-alaninal 
Addition of the achiral acetylene 117 to the prochiral a-amino aldehyde 53 was 
investigated more thoroughly than the similar reaction performed in the DFJ synthesis 
(Chapter 3, Scheme 19). It was anticipated that by utilising different metals and 
solvent systems the ratio of the resulting b-amino alcohols 118 a/b could be improved 
in favour of the desired diastereomer 118a which contains the required 
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The f3-amino alcohol 118a is expected to result from Cram-chelation control in the 
transition state (Figure 43), whereas non-chelation control is anticipated to proceed via 
the Felkin-Ahn model where the most stable conformation of the transition state is 
proposed to be that where the largest group is orthogonal to the plane of the carbonyl 
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Due to the presence of the nitrogen group in 53 it was anticipated that chelation control 
would be possible hence favouring the formation of the syn-adduct 118a. 
Literature precedence for the addition of acetylenes to aldehydes has highlighted that 
several factors can influence the diastereoselectivity of such reactions, e.g. solvent, 
counter-ion, the nature of the ligating group, and also the nature of the nucleophile. 108-
111 Consequently, a series of reactions were performed using different addition 
methods according to literature procedures to effect formation of the n-amino alcohols 
118a/b and these are outlined below; 
Method 1. Addition of the lithium acetylide in THF112 
i. 117, nBuLi, THF, -78°C. ii. N-Boc-L-alaninal 53, THE 
Method 2. Addition of the lithium acetvlide in ether 
as method 1, in ether. 
Method 3. Addition of the Grignard acetylide formed via transmetallation113  
i. 117, nBuLi, THF, -78°C. ii. MgBr2. iii. N-Boc-L-alaninal 53, THE 
Method 4. Addition of the Grignard acetvlide in THF at room temperature114 
i. 117, EtMgBr, THF, O°C-r.t. ii. N-Boc-L-alaninal 53, THF, r.t. 
Method 5. Addition of the Grignard acetylide in THF at low temperature 
i. 117, EtMgBr, THF, O°C-*r.t. ii. N-Boc-L-alaninal 53, THF, -78°C. 
Method 6. Addition of the Grignard acetylide in THF at low temperature- different 
addition71'109 
i. 117, EtMgBr, THF, O°C-r.t. ii. N-Boc-L-alaninal 53, THF, -78°C. 
Method 7. Addition of the copper acetylide108'115  
i. 117, EtMgBr, THF, O°C-3r.t. ii. Cul, Me2S, THF, -78°C. iii. N-Boc-L-alaninal 
53, THF, -30°C. 
Method 8. Addition of the zinc acetvlide108"° 
i. 117, nBuLi, THF, -78°C. ii. ZnBr2. iii. N-Boc-L-alaninal 53, THF, -78°C. 
The results obtained are shown in Table 1. 
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Table 1 
Method' Metal Solvent Temp' Yieldc(%) 118a:118bd 
1 U THF -78°C 55 78:22 













5 MgBr THF -78°C 59 90:10 
6 MgBr THF -78°C 77 86:14 
7 CuT THF -78°C 44 74:26 
8 ZnBr THF -78°C 18 - 
a  2.2 equivalents of the acetylene 117 was used in each case. b  The temperature stated is 
that on addition of the acetylene and N-Boc-L-alaninal. c  The combined yield of 13-amino 
alcohols liSa and 118b isolated after column chromatography of the crude mixture, is 
given as a percentage of the amount of N-Boc-L-alaninal 53 used in the reaction. d  The 
ratio of diastereomers was determined by HPLC using a Baker Chiralcel OD (4.6 x 250) 
column and detected by a Waters 486 tunable absorbance detector (? 254 nm). The 
column was eluted with 95:5 hexane/IPA at a flow rate of 0.2 ml/min. 
The ratio of diastereomers was deduced by HPLC analysis of the combined 
diastereomer mixture obtained after column chromatography of the crude mixture to 
remove unreacted starting material and other impurities. A representative sample of the 
HPLC chromatograms obtained is shown in Figure 44 and highlights that even after 
chromatography some impurity is still present. The ratio of the two isomers was 
determined by the area difference of the corresponding peaks and two examples are 
given for comparison in Figure 44 and correspond to the lowest and highest ratio of 
diastereomers obtained resulting from method 2 and 5 respectively. 
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Figure 44 
(1) 
RT  = Peak 1, 67 minutes 
Peak 2, 79 minutes 
In the methods 1-7 utilised for the [3-amino alcohol 118 formation it was evident from 
the HPLC chromatograms that the same diastereomer dominated, i.e. no interchange 
of the corresponding peaks 1 and 2 in the chromatograms was observed. 
Consequently, it was proposed that the major diastereomer was that resulting from 
Cram-chelation control in the transition state hence yielding the desired 0-amino 
alcohol 118a. The configuration of the major diastereomer was confirmed as that for 
the [3-amino alcohol 118a as descibed later in section 4.2.4.1. 
Table 1 highlights some interesting aspects. Initially, the lithium acetylide addition 
(method 1) was attempted as a model system as it is known to show low 
diasteroselectivity when added to chiral a-alkoxy aldehydes."° Even so, addition of 
the a-amino aldehyde 53 to the in situ generated lithium acetylide produced a moderate 
diastereomeric excess (78:22). The influence of solvent in these type of reactions was 
highlighted by a drop in diastereoselectivity (70:30) when the same reaction was 
performed in ether (method 2). 
An improvement in diastereoselectivity was observed by use of the corresponding 
Grignard acetylide at low temperature. Different methods using the Grignard acetylide 
were employed which included different addition modes (method 5 and 6), 
temperature (method 4), and formation of the in situ generated metal acetylide (method 
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3 and 5). Methods 3 and 5 which were essentially the same although involved slightly 
different ways of forming of the Grignard reagent, resulted in the best overall 
diastereoselectivity (90:10) of the resulting 3-amino alcohols 118aIb. Method 6 was a 
similar procedure to that utilised in the DFJ synthesis (Chapter 3, Scheme 19) and 
differed from method 5 only in the mode of addition, however a slight decrease in 
cliastereomer ratio was observed. An attempt to repeat method 5 in ether was 
abandoned due to the insolubility of the forming Grignard reagent in the solvent. 
The addition of the copper acetylide was attempted following a report by Herold 108  in 
which an acetylene unit was added to a N-Boc-serine derivative with very high 
selectivity via chelation control in the transition state. Application of this methodology 
to the acetylene 117 and N-Boc-L-alaninal 53 was performed but resulted in a low 
diastereoselectivity (74:26). The low selectivity was paralleled by experiments reported 
by Reetz and co-workers109 who concluded that vinyl and phenyl copper reagents 
produced lower diastereoselectivity on addition to a-amino aldehydes with respect to 
alkyl reagents, and although no alkynyl reagents were reported it was anticipated that 
these would parallel that of the vinyl type reagents. 
Method 8 employing the zinc bromide additive proved problematic due to the 
complexity of the reaction mixture when monitored by tic. A product corresponding to 
the amino alcohols 118a/b was isolated however the 'H nmr of the mixture was 
complex and contaminated hence the mixture was not subjected to HPLC analysis. 
Conclusion 
A satisfactory ratio of 13-amino alcohols 118a/b was obtained (90:10) in the 
procedures of method 3 and 5 and repetitions of the experiment were performed using 
the procedure in method 5 where N-Boc-L-alaninal was added to the Grignard 
acetylide (formed from ethylmagnesium bromide) in THF at low temperature. 
Repetitions of the reaction utilising method 3 were inconsistent and difficult to 
implement due to the insolubility of the magnesium bromide in THF and hence the 
difficult addition of the slurry to the reaction mixture. 
It is evident from both the HPLC and nmr spectra of the resulting 13-amino alcohols 
118a/b that little or no epimerisation of the a-methyl group has occurred under the 
conditions used in methods 1-7, which was also the case reported by Reetz.109 
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This study highlighted several key factors such as the effect of the solvent, 
temperature, metal and addition modes. An interesting effect that emerged from the 
experiments was the observed increase in selectivity between the addition of the 
acetylide of 117 (method 6 above) as compared to that of the acetylide of 54 (Chapter 
3, Scheme 19) using the conditions adapted from Hanson and Lindberg.71 Figure 45 


















Ratio (NMR) approx. 2:1 
O <O Me 	OBn 
BocHN 
OH liSa/b 
Ratio (HPLC) approx. 6:1 
This improvement in selectivity is proposed to result from a combination of effects 
including the increased size and functionality of the acetylene 117 with respect to that 
of 54 and the different solvent used, although the improved method of deducing the 
diastereomeric ratio would also result in a more accurate value. 
4.2.4 Continuation of the synthesis:- Hydroxyl and nitrogen 
protecting group manipulation 
Elaboration of the n-amino alcohols 118aTh was undertaken and proceeded via several 
different pathways due to unforeseen problems. This section will outline the attempted 
routes and the outcome. 
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4.2.4.1 Oxazolidine formation and nitrogen protecting group manipulation 
Oxazolidine formation 
It was anticipated that oxazolidine formation of the n-amino alcohols 118a/b would 
allow separation of the corresponding oxazolidines by column chromatography, hence 
enabling nmr experiments to be performed to confirm the configuration at the newly 
formed stereocentre and also to allow continuation of the synthesis on the single 
diastereomer 119, (Scheme 44). 
Scheme 44 
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Reagents and conditions: see Table 2. 
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Treatment of the mixture of 13-amino alcohols 118 under the conditions used 
previously for oxazolidine formation (2,2-DMPIBF3.OEt2/acetone) gave only a low 
yield of oxazolidine products 119/120 with recovered starting material 118a/b. This 
result was unexpected due to its previous success hence several other conditions were 
used and the results are summarised in Table 2. 
Nmr spectra of the isolated mixture of diastereomers although complex confirmed 
oxazolidine formation due to the presence of the two additional methyl signals in both 
the 'H and '3C nmr spectrum. 
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Table 2 
Reaction Conditions' Yield', % 
2,2-DMP, BF3.OEt2, acetone. 26 
2,2-DMP, BF3.OEt2, acetone, 4A sieves. 57 
2,2DMP, BF3.OEt2, DCM. 63 
2,2-DMP, BF3.OEt2, DCM, 4A sieves. 55 
2,2-DMP, pTSA. 44 
2,2-DMP, pTSA, DCM, reflux. 80 
reactions were performed using the same quantites of substrate (100mg), 2,2-DMP 
(1 .5m1), catalyst and solvent (2m1) at the temperature stated and were monitored by tic 
until no further reaction was observed. b.The  yield quoted is the yield of combined 
diastereomers 119 and 120 after column chromatography. 
Upon subjecting one of the combined oxazolidine 119 and 120 mixtures to HPLC 
analysis, an improvement in the quality of the chromatogram was observed with 
greater separation and lower retention time than seen for the precursor 118 a/b. The 
chromatogram also revealed an increase in ratio between the two oxazolidine 
diastereomers present with respect to that recorded on the corresponding starting 
material. This increase in diastereoselectivity suggested that formation of one 
oxazolidine was favoured, and a similar observation of increased diastereoselectivity 
was observed by Wagner and Mollath116 where oxazolidine formation of only one 
diastereomer from a mixture of two n-amino alcohols resulted under similar reaction 










Results and Discussion 
By comparing the anti- and syn-oxazolidines (Scheme 44) it was proposed that the 
anti-derivative 119 has a less strained ring conformation with respect to the syn-
derivative 120 which may result in faster formation of the former. 
To observe the diastereoselective enhancement in more detail - three of the f3-amino 
alcohols mixtures were subjected to identical conditions for oxazolidine formation 
(2,2-DMP, pTSA, DCM, reflux) and subjected to HPLC analysis. The results are 





Ratio' of 13- 
amino alcohol 





I Method 4 71:29 86 75:25 
II Method 5 90:10 83 94:6 
Ill Method 6 86:14 80 91:9 
aThe  starting material which resulted from the method as dipicted in Table 1. 'The ratio 
is as that reported in Table 1 .cThe  yield of combined oxazolidine 119/120 after column 
chromatography. d.The  ratio of the diastereomers 119/120 was determined by HPLC 
analysis using the same column and HPLC system as described in Table 1. The column 
was eluted with 90:10 hexane/IPA at a flow rate of 0.5 nil/min. 
The increase in diastereoselectivity is greatest (94:6) in case II which results from the 
amino alcohol 118a/b generated from method 5 in the previous section, although both 
the other two examples also showed an improved ratio of diastereomers after 
formation of the oxazolidines 119 and 120. The chromatograms of the resulting 
oxazolidines I-ill are shown in Figure 47. 
Unfortunately, efforts to separate the oxazolidine diastereomers by column 
chromatography failed as a suitable solvent system could not be found that would give 
sufficient separation of the compounds. Use of preparative HPLC analysis to aid 
separation was also investigated however an appropriate column could not be found. 
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Figure 47 
I = Oxazolidine mixture resulting from method 4 
II = Oxazolidine mixture resulting from method 5 
Ill = Oxazolidine mixture resulting from method 6 
R= Peak 1, 18 minutes 
Peak 2, 20 minutes 
Confirming the configuration of the anti-oxazolidine 119 
Due to the increased diastereoselectivity obtained in case II (Table 3) the product from 
this reaction was subjected to nmr nOe enhancement experiments to determine the 
configuration at the second stereocentre with respect to the a-methyl group. Figure 48 
highlights the percentage enhancements that resulted. 
The large enhancement between methyl and Ha  (15%) when compared to the small 
enhancement between methyl and Hb  (3%) suggests a strong through space interaction 
characteristic of a syn-relationship. No enhancement was observed between Hb  and  Ha 
confirming that the hydrogens Hb  and  Ha  have an anti- relationship with respect to each 
other. Although the minor diastereomer was not available for comparison of the nOe 
enhancements, these results correlate to those obtained for the anti- oxazolidine 56 in 
the DFJ synthesis. 
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Figure 48 
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Consequently, it was verified that the major product formed is the anti-oxazolidine 
119 which in turn results from syn-addition of the acetylene 117 to N-Boc-L-alaninal 
53 in the preceding reaction, as predicted. 
The synthetic pathway was now continued towards the target molecule 27 using the 
enriched samples of n-amino alcohol 118a and oxazolidine 119. Although the nmr 
spectra of these substrates indicated some signals due to the minor diastereomer, the 
relative proportion of this diastereomer was negligible and did not hinder assignment 
of the major diastereomeric products. Therefore, assignment and characterisation of 
compounds from this point onwards are quoted for the major isomer only, however 
optical rotations were not obtained on the compounds due to this contamination. 
Protecting group manipulation 
Removal of the N-Boc protecting group was now required to enable N-sulfonation to 
yield the N-Tosyl amide. Both 3-amino alcohol 118a and oxazolidine 119 were 
treated with acidic conditions followed by tosylation conditions in the anticipation of 
yielding the N-Tosyl amide 122, (Scheme 45). 
Employment of 3M hydrochloric acid in EtOAc required overnight stirring for both 3-
amino alcohol 118a and oxazolidine 119 substrates to be consumed when monitored 
by tic, yet neat trifluoroacetic acid or as a 1:1 mixture in DCM was effective in only 30 
minutes. 'H nmr spectroscopy was performed on the crude residue obtained from both 
the methods in the anticipation of obtaining the amine 121, and although loss of the 
Boc methyl signals was evident, both spectra were broad and complex. Several 
repetitions were performed using both sets of conditions but nmr spectra of the crude 
residues were inconsistent and as a result the signals were difficult to assign. 
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Scheme 45 
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Attempts to tosylate the products isolated from the acidic deprotection reactions using 
tosyl chloridelDMAP/pyridine or tosyl chloride/triethylaminelDCM gave varying 
mixtures ranging from baseline material to complex mixtures when monitored by tic. 
The highest yield obtained of the N-Tosyl amide 122 resulted from subjecting the 
oxazolidine 119 to neat trifluoroacetic acid, removal of the solvent in vacuo and 
treatment of the residue with tosyl chloride and triethylamine in DCMJ1,4-dioxane. 
The aniide 122 was isolated in a yield of 32% and was identified by the characteristic 
methyl and aromatic signals in both 1H and 13C nmr spectra. 
To aid confirmation of the intermediate amine 121, the 13-amino alcohol 118a was 
subjected to trifluoroacetic acid, the solvent removed under reduced pressure and the 
residue redissolved in acetic anhydride and pyridine in order to acetylate both the 
nitrogen and secondary hydroxyl group. After stirring overnight, a complex mixture 
was observed by tic but a product was isolated by column chromatography albeit in 
low yield (18%) and characterised as the diacetylated amino alcohol 123. The low 
yield of isolated product and complexity of the mixture observed in this reaction 
suggested that deprotection of the 13-amino alcohol 118a and oxazolidine 119 was not 
proceeding to yield the amine as well as had been expected. 








As a result of low formation of the amine 121 it was proposed that protection of the 
free hydroxyl group may aid the manipulation of nitrogen protecting group by 
blocking this site and also decreasing the polarity of the corresponding amine. 
4.2.4.2 Hydroxyl protection and nitrogen protecting group manipulation 
Use of an ester protecting group 
A protecting group that would be stable to the acidic conditions of N-Boc deprotection 
was required and after consideration it was decided to mask the hydroxyl group as the 
benzoyl ester, (Scheme 46). Benzoylation using benzoyl chloride in pyridine/DCM 
gave low yields of product (45-64%), but the yield was improved significantly by use 
of benzoyl chloride in triethylaminefDCM under anhydrous conditions (85-90%). The 
quality of the nmr spectra of the benzoate 124 were significantly improved in 
comparison to that of the precursor 118a and also showed very little evidence of the 
minor diastereomer present. 
Scheme 46 
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Removal of the N-Boc protecting group again proved problematic. Treatment of the 
benzoate 124 with 3M hydrochloric acid in EtOAc overnight followed by tosyl 
chloride and triethylamine in DCM resulted in a complex and streaky mixture when 
visualised by tic. Reaction with trifluoroacetic acid at 0°C gave baseline material and 
after removal of the solvent under reduced pressure the residue was taken up in DCM 
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and washed with sat. aq. NaHCO3 to remove any traces of acid. Two products were 
isolated after column chromatography. 
Nmr spectroscopy performed on the first product verified loss of the methyl signal 
corresponding to the Boc protons in the 'H nmr spectrum although initially it was also 
assumed that the benzoyl ester had been cleaved due to a shift to higher field of the 
methine signal adjacent to the ester function. This assumption was questioned by an 
infra-red spectrum which illustrated a carbonyl stretch at 1638 cm-'. After 
consideration of all the data obtained on the product it was evident that the compound 
obtained was the benzoyl amide 125 - which is postulated to result from migration of 
the benzoyl group from the oxygen to the nitrogen by a mechanism illustrated in 
Figure 49. 
Figure 49 
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Characteristic data of the benzoyl amide 125 included a broad OH signal in the 'H nmr 
spectrum and a sharp doublet at 8 6.41 corresponding to the amide proton. A low 
frequency carbonyl stretch and broad OH signal were also observed in the infra-red 
spectrum. 
The second product isolated from the reaction mixture also indicated loss of the Boc 
group in the 1H nmr spectrum yet suggested that the benzoyl ester was still intact due 
to very little shift of the adjacent methine doublet observed at ö 5.77 when compared to 
the precursor 124. Assignment of this structure was achieved by mass spectral 
analysis which gave a peak at mlz 396 which was confirmed as the MH ion of the free 
amine 126 by accurate mass giving a formula C23H26N05. Derivitisation of the amine 
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126 was performed (Ac20/pyridine) yielding the N-acetyl amide 127 in 66% yield 
from the benzoate 124. Detailed nmr studies were performed on this substrate 
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Migration of the benzoyl group in 126 was proposed to occur after work up due to 
production of the free amine, as opposed to the TFA salt, which is then able to 
undergo the mechanism shown in Figure 49. This postulation was strengthened by 
observation of some benzoyl migrated product shortly after isolation of the pure amine 
126 suggesting migration occurs quite readily in favour of the benzoyl amide 125. 
To prevent such migration, extraction of the product into the organic layer and 
washing with sat. aq. NaHCO3 was avoided and the trifluoroacetic acid was simply 
removed in vacuo and then subjected to tosylation conditions (T5C1IEt3NIDCM). 
Again, two products were isolated from the reaction mixture after column 
chromatography. The major product (RF 0.2, hexane/EtOAc 2:1) was identified as the 
N-Tosyl amide 128 and was isolated in a yield of 40%. Characteristic details of the 
data included the presence of a methyl signal and additional aromatic signals in both 'H 
and '3C nmr spectra corresponding to the tosyl group. 
Scheme 47 
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Reagents and conditions: i. TFA. ii. TsC1, Et3N, DCM, 40% (2 steps). 
Assignment of the minor product was not as straightforward. The 'H nmr spectrum 
contained proton signals corresponding to all the expected functionality such as an 
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amine doublet at 8 6.66 (1H), the adjacent benzoate methine at 8 5.71 (1H), the methyl 
doublet at 8 1.36 (3H), the aromatic protons (10H) and all the functionality in the 
acetylene unit. '3C nmr spectrum also showed the expected signals however also 
indicated the presence of two tertiary carbons at 8 156.3 and 8 117.8. After 
consideration of the reactants and conditions - a 19F nmr spectrum was recorded and 
highlighted the presence of a fluorine signal at 5 -76.2, characteristic of a 
trifluoroacetate group, and as a result the product was proposed to be the 
trifluoroacetamide 129. Nominal and accurate mass spectral analysis confirmed 
formation of this product with a MW ion peak at m/z 492 with the formula 
C25H25N06F3. 




Attempts to avoid trifluoroacetamide formation by thorough removal of the 
trifluoroacetic acid including co-evaporation with toluene and chloroform and high 
vacuum treatment did not significantly reduce the amount of by-product 129 formed 
after tosylation. 
A final attempt to avoid formation of the trifluoroacetamide 129 by deprotection with 
3M hydrochloric acid in EtOAc followed by the similar tosylation conditions only gave 
the N-Tosyl amide 128 in 25% yield. 
Use of an ether protecting group 
It was anticipated that protection of the hydroxyl group as an ether would avoid the 
problem of benzoyl migration on formation of the corresponding amine. 
Protection as the benzyl ether (Scheme 48) was targeted due to its stability under acidic 
and basic conditions, and could be cleaved simultaneously with the primary benzyl 
ether later in the synthesis. The use of benzyl bromide and silver (I) oxide in refluxing 
ether102 as used in the previous benzyl ether formation, gave very little of the desired 
product 130 (8%) along with recovered starting material 118a. Product formation 
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was evident due to the presence of two doublets in the 'H nmr spectrum due to the 
diastereotopic protons in the newly formed benzyl group and also the increased 
number of aromatic protons. 
Scheme 48 
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Reagents and conditions: BnBr, Ag2O, ether, reflux, 8%. or BnBr, NaH, DMF, 17%. 
Subjecting the 13-amino alcohol 118a to benzyl bromide with sodium hydride in DMF 
again gave only a small quantity of benzyl ether (17%) and what was thought to be 
recovered starting material. Surprisingly, the 1H nmr spectrum of the recovered 
starting material did not show any resemblance to that of the 13-amino alcohol 118 a 
but illustrated a much simplified spectrum with no Boc group and convergence of the 
aromatic signals into a broad singlet. The infra-red spectrum illustrated an 
unexpectedly high carbonyl stretch at 1759 cm' and the '3C nmr spectrum also 
confirmed the presence of a carbonyl with a tertiary carbon peak at 6 155.6. After 
consideration of the reaction conditions and the data obtained on the isolated product 















Results and Discussion 
It was proposed that the removal of the hydroxyl proton by sodium hydride results in 
the alkoxy anion which then attacks the carbonyl of the Boc group with subsequent 
loss of tert-butyl alcohol to give the oxazolidinone 131. In the presence of sodium 
hydride and benzyl bromide this can then undergo benzylation on the nitrogen to give 
the N-benzyl oxazolidinone 132. 
Due to the unsuccessful formation of the benzyl ether, a different ether protecting 
group was chosen - methoxymethyl (MOM-ether). Although this group is cleaved by 
harsh acidic hydrolysis, colleagues found that MOM ethers derived from secondary 
alcohols survived conditions of trifluoroacetic acid for up to 1 hour without significant 
cleavage. Formation of the MOM ether of the n-amino alcohol 118a could not be 
effected in the presence of sodium hydride due to problems of proton abstraction and 
rearrangement to the oxazolidinone 132 hence an attempt using methoxymethyl 
chloride and dimethylaniline in DCM was implemented but this resulted only in 
starting material after overnight stirring. Treatment of the -amino alcohol 118a with 
dimethoxymethane in the presence of phosphorous pentoxide in chloroform117 did 
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Unfortunately, treatment of the MOM ether 133 with trifluoroacetic acid followed by 
tosylation conditions (TsC1, Et3N, DCM) gave a multispot mixture when visualised by 
tic and due to the complexity and the various side reactions that could result from 
cleavage of the MOM protecting group no purification was performed. 
Conclusion 
Although the N-tosyl amide 128 was formed from the benzoate 124 the yield was 
only moderate. A potential way of increasing the overall yield of N-tosyl amide 128 
could be performed by 'recycling' the by-product trifluoroacetamide 129, (Figure 51). 
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Trifluoroacetamides are cleaved by potassium carbonate in methanol, however under 
these conditions the benzoyl ester would also be cleaved thus forming the amine 121. 
Theoretically this could be subjected to N-tosylation followed by benzoylation of the 
secondary alcohol to yield the N-tosyl amide 128. Although this involves several 
steps, at this stage in the synthesis it would allow more material to be available for 
continuation in the synthesis. 
Figure 51 
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Due to time constraints, this sequence was not implemented and the synthesis was 
continued from the N-tosyl amide 128 to attempt further functionalisation and ring 
closure. 
4.2.5 Continuation of the synthesis:- Functional group 
modification 
Due to the lack of time and material it was reasoned that manipulation of the N-Tosyl 
amide 128 to the epoxide 136 would align the system for a 6-exo-tet cyclisation to 
form the piperidine ring 137 as outlined in Scheme 50. Reduction of the acetylene unit 
of the N-Tosyl amide 128 to the Z-alkene 134 was effected by hydrogenation in the 
presence of the Lindlar catalyst in EtOAc-hexane in moderate yield (68%). Formation 
of the Z-a&ene was evident in the 'H nmr spectrum which illustrated a coupling 
constant J 8.0 Hz between the olefin protons, a characteristic value for Z-alkenes. 
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Reagents and conditions: i. Lindlar catalyst (Pd on CaCO3), H2, EtOAc-hexane, 68%. 
The next step in the synthesis involved removal of the 1 ,3-dioxolane protecting group 
to yield the Z-enone 135 which is usually achieved under acidic catalysed hydrolysis. 
Considering no significant hydrolysis of the acetal under the acidic conditions of N-
Boc deprotection was observed previously it was anticipated that removal of the acetal 
may prove problematic. 
The first endeavour to remove the acetal group was using neutral, anhydrous 
conditions following a procedure by Kerr and co-workers 118  with triphenylphosphine 
and carbon tetrabromide in DCM. Kerr reported the deprotection of a range of aliphatic 
and aromatic acetals and ketals including an E-aj3-unsaturated-1,3-dioxolane using 
one set of conditions, hence the a,3-unsaturated ketal 134 was subjected to the 
reported procedure. A complex mixture resulted from the reaction and only one 
product was isolated in significant quantity. This product was subjected to high field 
nmr spectroscopy and from the spectra it was evident that the 1 ,3-dioxolane had been 
cleaved due to the loss of the corresponding signals. The signals resulting from the 
alkene protons in the 1H nmr had also shifted to higher field due to the conjugation 
with the resulting carbonyl but unfortunately these alkene signals illustrated a large 
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coupling constant with a value of J 16.0 Hz when compared to that observed in the 
precursor 134 (J 8.0 Hz). This large coupling is more characteristic for E-alkenes 
than for Z- and as a result it was proposed that the product isolated from this reaction 
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Hydrolysis of the 1,3-dioxolane of the a,-unsaturated ketal 134 was also attempted 
using 80% acetic acid at 650C,11 but after column chromatography the E-isomer 138 
was again isolated in 51% yield. A final attempt using the activated clay 
montmorrillonite K10 in DCM by adapting a procedure by Taylor et al.,120 again led 
to the E-isomer. 
The E-alkene formation was unexpected and there is no literature precedent on the 
removal of 1,3-dioxolane groups of Z-acyclic cx,f-unsaturated ketals. However it is 
well documented that mono-substituted Z-alkenes readily undergo isomerisation to the 
corresponding E-isomers under various conditions including acid catalysis.121 A 
proposed mechanism for the E-alkene 138 formation is illustrated in Figure 52, and 
proposes that isomerisation to the more stable E-isomer occurs during the cleavage of 
the ketal in 128 via the enol cation. 
This resulting E-isomer 138 is unsuitable for piperidine ring formation due to the 
wrong configuration of the double bond, thus a different approach to the Z-enone 135 
was undertaken by simply reversing the order of the two steps above. Removal of the 
1,3-dioxolane in the a,3-acetylenic ketal 128 was performed first to avoid any 
isomerisation of the double bond, (Scheme 51). 
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Figure 52 
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Use of 80% acetic acid at 65°C for 26 hours only resulted in recovered starting 
material, but treatment of 128 with montmorrillonite K10 yielded the a,3-acetylenic 
ketone 139 in 40% yield although a large amount of K10 was used compared to that 
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Due to the small amount of material remaining at this stage only one attempt to reduce 
the acetylene to the Z-enone 135 using hydrogenation conditions in the presence of 
the Lindlar catalyst was effected. Unfortunately, the product isolated did not indicate 
the presence of any olefin protons and it was suggested from the 'H and '3C nmr 
spectra that the product was that resulting from over reduction of the acetylene to the 
saturated ketone 140. 
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Finally, a second approach that ran parallel to the above sequence is illustrated in 
Scheme 52. Reduction of the acetylene in 128 to the alkane 141 was effected by 
hydrogenation in the presence of palladium on carbon in EtOAc-hexane to give the 
alkane in 51% yield. The alkane 141 was subjected to montmorrilonite K1O in DCIvI 
however this resulted in very little isolated product. A 'H nmr spectrum did suggest 
cleavage of the 1,3-dioxolane to give the ketone 142, but was complex due to 
contamination and no further data was collected. 
Scheme 52 
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Reagents and conditions: i. Pd-C, H2, EtOAc, Hexane, 51%. ii. Montmorrillonite Kb, 
DCM. 
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43 SUMMARY OF CHAPTER 4 
Eleven steps have been completed en route to the key target molecule 1,1 -bis-
hydroxymethyl-1,5-dideoxy-1,5-imino-L-fucitol 27 and these are outlined in Scheme 
53. Good to excellent yields were obtained in the initial steps on moderate scale 
allowing sufficient material to be utilised for investigation of the 13-amino alcohol 118 
formation. Suitable conditions were found for this reaction step by differing the 
conditions and thus resulted in the desired 13-amino alcohol 118a as the major 
diastereomer in favorable diastereoselectivity. Conversion of the 13-amino alcohol 
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Reagents and conditions: (a) i. BnBr, A920, ether, reflux, 82%. ii. DIBAL (1M in 
toluene), DCM, -78°C, 60%. (b) i. Bis-trimethylsilyl acetylene, MeLi:LiBr, THF, 0°C, 
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75%. ii. TEMPO, NaOC1, BTAC, NaBr, sat. aq. NaHC031 sat. aq. NaCl, DCM, 0°C, 97%. 
(c) i. HOCH2CH20H, TMS-Cl, DCM, 88%. ii. K2CO3, MeOH, 93%. (d) EtMgBr, 53, -78°C, 
59%. (e) BzCl, Et3N, DCM, 90%. (0 i. TFA. ii. TsC1, Et3N, DCM, 40% (2 steps). (g) 
Montmorrillonite Kb, DCM, reflux, 40%. 
Continuation from the 3-amino-alcohol 118a traversed several pathways in an attempt 
to find an appropriate hydroxyl protecting group yet the first choice of the benzoyl 
ester 128 proved the most successful. 
Although various reactions gave low yields of desired products, the by-products from 
these reactions were identified and are illustrated in Figure 53. These unwanted 
products might be converted into more useful intermediates if considered in more 
detail. 
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4.4 FUTURE WORK 
4.4.1 Synthesis of analogues to investigate the 6-exo-tet 
cyclisation 
To enable the 6-exo-tet cycisation of the N-tosyl protected nitrogen onto the epoxide 
to be investigated, it is proposed that a semi-functionalised N-tosyl amide be prepared 
before introducing the remaining stereochemistry. This can be approached by several 
pathways as outlined below by continuation from where the research ended. 
Although problems were encountered in the conversion of the 1,3-dioxolane to the 
corresponding ketone, the a,3-acetylenic ketone 139 was isolated in 40% yield yet 
this yield could be improved by further investigation of cleavage conditions. Lindlar 
catalysed hydrogenation of the a43-acetylenic ketone 139 unexpectedly yielded the 
over-reduced alkane 140, however this could be converted to the epoxide 143 and 











































Results and Discussion 
Alternatively, if a similar Lindlar catalysed hydrogenation of the acetylene in 139 is 
performed in the presence of quinoline this may prevent over reduction and hence 
result in the Z-enone 135. Epoxidation of the carbonyl utilising an appropriate sulfur 
ylide followed by boron trifluoride etherate mediated cycisation is expected to afford 
the piperidine 146. 
4.4.2 Functionalisation of the piperidine 146 to yield the 
target molecule 27 
Successful formation of the piperidine analogue 146 would then allow the hydroxyl 
groups to be incorporated by an acid or base catalysed ring opening of an appropriate 
epoxide. It is reasoned that formation of the epoxide 147 will allow regioselective ring 
opening via the favoured trans-diaxial opening to yield the desired stereochemistry as 
in 148, (Scheme 55). Removal of the N-protecting group would then produce the 
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Infrared spectra were recorded as thin films either using sodium chloride plates or by 
use of disposable JR cards (3M, type 61, polyethylene 19mm aperture) and are 
denoted as (film, NaCl) or as (film, JR card) respectively. Solids were recorded as 
KBr discs and in other cases in solution, and were performed on a Perkin Elmer 881 
Infra-red spectrophotometer or a Perkin Elmer Paragon 1000 FT-JR, frequencies being 
measured in wavenumbers (cm'). 
Nmr spectra were recorded on either a Varian Gemini 2000 (200 MHz, 'H; 50.1 MHz, 
a Brucker AC 250 (250 MHz, 1H; 62.9 MHz, '3C), a Brucker AC 300 (300 
MHz, 'H; 75.5 MHz, '3C), a Brucker WH 360 (360 MHz, 'H; 90.6 MHz, '3C), a 
Brucker AM 400 (400 MHz, 'H; 100.6 MHz, 13C), or a Varian Inova 600 (600 MHz, 
'H) spectrometer. 'H chemical shifts in CDC13, CD30D and D20 are referenced with 
respect to residual CHC13, CHD2OD and HOD respectively, for 13C spectra in CDC13 
and CD30D chemical shifts are referenced to CDC13 and CD30D respectively. Spin 
coupling constants (J) are given in Hertz (Hz) and are rounded up to the nearest 0.5 
Hz, and the chemical shift quoted in parts per million (ppm). The following 
abbreviations are used in assignment of the nmr spectra: s, singlet; d, doublet; t, triplet; 
q, quartet; dd, double doublet; dt, double triplet; ddd, double doublet of doublets; in, 
multiplet; br, broad. 
Optical rotations were recorded on an AA-l000 polarimetry with a cell path length of 
0.5 dm and concentations (c) quoted in g/100 ml (measurements taken at 589 nm). 
{a] values are given in 101  deg cm2 g'. Optical rotations are recorded only on the 
compounds that were isolated as single isomers and not on inseparable mixtures or 
impure compounds. 
Fast Atom Bombarbment (F.A.B.) mass spectra were recorded on a Kratos MS50TC 
instrument and Electron Impact (E.I.) spectra on a Finnigan 4600 instrument. 
Chemical ionisation (C.I.) mass spectra were recorded on a VG Biotech Quattro II 
spectrometer (low resolution) and a VG ZAB-E spectrometer (high resolution) at the 
EPSRC Mass Spectrometry Service, University of Wales, Swansea, (no percentage 
enhancements were quoted for these samples). Values are quoted as m/z values. 
106 
Elemental analysis (CHN) was performed on a Perkin Elmer 2400 CHN Elemental 
Analyser. 
Melting point determinations were recorded on an Electrothermal Melting Point 
apparatus and are given in (°C) uncorrected. 
Thin layer chromatography (tic) was performed on Merck 60F254 (0.25 mm) glass 
backed silica gel plates. The plates were visualised by UV fluorescence, or by heating 
after treatment with solutions of an acidic soution of ninhydrin or alkaline solution of 
potassium permanganate (KMnO4). Column chromatography was performed using 
Merck silica gel 60H (230-400 mesh) and eluant systems are quoted in volume ratios. 
Reactions which required anhydrous conditions were performed under an atmosphere 
of nitrogen or argon using glassware dried in an oven (T 150°C for at least 5 hours). 
Solvents tetrahydrofuran (THF) and diethyl ether (ether) were distilled from sodium 
benzophenone ketyl before use, and DCM was distilled from calcium hydride, or 
otherwise purchased directly from Aldrich. Pyridine was also distilled from calcium 
hydride, and stored over potassium hydride under a nitrogen atmosphere. Petroleum 
ether 40/60 (referred to as petrol) was distilled prior to use and all other solvents and 




5.2 EXPERIMENTAL FOR CHAPTER 3. THE SYNTHESIS OF L-
DEOXYFUCONOJIRIMYCIN 
5.2.1 N-(tert-butoxycarbonyl)-L-alanine N-methoxy-N-methylamide 52 
Me 	 Me Me 
BocHN CO2H 	 BocHN 	OMe 
51 	 520 
A stirred suspension of NO-dimethylhydroxylamine hydrochloride (10.7 g, 0.11 mol) 
in DCM (70 ml) under nitrogen was cooled to 4°C. N-Methylpiperidine (13 ml, 0.21 
mol) was added and the resulting solution of free NO-dimethylhydroxylamine was 
stirred at 4°C until required. 
N-Boc-L-alanine 51 (20.0 g, 0.11 mol) was dissolved in THF (200 ml) and DCM 
(100 ml) under nitrogen and cooled to -42°C. N-Methylpiperidine (13 ml, 0.11 mol) 
was added rapidly to the stirred solution and the temperature allowed to rise to -12°C 
where it was stabilised using an ice-methanol bath. Methyl chloroformate (8.5 ml, 
0.11 mol) was added and after 2 minutes the solution of free NO-dimethyl 
hydroxylamine added and the mixture allowed to warm to room temperature. After 21 
hours the resulting solution was cooled to -5°C and washed with 0.2M HCl (2 x 200 
ml), 0.5M NaOH (2 x 250 ml) and brine (250 ml). The organic phase was dried over 
anhydrous Na2SO41  concentrated under reduced pressure and the resulting solid 
recrystallised from EtOAc-petrol to give the Weinreb amide 70 52 as white crystals 
(19.72 g, 78%). mp 146-148°C; RF  (hexane-EtOAc 1:1) 0.32; [a]
21  -27.58 (c 0.99 in 
MeOH); (Found: C, 51.80; H, 8.82; N, 12.05; C10H20N204 requires C, 51.71; H, 
8.68; N, 12.06%); Dmjcm1  (CHC13) 3488-3683 (NH), 1705 (C=O urethane), 1661 
(C=O amide); 8H (300 MHz, CDC13) 1.31 (3H, d, J 7.0, CHMe), 1.44 (9H, s, 
OCMe3), 3.20 (3H, s, NMe), 3.76 (3H, s, OMe), 4.60-4.74 (1H, m, CHMe) and 
5.13-5.29 (1H, br s, NHCH); 8c (62.9 MHz, CDC13) 18.6 (CH31  CHMe), 28.3 
(CH3, OCMe3), 32.2 (CH31  NMe), 46.5 (CH, CHMe), 61.5 (CH31  OMe), 79.4 (C, 
OCMe3)
1 
 155.1 (C, C=0 urethane) and 173.3 (C, C=0 amide); m/z (F.A.B.) 233 
[(MH), 78.9%1, 159 (50), 116 (53), 57 (100); [Found: (MH), 233.14906. 
C10H21N204 requires MH, 233.15013]. 
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5.2.2 N-(tert-butoxycarbonyl)-L-alaninal 53 
Me Me 	 Me 
BocHN 
--Iy 
 OMe 	BocHN 'H 
0 	 0 
52 53 
Lithium aluminium hydride (1M solution in ether, 118 ml, 0.12 mol), was added to 
ether (50 ml) and stirred for 30 minutes under a nitrogen atmosphere. The solution was 
cooled to -60°C and a solution of the Weinreb amide 52 (25.31 g, 0.11 mol) in THF 
(300 ml) and DCM (100 ml) added dropwise over 45 minutes, whereafter the reaction 
was allowed to warm to 5°C. The reaction mixture was cooled to -60°C and quenched 
by slow addition of 30% aq. KHSO4 solution (50 ml) and the resulting white 
suspension stirred at room temperature for 2 hours then filtered through a plug of 
Celite and washed with ether (2 x 100 ml). The ether liquors were washed with cold 
1M HC1 (2 x 100 ml), sat. aq. NaHCO3 (2 x 100 ml), brine (100 ml) and dried over 
anhydrous Na2SO4. Removal of the solvent in vacuo yielded the a-amino aldehyde 70 
53 as a white solid (15.47 g, 82%), mp 90-92°C; RF  (hexane-EtOAc 2:1) 0.30; 
'u/cm' (KBr disc) 3341-3682br (NH), 1728 (C=O, aldehyde), 1700 (C=O, 
urethane), 1250, 1033 (C-U); H  (250 MHz, CDC13) 1.32 (3H, d, J 7.0, CHMe), 1.45 
(9H, s, OCMe3), 4.12-4.33 (1H, br.m, CliMe3), 5.00-5.19 (1H, br.s, NH) and 9.55 
(1H, s, CHO); Sc (50.1 MHz, CDC13) 13.3 (CH31  CHMe), 26.8 (CH31  OCMe3), 54.1 
(CH, CHMe), 78.6 (C, OCMe3)1  154.0 (C, C=O urethane) and 198.6 (C, C=O 
aldehyde); mlz (E.I.) 173 (Mt, 0.1%), 172 (1), 144 (28), 88 (31), 57 (100); (Found: 
M, 173.10467. C8H15NO3 requires M, 173.105 19). 
5.2.3 1 -(tert-buiyldimethylsilyloxy)prop-2-yne 54 
OH 	 OTBS 
H' 	 H/ 
54 
Solid tert-butyldimethylsilyichioride (19.80 g, 0.13 mol) was added to a stirred 
solution of iniidazole (1.62 g, 0.02 mol) in pyridine (50 ml) under a nitrogen 
atmosphere. Propargyl alcohol (6.65 g, 0.12 mol) was added and the mixture stirred at 
room temperature for 5 hours and the resulting precipitate filtered and washed with 
ether (10 ml). The organic extract was washed with dilute HC1 (2 x 25 ml), brine (20 
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ml), dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was 
purified by distillation under reduced pressure to give the TBS ether 54 as a colourless 
oil (16.56 g, 82%) at 21°C/0.1 mm Hg. RF  (petrol-EtOAc, 4:1) 0.86; 1)m /cm1  (film, 
NaCl) 3313 (CH acetylene), 1256 (SiMe3), 1098 (C-O), 837 (SiMe3); 8H  (250 MHz, 
CDC13) 0.11 (6H, s, SiMe2)
1 
 0.89 (9H, s, SiCMe3), 2.36 (1H, t, J 2.0, CH-
acetylene) and 4.28 (2H, d, J 2.0, CH2OSi); 5 (62.9 MHz, CDC13) -5.3 (CH31  
SiMe2)
1 
 18.2 (C, OCMe3), 25.7 (CH31  SiCMe3), 51.4 (CH21  CH20TBS), 72.7 (C, C-
acetylene) and 82.4 (CH, CH-acetylene); m/z (F.A.B.) 171 [(MH), 69.7%], 131 
(22), 115 (33); [Found; (MH) 171.12108. C9H19OSi requires MH, 171.12052]. 
5.2.4 (2S, 3RS)-N-(tert-butoxycarbonyl)-2-amino-6-(tert-butyldimethylsilyloxy)-3-
hydroxyhex-4-yne 55a/b 
Me 	 Me 
BocHN ' 	 BocHN 
0 	 OH 
53 55a1b 
A solution of 1-(tert-butyldimethylsilyloxy)prop-2-yne 54 (25.20 g, 0.15 mol) in 
ether (50 ml) under an atmosphere of nitrogen was cooled to 0°C and 
methylmagnesium iodide (3M in ether, 50.0 ml, 0.15 mol) added. The resulting 
solution was stirred at 0°C for 5 minutes and heated under reflux for 14 hours 
whereafter it was allowed to cool to room temperature before the dropwise addition to 
a cooled (-78°C) stirred solution of N-Boc-L-alaninal 53 (11.85 g, 0.68 mol) in ether 
(100 ml) under an atmosphere of nitrogen. The solution was warmed to room 
temperature and stirred for 1 hour before quenching by slow addition of sat. aq. 
NH4C1 solution (100 ml). The layers were separated and the organic phase washed 
with brine (100 ml), dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. The oily residue was subjected to column chromatography eluting with 
petrol-EtOAc (4:1) to yield an inseparable mixture of the j3-amino alcohols68 55a/b 
(14.70 g, 62%), RF  0.35; 8H (250 MHz, CDC13) 0.10 (6H, s, SiMe2), 0.90 (9H, 5, 
SiCMe3), 1.21 (3H, ov.d, CHMe diastereomers), 1.42 (9H, s, OCMe3), 3.00-3.40 
(1H, br.s, OH diastereomers), 3.60-4.00 (1H, br.m, CHMe diastereomers), 4.33-
4.50 (3H, in, CHOH and CH20TBS) and 4.51-4.80 (1H, ov.d, NH diastereomers); 
(62.9 MHz, CDC13) -5.2 (CH31  SiMe2)1  16.0, 16.2 (CH31  CHMe diastereomers), 
18.2 (C, OSiCMe3), 25.8, 28.3 (CH31  SiCMe3 and OCMe3), 50.7, 51.2 (CH, CHMe 
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diastereomers), 51.6 (CH2, CH20TBS), 65.9, 66.3 (CH, CHOH diastereomers), 
79.8, 79.9, 82.5, 83.0, 84.6, 85.0 (RC, 2xC-acetylene and OCMe3 diastereomers) 
and 155.8 (C, C=O). 
5.2.5 (4S, 5SR)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[3-(tert-butyldi 
methylsilyloxy)prop-1 -yn-1 -yl]oxazolidine 56157 







The diastereomeric mixture of the n-amino alcohols 55a/b (14.76 g, 43.0 mmol) was 
dissolved in acetone (150 ml) and 2,2-dimethoxypropane (50 ml) and boron trifluoride 
etherate (0.3 ml) were added and the solution stirred for 8 hours at room temperature. 
The solvent was removed under reduced pressure, diluted with DCM (100 ml) and 
washed with sat. aq. NaHCO3 (2 x 100 ml), water (2 x 100 ml) and brine (100 ml). 
The organic phase was dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to yield an oily residue which was subjected to several column 
chromatography steps eluting with petrol-ether (12:1) to afford the anti-56 (7.92 g, 
48%) and the syn-57 (3.31 g, 20%) oxazolidine diastereomers as colourless oils. 
(4S, 5S)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[3-(tert-butyldimethylsilyl 
oxy)prop-1-yn-1-yl]oxazolidine 56: RF  0.15; [a]
23  -21.1 (c 1.02, CHC13);v../cm-1  
(film, NaCl) 1700 (C=O), 1388 (CMe3)
1 
 1254 (SiMe2), 1078 (Si-O), 837 (SiMe2); 6H 
(300 MHz, CDC13) 0.10 (6H, s, SiMe2)1  0.89 (9H, s, SiCMe3)1  1.30 (3H, d, J 6.0, 
CHMe), 1.47 (9H, s, OCMe3)1  1.52, 1.68 (6H, 2xs, Me-oxazolidine), 3.90-4.00 
(1H, br.m, CHMe), 4.33 (2H, d, J 1.5, CH20TBS) and 4.40 (1H, m, CHCHMe); 6 
(100.6 MHz, CDC13) -5.2 (CH31  SiMe2)1  18.2 (C, SiCMe3)1  19.4 (brCH31  CHMe), 
25.7 (Cl3, SiCMe3), 26.3, 27.5 (2xbrCH31  Me-oxazolidine), 28.4 (CH3 , OCMe3)1  
51.6 (CH21  CH20TBS), 59.5 (CH, CHMe), 70.7 (CH, CHCI{Me), 79.8 (C, 
OCMe3), 83.1, 84.7 (2xC, C-acetylene), 95.3 (C, C-oxazolidine) and 151.6 (C, 
C=O); m/z (E.I.) 383 (M, 0.1%), 268 (73), 57 (100); (Found: M, 383.25050. 
C20H37NO4Si requires M, 383.24919). 
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Irradiated Proton Enhancement Observed (%) 
Ha  Hb  (2%); Me (6%) 
Hb Ha  (3%); Me (6%) 
Me Ha  (10%); Hb (12%) 
(4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5- [3-(tert-butyldimethylsilyl 
oxy)prop-1-yn-1-yl]oxazolidine 57: RF  0.13; [a]
21  +1.05 (c 0.95, CHC13); Um /cm' 
(film, NaCl) 1701 (C=O), 1384 (CMe3)
1 
 1254 (SiMe2), 1092 (Si-O), 837 (SiMe2); 8H 
(300 MHz, CDC13) 0.11 (6H, s, SiMe2), 0.9 (9H, s, SiCMe3)1  1.29 (311, m, CHMe), 
1.46 (9H, s, OCMe3)
1 
 1.50-1.66 (6H, br.m, 2xMe-oxazolidine), 3.71-4.10 (1H, 
br.m, CHMe), 4.31 (2H, d, J 1.5, CH20TBS) and 4.75 (1H, dt, J 5.5, 1.5, 
CHCHMe); m/z (E.I.) 383 (M1 , 1.1%), 368 (28), 268 (65), 57 (100); (Found: M, 
383.24980. C20H37NO4Si requires M, 383.24919). 
nOe data for 57:- 
OTBS 
0 H 
Irradiated Proton Enhancement Observed (%) 
Ha  Hb (10%) 
Hb Ha  (7%); Me (2%) 
Me Ha  (8%) 
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5.2.6 (4S, 5S)N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[(Z)-3-(tert-bUlYldi 
methylsilyloxy)prop-1 -en--yl]oxazolidine 
I 	'OTBS 
Boc—N" ' 	Boc- 
56 
A stirred deoxygenated solution of the acetylene 56 (422 mg, 1.10 mmol) in hexane 
(10 ml) was treated with palladium on calcium carbonate (Lindlar catalyst, 30 mg) and 
stirred under an atmosphere of hydrogen for 20 hours. The catalyst was removed by 
filtration through celite, washed with ether (2 x 5 ml), and the combined filtrates 
concentrated under reduced pressure. Column chromatography of the residue eluting 
with petrol-ether (7:1) yielded the Z-alkene68 (399 mg, 94%). RF  0.44; 814 (250 MHz, 
CDC13) 0.05 (6H, s, SiMe2)1  0.88 (9H, s, SiCMe3)1  1.26 (3H, d, J 6.0, CHMe), 
1.46 (9H, s, OCMe3)
1 
 1.49, 1.56 (6H, 2xs, Me-oxazolidine), 3.4-3.5 (1H, br.m, 
CHMe), 4.27-4.30 (2H, in, CH2OSi), 4.40 (1H, in, CHCHMe), 5.47 (1H, ov. dddd, 
J 11.0, 8.0, 2.0, 2.0, CHCHCH20TBS) and 5.75 (1H, dddd, J 11.0, 6.0, 6.0, 1.0), 
CHCH20TBS). 
5.2.7 	(4S, 5S)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(Z)-3-hydroxy 




OTBS 	 OH 
58 
A stirred solution of the Z-alkene (255 mg, 0.66 mmol) in THF (5 ml) was treated 
with TBAF (1M in THF, 1 ml, 0.99 mmol) at room temperature for 1 hour. The 
mixture was concentrated under reduced pressure and partitioned between ether (5 ml) 
and water (5 ml). The layers were separated and the organic extract washed with water 
(20 ml), 0.5M HC1 (10 ml), dried over anhydrous Na2SO4 and concentrated in vacuo. 
The resulting residue was subjected to column chromatography eluting with petrol-
EtOAc (2:1) to yield the Z-allylic alcohol68 58 as a colourless oily residue (138 mg, 





 1.50, 1.57 (6H, 2xs, Me-oxazolidine), 2.0-2.1 (1H, br.s, OH), 3.50 (1H, 
m, CHMe), 1.16-1.24 (2H, in, CH20H), 4.40 (111, m, CHCHMe), 5.47 (1H, ov. 
dddd, J 11.0, 8.5, 1.5, 1.5, CHCHCH20H) and 5.75 (1H, ov. dddd, J 11.0, 7.0, 
6.0, 6.0, CHCH20H). 
5.2.8 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(1RS, 2SR)- 1,2-




58 	 SUM 
To a solution of the allylic alcohol 58 (89 mg, 0.33 mmol) in dry DCM (5 ml) was 
added meta-chloroperbenzoic acid (116 mg, 0.67 mmol) and stirring continued at room 
temperature for 48 hours under a nitrogen atmosphere. The reaction was quenched by 
addition of sat. aq. Na2S203 (10 ml), the organic phase separated and washed with sat. 
aq. NaHCO3 (10 ml), brine (10 ml), dried over anhydrous Na2SO4 and concentrated in 
vacuo. The mixture was not purified by chromatography hence no yield was recorded. 
5.2.9 (4S, 5S)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[3-hydroxyprop-1 - 
yn-1 -yl]oxazolidine 
- OTBS 
Boc—N . 	 Boc- 
56 
.Th 
A stirred solution of the acetylene 56 (264 mg, 0.69 mmol) in THF (5 ml) was treated 
with TBAF (1M soin in THF, 0.88 ml, 0.97 mmol) at room temperature for 3 hours. 
The solvent was removed under reduced pressure and the residue dissolved in ether 
(10 ml) and washed with water (2 x 10 ml) and 0.5M HC1 (10 ml). The organic layer 
was dried over anhydrous Na2SO41  concentrated in vacuo and purified by column 
chromatography eluting with petrol-EtOAc (3:1) to yield the propargyl alcohol as a 
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colourless oil (168 mg, 90%). RF  0.20; [x]
27  -146.3 (c 0.99 in CHC13); )m /Cffl '  
(film, NaCl) 3440br (OH), 1694 (C=O), 1392 (CMe3), 1083 (C-O); 8H  (300 MHz, 
CDC13) 1.28 (3H, d, J 6.0, CHMe), 1.48 (9H, s, OCMe3)1  1.52, 1.68 (6H, 2xs, Me-
oxazolidine), 1.68-1.90 (1H, br.s, OH), 4.00-4.10 (1H, br.m, CHMe), 4.30 (2H, s, 
CH20H) and 4.43 (1H, m, CHCHMe); Sc (75.5 MHz, CDC13) 19.4 (CH31  CHMe), 
26.3, 27.3 (2xCH3, Me-oxazolidine), 28.3 (CH39  OCMe3), 50.3 (CH21  CH20H), 
59.4 (CH, CHMe), 70.6 (CH, CHCHMe), 80.0 (C, OCMe3), 82.8, 84.8 (2xC, C-
acetylene), 95.1 (C, C-oxazolidine) and 151.7 (C, C=O); m/z (F.A.B.) 269 (Mi, 
1.7%), 254 (74), 198 (78), 154 (77),57 (88); (Found: W, 269.16378. C14H23N04 
requires M, 269.34092). 
5.2.10 (4S, 5S)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(E)-3-hydroxy 
prop- I-en-i -yl]oxazolidine 62 
OH 
Boc— OH 
Lithium aluminium hydride (50 mg, 1.32 rnmol) was added slowly to a stirred solution 
of the prepared propargyl alcohol (225 mg, 0.83 mmol) in THF (12 ml) and stirring: 
continued under an atmosphere of nitrogen for 2 hours. The reaction was quenched by 
addition of EtOAc (10 ml) followed by sat. aq. NH4C1 (10 ml) and the resulting 
precipitate filtered through a plug of Celite and washed with EtOAc (2 x 3 ml). The 
combined filtrates were separated and the organic extract washed with brine (10 ml), 
dried over anhydrous Na2SO4 and concentrated before subjecting the residue to column 
chromatography eluting with petrol-EtOAc (2:1) resulting in the E-allylic alcohol 62 
(202 mg, 90%). RF  0.20; [a] +26.4 (c 0.99 in CHC13); ./cm'  (film, NaCl) 3200-
3600br (OH), 1699 (C=O), 1388 (CMe3), 1105, 1136 (C-O); 6H  (300 MHz, CDC13) 
1.28 (3H, d, J 6.0, CHMe), 1.45 (9H, s, OCMe3), 1.48, 1.56 (6H, 2xs, Me-
oxazolidine), 2.00-2.30 (1H, br.s, OH), 3.52 (1H, m, CHMe), 4.07 (1H, dd, J 7.5, 
7.5, CHCHMe), 4.15 (2H, dd, J5.0, 1.5, CH20H), 5.73 (1H, ddt, J 15.5, 7.5, 1.5, 
CHCHCH20H) and 5.96 (1H, dtd, J 15.5, 5.0, 0.5, CHCH20H); 6 (75.5 MHz, 
CDC13)
1 
 19.4 (CH31  CHMe), 26.4, 27.0 (2xCH31  Me-oxazolidine), 28.3 (CH31  
OCMe3), 57.9 (CH, CHMe), 62.5 (CH21  CH20H), 79.8 (C, OCMe3)1  81.9 (CH, 
CHCHMe), 95.3 (C, C-oxazblidine), 128.1, 134.2 (2xCH, CH-allcene) and 152.0 
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(C, C=O); m/z (E.I.) 271 (Mt, 0.1%), 256 (9), 57 (100); (Found: M, 271.17935. 
C14H25N04 requires M, 271.17836). 
5.2.11 (4S, 5S)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[( iRS, 2RS)- 1,2, 
3 -trihydroxypropan-1 -yl]oxazolidine 64/66 
OH 	Boc—N' 	 OH 
OH 
64/66 62 
Method 1. Catalytic osmium tetroxide:- 
The E-allylic alcohol 62 (1.50 g, 5.53 mmol) in acetone (20 ml) was added to a stirred 
solution of N-methylmorpholine-N-oxide (648 mg, 5.53 mmol) and osmium tetroxide 
(100 mg, 0.39 mmol) in acetone (10 ml) and water (10 ml) and the bi-phasic mixture 
stirred for 16 hours. The reaction was quenched by addition of sodium hydrosulfite 
(0.6 g) and fluorosil (5 g) in water (20 ml) and the slurry stirred for 20 minutes before 
filtration through a plug of Celite and concentration under reduced pressure. Column 
chromatography of the residue eluting with EtOAc gave the triol diastereomers 64 and 
66 in a combined yield of 1.35 g (84%) as an oily residue. This combined, mixture of 
diastereomers was then subjected to column chromatography eluting slowly with 
EtOAc to enable sufficient separation of the pure diastereomer triols 64 and 66. 
Method 2. Sharpless asymmetric dih'droxvlation mix (AD-mix):- 
To a stirred mixture of cooled (0°C) methane sulfonamide (30 mg, 0.32 mmol) and 
AD-mix- (446 mg) in t-butanol (1.6 ml) and water (1.6 ml) was added a solution of 
E-allylic alcohol 62 (86 mg, 0.32 mmol) in t-butanol (0.5 ml). Stirring was continued 
at 0°C for 10 hours then at room temperature for a further 24 hours, whereafter 
magnesium sulfate (0.5 g) was added and the mixture stirred for 30 minutes then 
extracted with EtOAc (3 x 5 ml). The combined organic fractions were washed with 
2M KOH (5 ml), brine (5 ml), dried over anhydrous Na2SO4 and concentrated in 
vacuo. Column chromatography of the residue eluting with EtOAc gave recovered 
starting material 62 (40 mg). and the triol diastereomers 6 4/66 in a combined yield of 
19 mg (20%). 
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Method 3. Catalytic ruthenium tetroxide:- 
To a stirred and cooled (0-5°C) solution of E-allylic alcohol (35 mg, 0.13 mmol) in 
EtOAc/CH3CN (1.54 ml, 1:1) was added a solution of ruthenium (III) chloride hydrate 
(2 mg, 7 mol%) and sodium periodate (43 mg, 1.5 eq.) in water (0.25 ml). The 
resulting biphasic mixture was stirred vigorously for 3 minutes and then quenched 
with sat. aq. Na2S203 (0.77 ml) and the aqueous liqours extracted with EtOAc (2 x 5 
ml), dried over anhydrous Na2SO4, and concentrated. Column chromatography of the 
residue (EtOAc) gave recovered starting material 62 (15 mg) and the triol 
diastereomers 64/66 (12 mg, 30%). 
N.B. Ratio determination of the triol diastereomers was obtained by comparison of the 
integrals of the oxazolidine methyl doublets in the 'H nmr spectrum which was 
recorded on the combined diastereomer mixture. 
(45, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[( 1 R, 2R)- 1 ,2,3-trihydro 
xypropan-1-yl]oxazolidine 64:- mp 40-45°C; RF  (EtOAc) 0.30; [a]
23  +8.79 (c 1.01 in 
CHC13); D,/cm' (KBr disc) 3600-3200br (OH), 1700 (C=O), 1392 (CMe3)1  1099 
(C-O); 3H  (400 MHz, CD30D) 1.36 (3H, d, J 6.0, CHMe), 1.48 (9H, s, OCMe3)1  
1.50, 1.54 (6H, 2xs, Me-oxazolidine), 3.55 (1H, dd, J9.0, 1.5, CHCHCH 2), 3.60 
(2H, m, CH20H), 3.84 (1H, dd, J 9.0, 4.0, CHCHMe), 3.85 (1H, m, CHCH2) and 
4.01-4.05 (1H, br.m, CHMe); 8c (100.6 MHz, CD30D), 19.5 (CH31  CHMe), 26.1, 
26.8 (2xCH3, Me-oxazolidine), 27.4 (CH3, OCMe3), 56.3 (brCH, CHMe), 62.9 
(CH21  CH20H), 69.9 (CH, CHCH2), 71.4 (CH, CHCHCH2), 80.7 (brC, OCMe3)1  
81.1 (brCH, CHCHMe), 94.1 (brC, C-oxazolidine) and 152.2 (C, C=O); m/z 
(F.A.B.) 306 [(MH), 54.4%], 290 (17), 109 (9); [Found: (MH), 306.19266. 
C14H28N06 requires MH, 306.19166]. 
(45, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[( iS, 2S)- 1 ,2,3-trihydro 
xypropan- 1 -yl] oxazolidine 66:- RF  (EtOAc) 0.25; 8H (200 MHz, CDC13) 1.32 (3H, m, 
CHMe), 1.45 (9H, s, OCMe3), 1.49, 1.52 (6H, 2xs, Me-oxazolidine), 3.0-3.1 (2H, 
br.s, 2xOH), 3.2-3.4 (1H, br.s, OH), 3.62 (1H, br.m, CH), 3.74 (3H, br.m, 
CH20H and CH) and 3.86 (2H, br.m, 2xCH); 8c (50.1 MHz, CDC13) 19.0 (CH31  
CHMe), 25.4 (CH3, 2xMe-oxazolidine), 27.0 (CH3, OCMe3), 52.7 (CH, CHMe), 
62.6 (CH2, CH20H), 69.2 (CH, CHCH2), 70.8 (CH, CHCHCH2), 78.8 (C, 
OCMe3), 80.8 (CH, CHCHMe), 93.4 (C, CMe2) and 150.7 (C, C=O). 
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5.2.12 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[( iRS, 2RS)-3-
(tert-butyldimethylsilyloxy)-1, 2-dihydroxypropan-1 -yl]oxazolidine 65/67 
Method 1. From the E-allvlic alcohol 62:- 
OH 	Boc—N' 	T 
OH 
65/67 62 
A stirred solution of E-allylic alcohol 62 (107 mg, 0.40 mmol) in DMF (5 ml) was 
treated with tert-butyldimethylsilyl chloride (72 mg, 0.47 mmol) and imidazole (69 
mg, 0.99 mmol) under a nitrogen atmosphere. Stirring was continued for 1. hour 
whereafter the ieaction was quenched by addition of water (5 ml) and extracted with 
EtOAc (2 x 5 ml). The combined organic extracts were washed with brine (5 ml), dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Column 
chromatography of the residue eluting with petrol-EtOAc (4:1) gave the TBS ether 63 
(138 mg, 90%). To a stirred solution of potassium hexaferricyanide (445 mg, 1.35 
mmol), potassium bicarbonate (191 mg, 1.38 mmol) and potassium osinate (Vi) 
dihydrate (5 mg, 0.013 mmol) in water (2.5 ml) was added the TBS ether 63 (58 mg, 
0.15 mmol) as a solution in t-butanol (2.5 ml). The resulting bi-phasic mixture was 
stirred at room temperature for 17 hours whereafter Na2SO3 (350 mg) was added and 
the mixture stirred for a further 20 minutes before separation of the layers. Extraction 
of the aqueous layer with chloroform (2 x 5 ml) was followed by drying of the 
combined organic extracts over anhydrous Na2SO4 and concentration in vacuo. 
Column chromatography eluting with petrol-EtOAc (5:1) gave the diol diastereomers 
65/67 in a combined yield 37 mg (77%), and a ratio of 3:1 (as determined by nmr 
analysis)., 








To a cooled (-10°C) stirred solution of the triol 64 (245 mg, 0.80 mmol) in DCM (10 
ml) was added 2,6-lutidine (215 tl, 0.18 mmol) and tert-butyldimethylsilyl thflate 
(2.03 pJ, 0.88 mmol) under an atmosphere of nitrogen. The mixture was stirred for 2 
hours at that temperature and then at room temperature for 1 hour. The reaction was 
quenched by addition of EtOAc (10 ml) and water (10 ml) and the organic layer 
washed with 0.3M KHSO4 (20 ml), water (10 ml) and brine (10 ml). The organic 
layer was dried over anhydrous Na2SO41  concentrated and the residue subjected to 
column chromatography eluting with petrol-EtOAc (3:1) to yield the single 
diastereomer (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-{(1R, 2R)-3-
(tert-butyldimethylsilyloxy)- 1 ,2-dihydroxypropan- 1 -yl]oxazolidine 65 (252 mg, 75%) 
as an oily residue. RF  (petrol-EtOAc 1:1) 0.75; [aJ +8.75 (c 0.98 in CHC13); 
maxkm 1  (film, NaCl) 3200-3600br (OH), 1704 (C=O), 1387 (CMe3)1  1261 (SiMe2)1  
1109 (Si-O), 851 (SiMe2); 8H (400 MHz, CDC13)1  0.06 (6H, s, SiMe2)1  0.88 (9H, s, 
SiCMe3)
1 
 1.34 (3H, d, J 6.0, CHMe), 1.44 (9H, s, OCMe3)1  1.48, 1.51 (6H, 2xs, 
Me-oxazolidine), 2.79 (1H, br.m, OH), 3.01 (1H, br.m, OH), 3.58 (1H, m, 
CHCHCH2), 3.68-3.70 (3H, m, CH20H and CHCHMe), 3.86 (lH, m, CHCH2) and 
3.86-3.97 (1H, br.m, CHMe); 6 (100.6 MHz, CDC13) -5.5 (CH31  SiMe2)1  18.2 (C,. 
OSiCMe3), 20.7 (CH31  CHMe), 25.8 (CH31  OSiCMe3), 27.0, 27.7 (2xCH1, Me-
oxazolidine), 28.5 (Cl3, OCMe3), 55.9 (CH, CHMe), 65.9 (CH21  CH20TBS), 69.1 
(CH, CHCH2), 72.8 (CH, CHCHCH2), 79.6 (C, OCMe3), 81.5 (CH, CHCHMe), 
94.5 (C, C-oxazolidine) and 151.8 (C, C=O); m/z (F.A.B.) 420 [(MH), 81.9%], 404 
(13), 304 (73), 115 (42), 57 (39); [Found: (MH), 420.27787. C20H42NO6Si requires 
MH, 420.27829]. 
5.2.13 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(1R, 2R)- 1,2,3-
triacetoxypropan-1 -yl]oxazolidine 74 
Boc—N 	Boc—N 
" 	
T OH 	 , 	 OAc-.-'.- 
r OH 	 0 OAc 
64 
	 74 
A solution of the triol 64 (38 mg, 0.12 mmol) in acetic anhydride (1 ml) and pyridine 
(1 ml) was stirred for 1 hour whereafter dilute HC1 (2 ml) was added and the product 
extracted with EtOAc, dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. The resulting oily residue was subjected to column chromatography eluting 
27 
with petrol-EtOAc (1:1) to give the acetylated triol 74 (45 mg, 83%) as an oil. [a] 
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+21.23 (c 0.80, CHC13); DmjC m '  (film, NaCl) 1750 (C=O, acetate), 1694 (C=O, 
urethane), 1388 (CMe3), 1212, 1030 (C-O); 8H  (250 MHz, CDC13) 1.28 (3H, d, J 
6.0, CHMe), 1.44 (9H, s, OCMe3), 1.45, 1.54 (6H, 2xs, Me-oxazolidine), 2.01, 
2.09, 2.10 (9H, 3xs, MeCO), 3.7-3.8 (1H, br.m, Cf/Me), 3.80 (1H, dd, J 8.0, 4.0, 
CHCHMe), 3.96 (1H, dd, J 11.5, 6.5, CH2OAc), 4.24 (1H, dd, J 11.5, 5.5, 
CH2OAc), 5.17 (1H, dd, J 8.0, 3.0, CHCHCH2) and 5.41 (1H, dq, J 6.5, 5.5, 3.0, 
CHCH2); 8c (62.9 MHz, CDC13) 19.5 (CH31  CHMe), 20.5 (CH31  COMe), 27.0, 27.2 
(2xCH3, Me-oxazolidine), 29.5 (CH3, OCMe3), 55.4 (CH, CHMe), 61.7 (CH21  
C'H20Ac), 68.6 (CH, cHCH2), 71.7 (CH, cHCHCH2), 78.8 (CH, CHCHMe), 79.3 
(C, OcMe1), 94.3 (C, C-oxazolidine), 151.4 (C, G=O urethane) and 169.6, 169.7, 
170.3 (RC, C=O acetate); m/z.(F.A.B.) 432 [(MH)', 35.6%), 416 (44), 372 (14), 57 
(69); [Found: (MH), 432.22340. C20H34N09 requires MH, 432.22334]. 
5.2.14 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(1R, 2S)-1,2-di 
hydroxy-3-oxo-propan-1 -yl]oxazolidine 78 
- 	-.'-- 	rT_r 	 - 
Boc—N '-"I Boc—N \ 
OH 	 —O OH 
64 	 \ 	78 
A solution of NaBr (4 ing, 12 mol %) and BTAC (4 mg, 5 mol%) in sat. aq. NaHCO3 
(0.5 ml) was added to a vigorously stirred solution of the triol 64 (101 mg, 0.33 
mmol) and TEMPO (2 mg, 3 mol%) in DCM (2 ml). The resulting bi-phasic mixture 
was cooled to 0°C, and a solution of sodium hypochiorite (1. 12M, 0.70 ml), sat. aq. 
NaHCO3 (0.6 ml) and brine (1.2 ml) was added dropwise over 40 minutes. The 
mixture was allowed to stir for 30 minutes at 0°C, then at 20°C for a further 20 
minutes. The phases were separated and the aqueous layer extracted with DCM (2 x 
lOml). The combined organic extracts were washed with sat. aq. NaHCO3 (10 ml), 
brine (10 ml), dried over anhydrous Na2SO4 and the solvent removed in vacuo to yield 
a white solid (100 mg) which was used in the next step without further purification. 
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5.2.15 Nitrogen deprotection and ring closure to yield (2S, 3R, 4R, 5S)-2,3-diacet 




The crude residue from the previous reaction was treated with 90% aq. trifluoroacetic 
acid (5 ml) and the mixture was stirred at room temperature for 30 minutes. The 
solvent was removed under reduced pressure and the residue dissolved in water (0.5 
ml), and passed through a column of Amberlyst A26 basic ion exchange resin (OH-) 
eluting with water. The eluant was removed in vacuo to produce an oily residue which 
was taken up in pyridine (5 ml) and treated with acetic anhydride (240 p1, 4.7 eq.) and 
DMAP (several crystals). The reaction was stirred at room temperature for 26 hours 
whereafter dilute HC1 (5 ml) was added and the product extracted with EtOAc (2 x 10 
ml). The combined extracts were combined, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. The residue was subjected to column 
chromatography eluting with DCM-ether (1:1), then freeze dried to yield the lactone 80 
(6 mg). D,,/cm' (CHC13) 1800 (C=O lactone), 1752 (C=O acetate), 1214 (C-O); oH 
(250 MHz, CDC13) 1.32 (3H, d, J 6.0, CHMe), 2.00, 2.10, 2.16 (9H, 3xs, 
3xCOMe), 4.38 (1H, dd, J 7.0, 2.0, CHCHNHAc), 4.48 (1H, m, CHNHAc), 5.29-
5.44 (2H, m, CHCHCOO), 5.66 (1H, br.d, J 8.0, NHAc); 8 (62.9 MHz, CDC13) 
17.8 (CH3, CHMe), 20.5, 23.2, 29.6 (3xCH3, COMe), 44.1 (CH, CHMe), 72.6, 
73.3, 81.2 (3xCH, CHCHCHCHMe), 168.7, 169.9, 169.7, 170.2 (4xC, 3xCO 
acetate and C=O lactone); m/z (E.I.) 288 [(MH), 1.6%], 272 (2); [Found (C.I.): 
(MH), 288.10832. C12H18N07 requires MH, 288.108301. 
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5.2.16 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(JR, 2R)-3-(tert-
butyldimethylsilyloxy)-1 -2-isopropylidenepropan-1 -yl]oxazolidine 82 
OTBS 	Boc— 
VR 
65 	 82 
A stirred solution of the diol 65 (220 mg, 0.53 mmol) in acetone (3 ml) under nitrogen 
was treated with 2,2-dimethoxypropane (2 ml) and boron trifluoride etherate (18 j.tl) at 
room temperature for 20 minutes. The reaction mixture was concentrated under 
reduced pressure and the residue taken up in DCM (10 ml) and washed with sat. aq. 
Nal-1CO3 (10 ml), water (10 ml) and brine (10 ml). The organic extract was dried over 
anhydrous Na2SO41  concentrated and subjected to column chromatography eluting 
with petrol-ether (12:1) to yield the acetal 82 (206 mg, 85%) as an oil. RF  (petrol- 
24 EtOAc 8:1) 0.71; [a] +13.74 (c 1.01 in CHC13); Dm /cm' (film, NaCl) 1710 (C=O), 
1390 (CMe3), 1260 (SiMe2), 1065 (Si-O), 851 (SiMe2); oH  (400 MHz, CDC13) 0.48, 
0.56 (6H, 2xs, SiMe2)
1 
 0.88 (9H, s, SiCMe3), 1.34 (3H, d, J 6.0, CHMe), 1.37, 
1.38 (6H, 2xs, Me-acetall), 1.46 (9H, s, OCMe3), 1.47, 1.53 (6H, 2xs, Me-
oxazolidine) and 3.68-3.96 (6H, m, 4xCH and CH20TBS); 8c (100.6 MHz, CDC13) 
-5.3, -5.4 (2xCH3, SiMe2), 18.4 (C, SiGN'1e1), 20.5 (CH31  CHMe), 25.9 (CH31  
SiCMe3), 27.2, 27.2 (2xCH3, Me-acetal), 27.6 (brCH3, 2xMe-oxazolidine), 28.5 
(CH3, OCMe3), 56.3 (CH, CHMe), 63.4 (CH21  CH20TBS), 77.7 (CH, CHCH2), 
79.7 (C, OCMe3), 81.0 (CH, CHCHCH2), 83.3 (CH, CHCHMe), 94.8 (C, C-
oxazolidine), 109.5 (C, C-acetal) and 151.8 (C, C=O); m/z (E.I.) 459 [(MH), 0.1%], 
444 (7), 344 (37), 328 (4), 244 (20), 114 (36), 57 (100); (Found: M, 459.29988. 
C23H24NO6Si requires M, 459.30162). 
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5.2.17 (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[(1R, 2R)-3-hyd 





A stirred solution of the TBS-ether 82 (212 mg, 0.46 mmol) in THF (8 ml) was 
treated with TBAF (1M in THF, 0.9 ml, 0.92 mmol) at room temperature for 1 hour. 
The solvent was removed under reduced pressure and the residue partitioned between 
ether and water (10 ml) The organic layer was washed with 0.5M HC1 (10 ml), dried 
over anhydrous Na2SO4 and concentrated in vacuo. Column chromatography of the 
residue eluting with petrol-EtOAc (2:1) yielded the primary alcohol 83 (127 mg, 
80%). RF  (petrol-EtOAc 5:1) 0.68; [a] 1_19.9 (c 1.05 in CHCI3); Dmax/cm '  (film, 
NaCl) 3200-3700br (OH), 1695 (C=O), 1368 (CMe3)
1 
 1091 (C-O); 6H  (400 MHz,. 
CDC13) 1.34 (3H, d, J6.0, CHMe), 1.36, 1.38 (6H, 2xs, Me-acetal), 1.45 (9H, s, 
OCMe3)
1 
 1.47, 1.53 (6H, 2xs, Me-oxazolidine), 2.25-2.40 (1H, br.s, Oil) and 3.67-
3.99 (6H, m, 4xCH and CH2); (100.6 MHz, CDCI1) 19.2-20.5 (brCH31  CHMe), 
26.5, 26.9 (2xCH3, Me-acetal), 27.0-28.4 (2xbrCH3, Me-oxazolidine), 28.4 (CH39  
OCMe3), 56.9 (brCH, CHMe), 62.6 (CH21  GH20H), 78.5 (CH, CHCH2), 79.9 (C, 
OCMe1), 81.0 (CH, CHCHCH2), 83.0 (CH, CHCHMe), 94.9 (C, C-oxazolidine), 
109.5 (C, C-acetal) and 151.7 (C, C=O); m/z (E.I.) 345 (Mi, 0.1%), 330 (20)9 230. 
(45), 214 (10), 57 (100); (Found: M, 345.21478. C17H31N06 requires M, 
345.21514). 
5.2.18 (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[(1R, 2S)-1-2-iso 
propylidene-3-oxo-propan-1 -yl]oxazolidine 84 
Me O 









Method 1. TPAP Oxidation:- 
A solution of the alcohol 83 (42 mg, 0.12 mmol) in DCM (4 ml) was stirred with 
crushed 3A molecular sieves under a nitrogen atmosphere for 10 minutes. N-Methyl-
N-morpholine-N-oxide (24 mg, 0.18 mmol) was added followed by tetrapropyl 
ammonium perruthenate, TPAP (3 mg, 5 mol%) and the mixture stirred at room 
temperature for 28 hours. Concentration of the solution under reduced pressure and 
column chromatography of the residue eluting with petrol-EtOAc (5:1) gave a product 
84 as an oily residue at RF  0.45 (6 mg) along with recovered starting material 83 (10 
mg), both were complex by nmr analysis. 
Method 2. Swern Oxidation:- 
A solution of dimethyl sulfoxide (21 p1, 0.30 mmol) in DCM (2 ml) was added 
dropwise to a cooled (-70°C) stirred solution of oxalyl chloride (71 jil, 0.14 mmol) in 
DCM (6 ml) under a nitrogen atmosphere. The resulting mixture was stirred at -50°C 
for 10 minutes and then cooled to -70'C and a solution of the alcohol 83 (44 mg, 0.13 
mmol) in DCM (2 ml) added dropwise whilst maintaining the temperature below - 
65°C. The solution was stirred for 30 minutes at this temperature before dropwise 
addition of triethylamine (52 j..ti, 0.38 mmol), and then stirred for a further 30 minutes 
at -50°C. DCM (10 ml) was added and the reaction warmed to 0°C where water (5m1) 
was added and the organic phase washed with 0.1M HC1 (10 ml), brine (10 ml), dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Column 
chromatography eluting with petrol-EtOAc (2:1) yielded starting material 83 (36 mg). 
Method 3. IBX oxidation:- 
A stirred solution of o-iodoxybenzoic acid, ifiX (45 mg, 0.16 mmol) in DMSO (2 ml) 
was stirred for 10 minutes at room temperature before addition of the alcohol 83 (50 
mg, 0.15 mmol) as a solution in DMSO (1 ml). Stirring was continued for 48 hours 
then the reaction was quenched by the addition of water (5 ml). The mixture was 
filtered through a plug of Celite and the filtrates extracted with EtOAc (2 x 10 ml). The 
organic fraction was washed with brine (10 ml), dried over anhydrous Na2SO4 and 
concentrated to give a residue (41%) which was observed to be a streaky mixture when 
visualised by tic. 
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Method 4. TEMPO oxidation: - 
A solution of NaBr (7 mg, 12 mol%) and BTAC (5 mg, 5 mol%) in sat. aq. NaHCO3 
(0.8 ml) was added to a vigorously stirred solution of the diol 83 (179 mg, 0.52 
mmol) and TEMPO (2 mg, 2.5 mol%) in DCM (2 ml). The bi-phasic mixture was 
cooled to 0°C and a solution of sodium hypochiorite (0.6 ml, 30% excess), sat. aq. 
NaHCO3 (0.5 ml) and brine (1.0 ml) added dropwise over 20 minutes. The mixture 
was allowed to stir for 30 minutes at 0°C, then at room temperature for a further 15 
minutes. The aqueous layer  was extracted with DCM (2 x 5 ml) and the combined 
organic fractions washed with sat. aq. NaHCO3 (5 ml), brine (5 ml) and dried over 
anhydrous Na2SO4. Removal of the solveflt in vacuo gave the crude aldehyde 84 (165 
mg, 93%) as an oil. Dmjcm 1  (CH03) 1736 (CO, aldehyde), 1689 (C=O, urethane), 
1375 (CMe2), 1075 (C-O); S (62.9 MHz, CDC13) 20.0 (brCH31  CHMe), 26.2-28.3 
(4xCH3, 2xMe-oxazolidine, 2xMe-acetal), 29.5 (CH3, OCMe3), 55.9 (CH, CHMe), 
77.7 (C, CHCHO), 79.8 (C, OCMe3), 82.2, 83.1 (2xCH, CHCHCHCHO), 95.6 (C, 
C-oxazolidine), 111.5 (C, C-acetal), 151.5 (C, C=O) and 199.8 (CH, C=O aldehyde); 
m/z (F.A.B.) 344 [(MH), 10.6%], 244 (82), 57 (63); [Found: (MH), 344.20464. 
C17H10N06 requires MH, 344.207311. N.B The 1H nmr spectrum was complex and 
difficult to assign. 
5.2.19 (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[(1R, 2S)-3-di 
ethylacetal-1 -2-isopropylidenepropan-1 -yl]oxazolidine 85 
84 	 85 
A stirred solution of the aldehyde 84 (37 mg, 0.11 mmol) in ethanol (1.5 ml) over 
activated 4A molecular sieves was treated with triethyl orthoformate (0.5 ml) under an 
argon atmosphere. para-Toluenesulfonic acid (several crystals) was added and the 
solution stirred for 18 hours before addition of triethylamine (2 drops) to neutralise the 
solution. The sieves were removed by filtration and the solvent removed under reduced 
pressure. Column chromatography eluting with DCM gave the diethyl acetal 85 (18 
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mg,.40%) as an oil. RF  0.28; Dm 1Crrf' (film, NaCl) 1700 (C=O), 1372 (CMe2)1  1087 
(C-O); 8H (360 MHz, CDC13), 1.18-1.28 (6H, ov.t, J7.0, 2xOCH2Me), 1.32 (3H, d, 
J 6.0, CHMe), 1.45 (9H, s, OCMe3)1  1.46-1.65 (12H, 4xs, 2xMe-oxazolidine and 
2xMe-acetal), 3.58 (2H, dq, J 7.0, 2.0, OCH2Me), 3.75 (2H, dq, J 7.0, 2.0, 
OCH2Me), 3.85 (1H, t, J 5.0, CHCHMe), 3.99 (1H, dd, J 6.0, 5.0, CHCHOEt2), 
3.90-4.00 (1H, br.m, CHMe), 4.09 (1H, ov.dd, J 6.0, 5.0, CHCHCHOEt2) and 
4.49 (1H, d, J 5.0, CHOEt2); ö (62.9 MHz, CDC13) 15.0, 15.1 (2xCH31  
2xOCH2Me), 20.4 (CH31  CHMe), 27.0-27.6 (brCH3 , 2xMe-oxazolidine and 2xMe-
acetal), 28.3 (CH3, OCMe3), 54.4 (CH, CHMe), 62.9, 63.8 (2xCH2, 2xOCH2Me), 
78.5, 78.9 (2xCH, CHCHCHOEt2), 79.4 (C, OCMe3), 82.2 (CH, CHCHMe), 94.5 
(C, C-oxazolidine), 102.3 (CH, CHOEt2)1  110.4 (C, C-acetal) and 151.6 (C, C=O); 
m/z (F.A.B.) 418 [(MH), 68.4%], 402 (28), 372 (19), 360 (3), 29 (100); [Found: 
(MH), 418.28048. C21H40N07 requires MH, 418.281941. 




Me" N SO3  
H2 
85 	 87 
An ice cold suspension of the acetal 85 (45 mg, 0.11 mmol) in water (2.5 ml) was 
saturated with SO2 gas and then stirred for 2 days at 40°C. Methanol (I ml) was added 
and the solution cooled to 0°C and saturated once again with SO2. This solution was 
allowed to stand at this temperature for 15 hours, however no precipitate resulted. 
Removal of the solvent under reduced pressure yielded a white solid which was then 
redissolved in water (1 ml) and methanol (1 ml) and again saturated with SO2 at 0°C. 
After 12 hours a white precipitate was collected by filtration and identified as the 







Me' N SO3  
H2 
84 	 87 
An ice cold suspension of the aldehyde 84 (165 mg, 0.48 mmol) in water (2 ml) was 
saturated with SO2 gas and then stirred at 40°C for 48 hours. The resulting suspension 
was filtered to collect the precipitate and the mother liquors treated with methanol (1 
ml), cooled to 0°C and saturated once more with SO2. The resulting mixture was 
allowed to stand at this temperature for 8 hours and then filtered to collect the solid. 
The combined solid were washed with methanol (2 x 3m1) and dried to yield the 
bisulfite adduct 87 as a white solid (72 mg, 66%). 
Dmax/Cm 1  (KBr disc) 3353br (OH), 2489br (NH), 1157 (SO2), 1046 (S=0); 8H  (600 
MHz, D20) 1.22 (3H, d, J 6.5, CHMe), 3.57 (1H, dq, J 6.5, 1.0, CHMe), 3.75 (1H, 
dd, J 9.0, 3.0, CHCHCHMe), 4.01 (1H, dd, J 3.0, 1.0, CHCHMe), 4.09 (lH, d, J 
10.5, CHS03) and 4.18 (1H, dd, J 10.5, 9.0, CHCHS03); E (62.9 MHz, D20) 13.8 
(CH3, CHMe), 55.7, 66.7,. 69.4, 70.3 and 72.7 (5xCH); m/z (F.A.B.) 228 [(MH), 
14.5%], 146 (100), 129 (17); [Found: (MH), 228.05360. C6H13N06S requires MH, 
228.054191. 
5.2.21 L-deoxyfuconojirimycin 7 (1,5-dideoxy-1,5-imino-L-fucitol) 
OH 
OH 	 HO 	,OH 
SO3 	 Me N 
H 
87 	 7 
To a stirred suspension of the bisuiphite adduct 87 (40 mg, 0.17 mmol) in water (3 
ml) was added Ba(OH)2.8H20 (55 mg, 0.18 mmol) and the resultant mixture stirred at 
room temperature for 1 hour. The precipitate was filtered through a plug of Celite, 
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washed with water (1 ml) and the combined filtrates treated with palladium (5% on 
charcoal, 5 mg) and the deoxygenated suspension stirred under an atmosphere of 
hydrogen for 15 hours. The mixture was filtered through a plug of Celite to remove the 
catalyst, concentrated in vacuo and then passed down a cation exchange resin (strong 
acid, Na) eluting with a gradient of 1M NH40H. The appropriate fractions were 
collected and freeze dried to give L-deoxyfuconojirimycin26 7 (22 mg, 86%). [a]' - 
48.3 (c 0.46, H20); 8H  (250 MHz, D20) 1.06 (3H, d, J 7.0, CHMe), 2.35 (1H, dd, J 
13.0, 11.01  CH2NH), 2.80 (1H, dq, J 7.0, 1.0, CHMe), 3.06 (1H, dd, J 13.0, 5.5, 
CH2NH), 3.45 (1H, dd, J 10.0, 3.0, CHCHCH2), 3.67 (1H, m, CHCH2) and 3.77 
(1H, dd, J 3.0, 1.0, CHCHMe); 8c (62.9 MHz, D20) 15.9 (CH31  CHMe), 18.4 
(CH2, CH2NH), 53.2 (CH, CHNH), 67.3, 72.2 and 74.7 (3xCH, GHOH). 
5.2.22 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(JR, 2S)-3-iodo-
1 -2-isopropylidenepropan-1 -yl]oxazolidine 88 
Me 	 Me 




83 	 88 
Iodine (41 mg, 0.16 mmol) was added in portions to a stirred solution of the primary 
alcohol 83 (38 mg, 0.11 mmol), imidazole (12 mg, 0.17 mmol), and triphenyl 
phosphine (42 ing, 0.16 mmol) in ether/acetonitrile (3:1, 4 ml) and the mixture stirred 
at room temperature for 22 hours. The precipitate was filtered through a plug of Celite, 
washed with ether (2 x 5 ml)- and the combined filtrates concentrated under reduced 
pressure. The oily residue was subjected to column chromatography eluting with 
petrol-EtOAc (5:1) to yield the iodo compound 88 (23 mg, 45%) as a white solid and 
recovered starting material 83(13 mg). R 085; 8H (400 MHz, CDC13) 1.35 (3H, d, J 
6.0, CHMe), 1.39, 1.47 (6H, 2xs, Me-acetal), 1.47 (9H, s, OCMe3)1  1.49, 1.57 
(6H, 2xs, Me-oxazolidine), 3.32 (1H, dd, J 10.5, 5.5, CH2I), 3.53 (1H, d.d, J 10.5, 
3.5, CHI), 3.67-3.74 (2H, m, CHCHCH2 and CHCHMe) 3.80-3.84 (1H, in, 
CHCH2) and 3.90-4.00 (1H, br.m, CHMe); 8c (100.6 MHz, CDC13) 7.8 (CH21  
'H21), 19.2 (brCH3, CHMe), 27.4, 27.5 (4xbrCH3, Me-acetal and Me-oxazolidine), 
28.5 (CH3, OCMe3),- 56.8 (CH, CHMe), 79.0 (CH, CHCH2), 79.9 (C, OCMe3)1  
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81.5 (CH, CHCHCH2), 83.1 (CH, CHCHMe), 94.9 (C, C-oxazolidine), 109.9 (C, 
C-acetal) and 151.7 (C, C=O); mlz (E.I.) 440 [(M-15), 19.8%], 384 (25), 340 (20), 
57 (100). (Found; W, 455.11841. C17H30N051 requires M, 455.11841). 
5.2.23 Attempted deprotection of (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-
methyl-5-[(1 R, 2S)-3 '-iodo-1 -2-isopropylidenepropan-1 -yl]oxazolidine and ring 
closure 
The iodo compound 88 (20 mg, 0.04 mmol) was dissolved in THF (3 ml) and 50% 
aq. trifluoroacetic acid (1 nil) added and stirred at room temperature for 24 hours. The 
solvent was removed in vacuo and co-evaporated with CHC13 to remove traces of 
trifluoroacetic acid, but a complex mixture was observed by tic and no purification was 
attempted. 
5.2.24 (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[(JS, 2S)-3-(tert-
butyldimethylsilyloxy)-1 -2-isopropylidenepropan-1 -yl]oxazolidine 89 
Me OH 	 Me O 






A stirred solution of the triol 66 (160 mg, 0.53 mmol) in DCM (10 ml) under an 
atmosphere of argon was treated with 2,6-lutidine (140 pJ, 1.2 mmol) and cooled to - 
10°C. tert-Butyldimethylsilyl trifiate (132 p1, 0.60 mmol) was added slowly and the 
solution stirred at this temperature for 1 hour. EtOAc (10 ml) and water (10 ml) were 
added and the reaction allowed to warm to room temperature where the organic liquors 
were washed with 0.3M KHSO4 (10 ml), water (10 ml) and brine (10 ml). 
Concentration of the liquors under reduced pressure gave the TBS ether as an oil, 
which was used in the next step without purification. 
A stirred solution of the TBS ether in acetone (3 ml) was treated with 2,2-
dimethoxypropane (1 ml) and boron trifluoride etherate (10 j.i1) for 2 hours at room 
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temperature. The solvent was removed in vacuo, the residue taken up in DCM (5 ml) 
and washed with sat. aq. NaHCO3 (5 ml), brine (5 ml), and dried over anhydrous 
Na2SO4. Concentration in vacuo followed by column chromatography eluting with 
petrol-EtOAc (20:1) gave the acetal 89 as an oil (150 mg, 62%). RF  (petrol-EtOAc 8:1) 
0.67; [a] -221  .39 (c 0.96 CHC13); Dm/Cffl'  (film, NaCl) 1698 (C=O), 1385 (CMe2), 
1253 (SiMe2), 1084 (Si-O), 836 (SiMe2); 8H (250 MHz, CDC13) 0.44 (6H, s, SiMe), 
0.86 (9H, s, SiCMe3), 1.22 (3H, s, Me-acetal), 1.29 (3H, d, J 6.0, CHMe), 1.38 
(3H, s, Me-acetal), 1.44 (9H, s, OCMe3), 1.45, 1.46 (6H, 2xs, Me-oxazolidine) and 
3.65-4.06, (611, m, 4xCH and CH20TBS); 8c (62.9 MHz, CDC13) -5.6 (CH31  
SiMe2), 18.2 (C, SiCMe3), 20.0 (brCH31  CHMe), 25.7 (CH3, SiCMe3), 26.6, 27.1 
(brCH3, 2xMe-acetal and 2xMe-oxazolidine), 28.3 (CH3, OCMe3), 53.8 (CH, 
CHMe), 63.7 (CH2, CHOTBS), 76.5, 77.5 (2xCH, CHCHCH2), 79.5 (C, OCMe3), 
80.8 (CH, CHCHMe), 94.8 (C, C-oxazolidine), 109.36 (C, C-acetal) and 151.8 (C, 
C=O); m/z (F.A.B.) 460 [(MH)1 , 6.6%]9 444 (14)9 344 (31), 57 (53); [Found; 
(MH), 459.30331. C23H46NO6Si requires MH, 459.30162]. 
5.2.25 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(1 S, 2S)-3-hydro 
xy-1 -2-isopropyiidenepropan-1 -yl]oxazolidine 90 
Me O 	 Me 






A stirred solution of the TBS ether 89 (150 mg, 0.33 mol) in THF (4 ml) was treated 
with TBAF (1M solution in THF, 0.51 ml, 0.51 mmol) for 1 hour at room 
temperature. The solvent was removed in vacuo, the residue taken up in ether (5 ml) 
and washed with water (5 ml), dilute HC1 (5 ml), brine (5 ml) and dried over 
anhydrous Na2SO4. Evaporation of the solvent under reduced pressure and column 
chromatography of the residue eluting with petrol-ether (1:1) gave the primary alcohol 
90 as an oil (90 mg, 80%). RF  (petrol-EtOAc 5:1) 0.65; [aJ -6.12 (c 0.57 in 
CHC13); i. m /cm1  (film, NaC1) 3462br (OH), 1694 (C=O), 1391 (CMe2), 1080 (C-O); 
6H (200 MHz, CDC13) 1.31 (3H, d, J 6.0, CHMe), 1.40 (6H, br.s, 2xMe-acetal), 
1.45 (12H, br.s, OCMe3 and Me-oxazolidine), 1.56 (3H, s, Me-oxazolidine) and 
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3.59-4.14 (6H, m, 4xCH and CH20H); 8c (50.1 MHz, CDC13) 18.2 (CH31  CHMe), 
25.3-25.7 (4xCH3, 2xMe-acetal and 2xMe-oxazolidine) 27.0 (CH3, OCMe3), 52.7 
(CH, CHMe), 60.8 (Cl21  CH20H), 75.0, 75.7 (2xCH, CHCHCH2), 78.5 (C, 
OCMe3), 78.8 (CH, CHCHMe), 93.4 (C, C-oxazolidine), 108.3 (C, C-acetal) and 
150.7 (C, C=O); m/z (F.A.B.) 346 [(MH), 19.6%], 330 (26), 57 (61); [Found; 
(MH), 346.22249. C17H32N06 requires MH, 346.22296]. 
5.2.26 (4S, 5R)-N-(tert-butoxycarbonyl)-2, 2-dimethyl-4-methyl-5-[(1 S, 2R)-1 -2-iso 
propylidene-3-oxo-propan-1 -yl]oxazolidine 91 









A solution of NaBr (4 mg, 0.04 mmol) and BTAC (3 mg, 0.02 mmol) in sat. aq. 
NaHCO3 (0.87 ml) was added to a vigorously stirred solution of the alcohol 90 (90 
mg, 0.26 mmol) and TEMPO (2 mg, 0.01 mmol) in DCM (1.5 ml) at 0°C. A solution 
of sodium hypochiorite (1.12M, 0.30 mmol) in sat. aq NaHCO3 (0.52 ml) and brine 
(1.04 ml) were added dropwise over 45 minutes and stirring was continued for a 
further 45 minutes at 0°C and then at room temperature for 15 minutes. The layers 
were separated, the aqueous layer extracted with DCM (2 x 3 ml) and the combined 
organic fractions washed with sat. aq. NaHCO3 (5 ml), brine (5 ml), dried over 
anhydrous Na2SO4 and concentrated in vacuo to give the crude aldehyde 91 (74 mg, 
83%). um /cm 1  (film, NaCl) 1736 (C=O aldehyde), 1693 (C=O urethane), 1392 
(CMe2)1  1097 (C-O); t5H  (200 MHz, CDC13) 1.19 (3H, s, Mè-acetal), 1.28 (3H, d, J 
6.0, CHMe), 1.35 (3H, s,. Me-acetai), 1.41-1.43 (12H, br.s, 0(,Me3 and Me-
oxazolidine), 1.53 (3H, s, Me-oxazolidine), 3.75-3.80 (2H, br.m, CHCHIVIe), 4.13 
(1H, dd, J 7.0, 3.5, CHCHCHO), 4.28 (1H, dd, J 7.0, 1.5, CHCHO) and 9.74 (1H, 
d, J 1.5, CHO); 8c (50.1 MHz, CDC13) 18.1 (CH31  CHMe), 24.8-25.5 (brCH31  
2xMe-acetal and. 2xMe-oxazolidiiie), 27.0 (CH3, OCMe3), 52.6 (CH, CHMe), 77.5 
(C, OCMe3), 78.6, 78.8 (3xCH, CHCHCHCHO), 93.9 (C, C-oxazolidine), 110.5 
(C, C-acetal), 150.6 (C, C=O urethane) and 199.8 (C, C=O aldehyde); m/z (F.A.B.) 
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344 [(MH), 10.6%1. 244 (82), 57 (63); [Found: (MH), 344.20665. C17H30N06 
requires MH, 344.207311. 
5.2.27 Attempted ring closure of (4S, 5R)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-
methyl-5-[(1 S, 2R)-1 -2-isopropylidene-3-oxo-propan-1 -yl]oxazolidine 91 via the 
bisulfite adduct 92 
	





08 0 	 Me N 
-1--v 	
H 
91 	 93 
A cold (0°C) suspension of the aldehyde 91 (70 mg, 0.2 Ommol) in water (2 ml) was 
saturated with SO2, then allowed to stir at 40°C for 2 days before cooling to 0°C. 
Methanol (1.5 ml) was added and the mixture re-saturated with SO2 and allowed to 
stand for 12 hours at 0 °C, no precipitate resulted hence the solvent was removed in 
vacuo. The residue was dissolved in water (2 ml) and treated with Ba(OH)2.8H20 (62 
mg, 0.19 mmol) for 4 hours. The precipitate was filtered, dissolved in water (3 ml) 
and stirred under an atmosphere of hydrogen in the presence of palladium (5% on C, 5 
mg) for 24 hours. Removal of the catalyst by filtration through a plug of Celite and 
concentration of the filtrate under reduced pressure gave an oily residue which was 
complex by 'H nmr spectroscopy and did not illustrate the presence of a cyclised ring. 
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53 EXPERIMENTAL FOR CHAPTER 4. THE SYNTHESIS OF 191-
BIS-HYDROXYMETHYL- 1,5-DIDEOXY- 1,5-IMIN0-L-FucITOL 
5.3.1 (2S, 3R)-N-(4-toluenesulfonyl)-2-amino-3,6-dihydroxy-hex-4-yne 101 






The oxazolidine 57 (52 mg, 0.14 mmol) was dissolved in EtOAc (1 ml), 3M HCl 
(imi) added and the reaction stirred for 24 hours. Concentration under reduced 
pressure gave an oily residue which was then suspended in DCM (1 ml) and cooled to 
0°C. Triethylamine (59 p1, 0.42 mmol) was added, followed by slow addition of tosyl 
chloride (30 mg, 0.15 mmol) and the solution warmed to room temperature and stirred 
for 26 hours. EtOAc (5 ml) and water (5 ml) were added, the layers separated and the 
organic liquors washed with brine (5 ml), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The residue was subjected to column chromatography eluting 
with EtOAc-petrol (2:1) to give the N-Tosyl amide 101 (22. mg, 56%) as a solid. 
Method 2. 
The oxazolidine 57 (56 mg, 0.15 mmol) was treated with trifluoroacetic acid (99%, 
0.5 ml) at 0°C with stirring for 1 hour at room temperature. Concentration under 
reduced pressure gave an oily residue, which was suspended in DCM (1 ml) and 
cooled to 0°C. Triethylamine (70 p1, 0.67 mmol) was added followed by tosyl chloride 
(32 mg, 0.17 mmol) and the mixture stirred for 26 hours at room temperature. The 
solvent was removed in vacuo and the residue subjected to column chromatography 
eluting with EtOAc-petrol (2:1) to give the N-Tosyl arnide 101 as a white solid (18 
mg, 44%). 
Method 3. 
Trifluoroacetic acid (99%, 0.5 ml) was added to the oxazolidine 57 (23 mg, 0.06 
mmol) and the mixture stirred for 30 minutes at room temperature. Water (1 ml) was 
added, and the mixture was concentrated under reduced pressure and the residue 
dissolved in DCM (0.5 ml) and 1,4-dioxane (5 ml). Trlethylamine (18 p1, 0.13 mmol) 
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was added to the stirred solution at 0°C followed by tosyl chloride (13 mg, 0.07 
mmol) and stirring was continued at room temperature for 26 hours. EtOAc (5 ml) and 
water (5 ml) were added and the organic liquors were separated and washed with brine 
(5 ml), dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue eluting with EtOAc-petrol (2:1) gave the N-Tosyl amide 
101 as a white solid (8 mg, 5 1%). 
RF 0.25; Dm/cm' (film, JR card) 3273br (OH), 1325, 1159 (S02-N), 1091 (C-O); 6H 
(250 MHz, DMSO) 0.89 (3H, d, J 6.5, CHMe), 2.34 (3H, s, Me-aryl), 3.21 (1H, m, 
CHMe), 4.01 (2H, dd, J 6.0, 2.0, CH20H), 4.17 (1H, m, CHOH), 5.13 (1H, t, J 
6.0, CH20H), 5.54 (1H, d, J 6.0, CHOH), 7.38 (2H, d, J 8.5, CH-aryl), 7.60 (1H, 
d, J 8.0, NH) and 7.70 (2H, d, J 8.5, CH-aryl); 8c (62.9 MHz, DMSO) 14.8 (CH11 
CHMe), 21.1 (CH3, Me-aryl), 49.1 (CH21 CH20H), 54.1 (CH, CHMe), 83.9, 84.7 
(2xC, C-acetylene), 126.6, 129.6 (CH, aryl), 138.9 and 142.6 (2xC, aryl); m/z 
(F.A.B.) 284 [(MH), 100%1, 268 (39), 198 (61); [Found: (MH), 284.09537. 
C13H18N04S requires MH, 283.095661. 
5.3.2 Benzyloxy-acetic acid ethyl ester 109 
EtO 	
OH 	
EtO )t,'~ OBn 
108 	 109 
To a solution of ethyl glycolate 108 (12.5 ml, 0.13 mol) in ether (220 ml) was added 
silver (I) oxide (33.60 g, 0.15 mol) and benzyl bromide (17.8 ml, 0.15 mol) and the 
resulting black suspension brought to reflux for 24 hours. The solid was removed by 
filtration through a pad of Celite, washed with ether (2 x 40 ml) and the combined 
filtrates concentrated in vacuo. The crude product was subjected to column 
chromatography eluting with petrol-ethyl acetate (5:1) to yield the benzyl ether 109 as 
an oil (20.71 g, 82%). RF 0.38; 1/cm' (film, NaC1) 1750 (C=O), 1201, 1128 (C-
0); 8H (250 MHz, CDC13) 1.28 (3H, t, J 7.0, MeCH2), 4.08 (2H, s, CH2OBn), 4.22 
(2H, q, J 7.0, CH2Me), 4.62 (2H, s, CH2Ph) and 7.25-7.38 (5H, in, Ph); öc (62.9 
MHz, CDC13) 14.0 (CH3, CH2Me), 60.7 (CH21 CH2Me), 67.0 (CH21 CH20Bn), 73.2 
(CH2, CH2Ph), 127.9, 128.3 (CH, Ph), 136.9 (C, Ph) and 170.2 (C, C=O); m/z 
(F.A.B.) 195 [(MH), 100%1, 181 (89), 149 (3), 77 (18); [Found: (MH), 
195.10212. C11H1503 requires MH, 195.10221). 
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5.3.3 Benzyloxyacetaldehyde 110 
EtO)L,'~ OBn 	
H"~OBn 
109 	 110 
A cooled (-78°C) stirred solution of the ester 109 (14.60 g, 0.08 mol) in DCM (150 
ml) under a nitrogen atmosphere was treated with di-isobutylaluminium hydride (1M 
solution in toluene, 75 ml, 0.08 mol) by slow addition and stirring was continued at 
this temperature for 2 hours. After addition of sat. aq. NH4C1 (50 ml) and 1M HC1 (50 
ml) the resulting suspension was warmed to room temperature and the organic phase 
separated, dried over anhydrous Na2SO4 and concentrated in vacuo to give the crude 
aldehyde. Column chromatography of the residue eluting with petrol-ethyl acetate (4:1) 
gave the aldehyde 122 110 (6.38 g, 60%). RF (hexane-EtOAc 2:1) 0.35; Dmjcm' (film; 
NaCl) 1736 (C=O), 1116 (C-O); 6H (200 MHz, CDC13) 4.09 '(2H, d, J 0.5Hz, 
CH2CHO), 4.62 (2H, s, CH2Ph), 7.25-7.41 (51-I, m, Ph) and 9.70 (1H, t, J 0.5, 
CH2CHO); 8c (50.1 MHz, CDC13) 73.4 (CH21 CH2Ph), 75.1 (CH21 CH20Bn),, 
127.6, 127.8, 128.0, 128.2, 128.4 (CH, ph), 136.7 (C, Ph) and 200.2 (C, =O); 
m/z (F.A.B.) 151 [(MH), 1.2%1, 149 (5), 107 (4), 91(100); [Found: (MH), 
151.07570. C9H1102 requires MH, 151.07590]. 




 H	 TMS 
1I0 	 111 
A solution of bis-trimethylsilylacetylene (8.04 g, 0.05 mol) in THF (100 ml) was 
cooled to -30°C under nitrogen and methyl lithium (1.5M solution in ether as a 
complex with LiBr, 32 ml, 0.05 mol) was added rapidly. The solution was stirred at 
room temperature for 1 hour then cooled to 0°C whereupon a solution of the aldehyde 
110 (3.93 g, 0.03 mol) in THF (20 ml) was added dropwise over 15 minutes. 
Stirring was continued at room temperature for a further 2 hours then the reaction was 
quenched by addition of the reaction mixture to ice cold sat. aq. NH4C1 (50 ml). After 
separation of the two phases the aqueous layer was extracted with ether (2 x 40 ml) 
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and the combined organic extracts washed with sat. aq. NaHCO3 (40 ml), brine (40 
ml), dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue eluting with petrol-ethyl acetate (6:1) gave racemic TMS 
propargyl alcohol105 111 (4.74 g, 75%). RF  (hexane-EtOAc 5:1) 0.29; -Om./cm-1 (film, 
NaCl) 3419br (OH), 2171 (acetylene), 1093 (C-O), 843 (SiMe3); 8H  (250 MHz, 
CDC13) 0.17 (9H, s, SiMe3), 2.55 (1H, br.s, OH), 3.55 (1H, dd, J 10.0, 7.5, 
CH2OBn), 3.64 (1H, dd, J 10.0, 3.5, CH2OBn), 4.56 (1H, dd, J 7.5, 3.5, 
CHCH20Bn) 4.60 (2H, s, CH2Ph) and 7.28-7.39 (5H, m, Ph); Sc  (62.9 MHz, 
CDC13) -0.4 (CH31  SiMe3), 62.0 (CH, CHOH), 73.2 (CH21  CH2Ph), 76.4 (CH21  
CH20Bn), 90.4, 102.9 (2xC, C-acetylene), 127.6, 127.7, 127.7 (CH, Ph), and 
137.5 (C, Ph); m/z (F.A.B.) 249 [(MH), 1.3%1, 247 (2)1 91 (93), 73 (100); [Found: 
(MH), 249.13056. C14H2102Si requires MH, 249.13108]. 
5.3.5 (3RS)-4-benzyloxy-3-tetrahydropyran-2-yloxy-1 -trirnethylsilylbut-1 -yne 112 
	
OH 	 OTHP 
OBn 	 OBn 




A stirred solution of the racemic propargyl alcohol 111 (240 mg, 0.99 mmol) in DCM 
(3 ml) was treated with 3,4-dihydro-2H-pyran (117 j.tl, 1.29 mrnol) and para-
toluenesulfonic acid (9 mg, 5 mol%) and stirring continued for 1 hour. The mixture 
was diluted with ether (5 ml) and partitioned between a mix of brine (3 ml), sat. aq. 
NaHCO3 (3 ml) and water (6 ml). The organic extract was dried over anhydrous 
Na2SO4 and concentrated in vacuo. The resulting residue was subjected to column 
chromatography eluting with petrol-ether (12:1) to give the THP -ether 112 as an oil 
(276 mg, 84%). RF  (petrol-ether 9:1) 0.37-0.47; um/cm  (film, JR card) 2171 
(acetylene), 2148 (SiMe3), 1118, 1075 (C-O), 839 (SiMe3); 6H  (250 MHz, CDC13) 
0.18 (9H, s, SiMe3), 1.48-1.90 (6H, m, CH2CH2CH2), 3.47-4.03 (4H, m, CH2OBn, 
and CH2CH20), 4.53-4.63 (1H9  in, CHOTHP), 4.66 (2H, s, CH2Ph), 4.68-5.04 
(1H, rn, O-CH-O) and 7.23-7.40 (5H, m, Ph); Sc  (62.9 MHz, CDC13)  -0.3 (CH31  
SiMe3)
1 
 18.6, 25.3, 30.2 (3xCH2, CR2CH2CH2), 61.7 (CH21  CH2CH2O), 64.8, 67.1 
(CH, CHOTHP diastereorners), 72.1, 73.1 (2xCH21  CH2Ph and CH20Bn), 91.1 (C, 
C-acetylene), 94.9, 98.5 (CH, O-CH-O diastereomers), 101.7 (C, C-acetylene), 
127.3, 127.4, 128.2 (CH, Ph) and 138.1 (C, Ph); in/z (F.A.B.) 333 [(MH), 6.3%1, 
Experimental 
247 (1), 231 (5), 85 (100), 73 (19); [Found: (MH), 333.18944. C19H2903Si requires 
MH, 333.188601. 
5.3.6 (2RS)-1-benzyloxy-2-tetrahydropyran-2-yloxybut-3-yne 113 
THP 	 OTHP 
OBn 	 OBn 
TMS 	 H 
112 	 113 
A stirred solution of the TMS-acetylene 112 (276 mg, 0.83 mmol) in methanol (8 ml) 
was treated with potassium carbonate (172 mg, 1.25 rnmol) and the mixture stirred at 
room temperature for 2 hours. Ether (5 ml) and water (5 ml) were added and the 
aqueous layer extracted with ether (2 x 5 ml), the combined organic phases were dried 
over anhydrous Na2SO4 and concentrated in vacuo. Column chromatography of the 
residue eluting with petrol-EtOAc (5:1) gave the terminal acetylene 113 (196 mg, 
90%). RF  (hexane-EtOAc 5:1) 0.56; umaxlcm'  (film, NaCl) 3287 (CH acetylene), 2114 
(acetylene), 1123, 1075 (C-U); H (250 MHz, CDC13) 1.52-1.84 (6H, m, 
CH2CH2CH2), 2.41 (1H, d, J 2.0, CH-acetylene), 3.49-3.90 (4H, m, CH2OBn and 
CH2CH20), 4.55-4.88 (311, m, CH2Ph and CHOTHP), 5.00-5.03 (1H, t, J 3.0, 0-
CH-0) and 7.25-7.39 (5H, m, Ph); Sc (62.9 MHz, CDC13) 18.8, 25.2, 30.2 (3xCH21  
CH2CH2CH2), 61.7 (CH21  CH2CH20), 64.2, 66.3 (CH, O-CH-OTHP), 71.9, 72.9 
(CH2, CH2Ph and CH20Bn), 74.1 (CH, CH-acetylene), 80.2 (C, C-acetylene), 95.2, 
98.8 (CH, O-CH-U diastereomers), 127.4, 128.2 (CH, Ph) and 138.0 (C, Ph); m/z 
(F.A.B.) 261 [(MH), 11.5%], 85 (100); [Found: (MH), 261.14803. C16H2103 
requires MH, 261.149071. 
5.3.7 (2S, 3RS, 6RS)-N-(tert-butoxycarbonyl)-2-amino-3-hydroxy-6-tetrahydropyr 
an-2-yloxy-7-benzyloxyhept-4-yne 114 
OTHP 
Me 	, -LOBn 
BocHN BocHN 




To a cooled (-100°C) stirred solution of the terminal acetylene 113 (196 mg, 0.75 
mmol) in THF (8 ml) and ether (2 ml) was added n-butyllithium (1.44M in hexanes, 
0.52 ml, 0.75 mmol) dropwise and stirring continued for 5 minutes. A solution of N-
Boc-L-alaninal 53 (63 mg, 0.36 mmol) in THF (2 ml) was added slowly and after a 
further 5 minutes the reaction was quenched by addition of sat. aq. NH4C1 (5 ml) and 
the resulting suspension warmed to room temperature. The aqueous layer was 
extracted with ether (2 x 5 ml) and the combined organic phases dried over anhydrous 
Na2SO4 and concentrated in vacuo. Column chromatography of the residue eluting 
with petrol-EtOAc (2:1) yielded the unreacted terminal acetylene 113 (137 mg) and the 
fl-amino alcohol 114 (89 mg, 56%). RF  (hexane-EtOAc 2:1) 0.30; D,/cm' (film, JR 
card) 3384br (OH), 1691 (C=O), 1364 (CMe3), 1166, 1114, 1022 (C-O); 8H  (250 
MHz, CDC13) 1.13-1.23 (3H, m, CHMe), 1.41 (9H, s, OCMe3)1  1.46-1.79 (6H, m, 
CH2CH2CH2), 3.46-3.87 (6H, m, CH2OBn, CH2CH20, CHMe and OH), 4.34-4.97 
(6H, m, CH2Ph, O-CH-O, CHOTHP, NH, CHOH) and 7.28-7.35 (5H, Ph); & 
(62.9 MHz, CDC13) 15.9 (CH31  CHIVIe), 18.7, 25.2, 30.1 (3xCH2, CH 2CH 2CH 2), 
28.2 (CH3, OCMe3)1  50.5 (CH, CHMe), 61.6 (CH21  CH2CH20), 64.4, 65.5 (CH, 
C'HOH diastereomers), 71.9, 73.2 (2xCH2, cH2Ph and CH20Bn), 79.5, 82.1,'84.6 
(3xC, 2xC-acetylene and OCMe3), 95.1, 98.9 (2xCH, CHOTHP and O-CH-O), 
127.5, 128.2 (CH, Ph), 137.8 (C, Ph) and 155.7 (C, G=O); rn/z (F.A.B.) 434 
[(MH), 3.1%], 85 (20), 57 (13); [Found: (MH)', 434.25401. C24H36N06 requires 
MH, 434.254261. 






A solution of NaBr (240 mg, 2.41 mmol, 10 mol%) and BTAC (220 mg, 1.20 mmol, 
5 mol%) in sat. aq. NaHCO (40 ml) was added to a vigorously stirred solution of the 
propargyl alcohol 111 (5.87 g, 21.12 mmol) and TEMPO (39 mg, 0.26 mmol, 1 
mol%) in DCM (60 ml). The bi-phasic mixture was cooled to 0°C and a solution of 
sodium hypochlorite (0.86M, 36 ml, 30% excess), sat. aq. NaHCO3 (24 ml) and brine 
(48 ml) were added dropwise over 1 hour. Stirring was continued for a further 1 hour 
at 0°C and then at room temperature for a further 2 hours. The phases were separated, 
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the aqueous layer extracted with DCM (2 x 30 ml) and the combined organic extracts 
washed with sat. aq. NaHCO3 (50 ml), brine (50 ml), dried over anhydrous Na2SO4 
and the solvent removed in vacuo to yield the crude a;f3-aceiylenic ketone 115 (5.74 
g, 97%). 'um/cm'  (film, NaCl) 2150 (acetylene), 1678 (C=O), 1251 (SiMe3), 1080 
(C-O), 846 (SiMe3); 8H (250 MHz, CDC13) 0.24 (9H, s, SiMe3), 4.22 (2H, s, 
CH2OBn), 4.63 (2H, s, CH2Ph) and 7.27-7.37 (5H, m, Ph); 8c (62.9 MHz, CDC13) - 
1.1 (CH3, SiMe3), 73.2 (CH21 CH2Ph), 77.5 (CH21 CH20Bn), 99.6, 101.1 (2xC, C-
acetylene), 127.7, 127.8, 128.3 (CH, Ph), 136.9 (C, Ph) and 184.5 (C, C=O); mlz 
(E.I.) 246 (M, 6.3%), 172 (15), 139 (78), 73 (100); (Found: M, 246.10761. 
C14H1802Si requires M, 246. 10728). 
5.3.9 4-benzyloxy-3,3-ethylenedioxy-1-trimethylsilylbut-1-yne 116 
OBn )KOBn 
TMS 	 TMS 
115 	 116 
Ethylene glycol (70 ml) and trimethylsilyl chloride (7.3 ml) were added to a stirred 
solution of the a,13-acetylenic ketone 115 (3.55 g, 14.41 mmol) in DCM (35 ml) 
under a nitrogen atmosphere. The solution was stirred at room temperature for 48 
hours whereafter the reaction was quenched by addition of sat. aq. NaHCO3 (30 ml). 
The phases were separated and the organic phase was dried over anhydrous Na2SO41  
concentrated in vacuo and the residue subjected to column chromatography eluting 
with petrol-ether (10:1) to yield the 1,3-dioxolane 116 (3.69 g, 88%). RF  (hexane-
ether 5:1) 0.28; (Found: C, 68.81, H, 8.66; C16H2203Si requires C, 68.68; H 8.49%); 
hJmjCm '  (film, NaCl) 1251 (SiMe3), 1103 (C-O), 843 (SiMe3); 6H  (250 MHz, CDC13) 
0.18 (9H, s, SiMe3), 3.70 (2H, s, CH2OBn), 3.99-4.14 (4H, m, CH2CH2), 4.70 
(2H, s, CH2Ph) and 7.26-7.39 (5H, m, Ph); Sc  (62.9 MHz, CDC13) -0.5 (CH31  
SiMe3), 65.1 (CH21  CH2CH 2), 72.8 (CH21  CH20Bn) 73.6 (CH21  CH2Ph), 89.8 (C, 
C-ketal), 100.9, 101.6 (2xC, C-acetylene), 127.4, 127.4, 128.1 (CH, Ph) and 137.9 
(C, Ph); m/z (F.A.B.) 291 [(MH), 15.5%), 290 (8), 213 (20), 169 (100), 97 (74), 
91(12); [Found: (MH), 291.14215. C16H2103Si requires MH, 291.14165]. 
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Potassium carbonate (2.61 g, 18.9 mmol) was added to a stirred solution of TMS-
acetylene 116 (3.65 g, 12.5 mmol) in methanol (100 ml) and stirring continued for 2 
hours at room. temperature. Ether (50 ml) and water (30 ml) were added and the 
aqueous layer was separated and extracted with ether (2 .x 20 ml). The combined 
organic fractions were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Column chromatography of the residue eluting with petrol-EtOAc (5:1) gave 
the terminal acetylene 117 (2.56 g, 93%). RF  (petrol-EtOAc 6:1) 0.31; 1)m/cm1  (film, 
NaC1) 3276 (acetylene CH), 2110 (acetylene), 1104 (C-O); oH  (250 MHz, CDC13) 
2.56 (1H, s, CH-acetylene), 3.70 (2H, s, CH2OBn), 4.01-4.14 (4H, m, CH2CH,), 
4.70 (2H, s, CH2Ph) and 7.27-7.37 (5H, rn, Ph); O (62.9 MHz, CDC13) 65.0 (CH21  
CH2CH2), 72.7 (CH21  CH20Bn), 72.9 (CH, CH-acetylene), 73.7 (CH2, CH2Ph), 
78.0 (C, C-ketal), 101.5 (C, C-acetylene), 127.4, 127.5, 128.2 (CH, Ph) and 137.7 
(C, Ph); nilz (F.A.B.) 219 [(MH), 52.7%1, 193 (33), 97 (97), 91 (68); [Found: 
(MH)', 219.10268. C13H1503 requires MH, 219.10212] 
5.3.11 (2S, 3SR)-N-(tert-butoxycarbonyl)-2 -amino- 7-benzyloxy-6, 6-ethylenedioxy-
3-hydroxyhept-4-yne 118a/b 
0 o 
Me 	 Me 	 OBn 
BocHN 	 BoeHN 
0 	 OH 
53 118a/b 
Method 1. Use of the lithium acetvlide in THF:- 
To a stirred solution of acetylene 117 (283 mg, 1.30 mmol) in THF (5 ml) at -78°C 
was added slowly n-butyllithium (1.34M in hexanes, 1.0 ml, 1.34 mmol) under a 
nitrogen atmosphere and stirring continued at that temperature for 1 hour. A solution of 
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N-Boc-L-alaninal 53 (100 mg, 0.58 mmol) in THF (2 ml) was then added dropwise 
and after 1 hour the reaction was quenched by addition to ice cold 1M NaH2PO4 (10 
ml) with swirling. The mixture was extracted with ether (3 x 5 ml), and the combined 
organic phases washed with brine (10 ml), dried over anhydrous Na2SO4 and 
concentrated in vacuo to give an oil. Column chromatography of the residue eluting 
with hexane-EtOAc (6:1) gave the recovered acetylene 117 (193 mg) and the /3-amino 
alcohols 118aIb (133 mg, 55%). 
Method 2. Use of the lithium acetvlide in ether:- 
To a stirred solution of acetylene 117 (282 mg, 1.30 mmol) in ether (5 ml) under a 
nitrogen atmosphere at -78°C was added slowly n-butyllithium (1.48M in hexanes, 0.9 
ml, 1.33 mmol) and the resultant suspension stirred for 1 hour at this temperature. A 
solution of N-Boc-L-alaninal 53 (100 mg, 0.58 mmol) in ether (2 ml) was added 
dropwise and the mixture stirred at -78°C for 4 hours before pouring into ice cold 1M 
NaH2PO4 (20 ml) and extracting with ether (2 x 5 ml). The organic liquors were 
washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue eluting with hexane-EtOAc (6:1) gave the recovered 
acetylene 117 (197 mg) and the .f3 -amino alcohols 118a/b (104 mg, 44%). 
Method 3. Use of the Grignard acetvlide formed via transmnetallation:- 
A cold (-780C) and stirred solution of the acetylene 117 (290 mg, 1.33 mmol) in THF 
(5 ml) under a nitrogen atmosphere was treated with n-butyllithium (1.34M in 
hexanes, 1.0 ml, 1.34 mmol) and stirring was continued for 1 hour. A slurry of 
magnesium bromide (275 mg, 1.49 mmol) in THF (2 ml) was added via canula and 
after 20 minutes was followed by addition of N-Boc-L-alaninal 53 (103 mg, 0.59 
mmol) in THF (2 ml). The mixture was stirred for 1 hour at -78°C and then quenched 
by addition of sat. aq. N1440 (5 ml), extracted with ether (2 x 5 ml) and the combined 
organic extracts dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue (hexane-EtOAc 6:1) gave the recovered acetylene 117 
(180 mg) and the /3-amino alcohols 118a/b (131 mg, 56%). 
Method 4. Use of the Grignard acetvlide at room temperature:- 
Ethylmagnesium bromide (1M in THF, 1.30 ml, 1.30 mmol) was added dropwise to a 
stirred solution of the acetylene 117 (290 mg, 1.33 mmol) in THF (3 ml) at 0°C under 
a nitrogen atmosphere. After stirring at room temperature for 1 hour, a solution of N-
Boc-L-alaninal 53 (105 mg, 0.60 mmol) in THF (2 ml) was added dropwise and the 
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reaction mixture stirred for 1 hour. The reaction was quenched by dropwise addition of 
sat. aq. NH4C1 (5 ml), extracted with ether (2 x 5 ml), and the combined organic 
extracts dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography eluting with hexane-EtOAc (6:1) gave recovered acetylene 117 (187 
mg) and the /3-amino alcohols 118a/b (162 mg, 69%). 
Method 5. Use of the Gri'nard acetvlide at low temperature:- 
A stirred solution of the acetylene 117 (285 mg, 1.31 mmol) in THF (5 ml) was 
cooled to 0°C and ethylmagnesium bromide (1M in THF, 1.3 ml, 1.30 mmol) added 
dropwise and the resulting solution stirred at room temperature for 1 hour then cooled 
to -78°C. A solution of N-Boc-L-alaninal 53 (102 mg, 0.59 mmol) in THF (2 ml) was 
added dropwise, stirring continued for 1 hour whereafter the reaction was quenched 
with sat. aq. NH4C1 (5 ml). Extraction of the aqueous layer with ether (2 x 5 ml) 
followed by drying of the organic extracts with anhydrous Na2SO4 and removal of the 
solvent under reduced pressure gave an oily residue which was subjected to column 
chromatography yielding recovered acetylene 117 (207 mg) and the /3-amino alcohols 
118a/b (133 mg, 59%). 
Method 6. Use of the Grignard aceivlide at rooin temperature-different addition:- 
A stirred solution of acetylene 117 (292 mg, 1.34 mmol) in THF (3 ml) was cooled to 
0°C and ethylmagnesium bromide (1M in THF, 1.35 ml, 1.35 mmol) added dropwise 
and stirring continued at room temperature for 1 hour. The resulting solution was 
added to a cold (-78°C) solution of N-Boc-L-alaninal 53 (101 mg, 0.58 mmol) in THF 
(5 ml) and stirred for 1 hour at this temperature and for a further 30 minutes at room 
temperature. The reaction was quenched with sat. aq. NH4C1 (10 ml), extracted with 
ether (2 x 5 ml) and washed with brine (5 ml), dried over anhydrous Na2SO4 and 
concentrated in vacuo. Column chromatography of the residue yielded recovered 
acetylene 117 (166 mg) and the /3-amino alcohols 118a/b (175 mg, 77%). 
Method 7. Use of the copper acetvlide:- 
Ethyl magnesium bromide (1M in THF, 1.30 ml, 1.30 mmol) was added dropwise to 
a solution of acetylene 117 (282 mg, 1.29 mmol) in THF (3m1) at 0°C under a 
nitrogen atmosphere. After stirring for 1 hour at room temperature the solution was 
transferred via canula to a cooled (-78°C) solution of copper iodide (370 mg, 1.94 
mmol) and dimethyl sulfide (1 ml) in THF (5 ml). Stirring was continued at -30°C for 
30 minutes then cooled to -78°C whereupon a solution of N-Boc-L-alaninal 53 (102 
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mg, 0.59 mmol) in THF (2 ml) was added dropwise. The resulting suspension was 
stirred at room temperature for 3 hours, quenched by addition of sat. aq. NH4C1 (5 ml) 
and extracted with ether (2 x 5 ml). The combined organic extracts were washed with 
brine (10 ml), dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Column chromatography of the residue (hexane-EtOAc 6:1) gave the recovered 
acetylene 117 (204 mg) and the /3-amino alcohols 118aTh (100 mg, 44%). 
Method 8. Use of the zinc aceivilde:- 
A cold (-78°C) and stirred solution of the acetylene 117 (283 mg, 1.30 mmol) in THF 
(5 ml) under a nitrogen atmosphere was treated with n-butyllithium (1.38M in 
hexanes, 1.0 ml, 1.38 mmol) and stirring was continued for 1 hour then warmed to 
0°C. Anhydrous zinc bromide (310 mg, 1.38 mmol) was added and the resulting 
solution stirred at room temperature for 1 hour. A solution of N-Boc-L-alaninal 53 
(100 mg, 0.58 mmol) in THF (2 ml) was added to the above solution at -78°C, then 
stirred for a further 24 hours at room temperature whereafter sat. aq. NH4C1 (5m1) was 
added and the layers separated. The aqueous layer was extracted with ether (2 x 5 ml), 
the combined organic extracts washed with brine, dried over anhydrous Na2SO4 and. 
concentrated in vacuo. Column chromatography of the residue (hexane-EtOAc 6:1) 
gave the recovered acetylene 117 (223 mg) and the /3-amino alcohols 118a/b (41 
mg, 18%). 
N.B. The ratio of diastereomers 118a and 118b was determined by HPLC analysis 
using a Baker Chiralcel OD (4.6 x 250) column and detected by a Waters 486 tunable 
absorbance detector (A. 254 nm). The column was eluted with 95:5 hexane/IPA at a 
flow rate of 0.2 ml/min. The diastereomers were not separated due to dificulites in 
finding an appropriate chromatography solvent system, hence the nmr data given 
below, results from peak selection. 
(2S, 3S)-N-(tert-butoxycarbonyl)-2-amino-7-benzyloxy-6,6-ethylenedioxy-3-hydroxy 
hept-4-yne 118a: RF  (hexane-EtOAc 1:1) 0.42; u,/cm' (film, JR card) 3124-3586 
(OH), 1705 (C0); 1365 (CMe3)
1 
 1165 (C-O); 811  (250 MHz, CDC13) 1.14 (3H, d, J 
6.5, CHMe), 1.41 (9H, s, OCMe3), 3.4-3.5 (1H, br.s, CHOH), 3.66 (2H, s, 
CH2OBn), 3.78-3.98 (1H, br.m, CHMe), 3.99-4.11 (4H, m, CH2CH2), 4.36 (1H, t, 
J 5.0, CHOH), 4.66 (2H, s, CH2Ph), 4.80 (1H, br.d., J 8.5, NH) and 7.25-7.33 
(5H, in, Ph); 8c (62.9 MHz, CDC13) 15.8 (CH3, CHMe), 28.2 (CH31  OCMe3), 50.4 
(CH, CHMe), 65.0 (CH2, CH2CH2), 65.4 (CH, CHOH), 72.9, 73.7 (2xCH21  CH2Ph 
and CH20Bn), 79.6, 81.9,816 (C, 2xC-acetylene and OCMe3), 127.5, 127.6, 128.2 
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(CH, Ph), 137.6 (C, Ph) and 155.6 (C, C=O); m/z (F.A.B.) 392 [(MH), 4.7%], 391 
(34), 334 (6), 57 (86); [Found; (MH), 392.20689. C21H30N06 requires MR, 
392.207311. 
5.3.12 (4S, 5SR)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5-[4-benzyloxy-3, 
3-ethylenedioxybut-1 -yn-I-yl]oxazolidine 119/120 
0 0 d~ 0 
ye 	,>OBn 	 Me 	 OBn  





To a stirred solution of the n-amino alcohol 118a/b (165 mg, 0.42 mmol) in DCM (5 
ml) was added 2,2-dimethoxypropane (5 ml) and a catalytic amount of para-
toluenesulfonic acid and the solution heated under reflux for 2 hours. Water (10 ml) 
was added, the phases separated and the organic fraction washed with brine (5 ml), 
dried over anhydrous Na2SO4 and concentrated in vacuo. Column chromatography of 
the residue eluting with hexane-ethyl acetate (5:1) gave the oxazolidine derivative 
119/120 as an oil (144 mg, 80%). 
N.B. The ratio of the diastereomers was determined by HPLC analysis using a Baker 
Chiralcel OD (4.6 x 250) column and detected by a Waters 486 tunable absorbance 
detector (X 254 nm). The column was eluted with 90:10 hexane/IPA at a flow rate of 
0.5 mI/mm. The relevant data for the minor diastereomer 120 was unobtainable due to 
insufficient quantites isolated 
O 






(4S, 5S)-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-methyl-5- [4-benzyloxy-3,3-ethylene 
dioxybut-1-yn-1-yl]oxazolidine 119 RF 0.31; ii,,jcm' (film, JR card) 1696 (C=O), 
1383 (CMe2)1 1109, 1085 (C-O); 8H (250 MHz, CDC13) 1.29 (3H, d, J 6.5, CHMe), 
1.46 (9H, s, OCMe3)1 1.51, 1.67 (6H, 2xs, Me-oxazolidine), 3.67 (2H, s, CH2OBn), 
4.01-4.10 (5H, ; CH2CH and CHMe), 4.42 (1H, d, J 3.0, CHCHMe), 4.66 (2H, 
s, CH2Ph) and 7.24-7.34 (5H, m, Ph); 8c (62.9 MHz, CDC13) 19.3 (CH31 CHMe), 
27.7 (brCH3,. 2xMe-oxazolidine), 28.3 (CH3, OCMe3), 59.3 (CH, CHMe), 65.2 
(CH2, CH2CHI), 70.4 (CH, CH-O), 72.8, 73.8 (2xCH21 CH2Ph and CH20Bn), 
79.9, 82.39 83.4 (RC, 2xC-acetylene and OCMe3)1 95.8 (C, C-oxazolidine), 101.8 
(C, C-ketal), 127.5, 127.6, 128.2 (CH, Ph), 137.7 (C, Ph) and 151.5 (C, C=O); m/z 
(F.A.B.) 432 [(MH), 9.4%], 430 (10), 416 (4), 91(90), 57 (100); [Found: (MH)1 , 
432.23685. C24H33N06 requires MH, 432.23861]. 
nOe data:- 
Irradiated Proton Enhancement Observed (%) 
Ha HI, (3%); Me (2%) 
Hb 	- Me(1%) 
Me Ha (3%); Hb (15%) 
5.3.13 (2S, 3S)-N-(4-rnethylphenylsulfonyl)-2-amino- 7-benzyloxy-6, 6-ethylenedi 
oxy-3-hydroxyhept-4-yne 122, 
f~o 	 0 0 
Me 	 OBn 	 Me 	 OBn 
j~  Boc— 	 TsHN 2 
0 	 OH 
119 	 122 
The oxazolidine 119 (28 mg, 0.07 mmol) was treated with trifluoroacetic acid (99%, 1 
ml) at room temperature for 30 minutes and then concentrated in vacuo. The residue 
was suspended in DCM (1 ml) and 1,4-dioxane (1 ml) and cooled to 0°C before 
addition of triethylamine (36 jil, 0.26 mmol) and tosyl chloride (13 mg, 0.07 mmol) 
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and the mixture stirred for 30 minutes at 0°C then at room temperature for a further 24 
hours. Water (5 ml) and EtOAc (5 ml) were added, the layers separated and the organic 
fraction washed with brine (5 ml), dried over anhydrous Na2SO4 and concentrated in 
vacuo. Column chromatography of the residue eluting with hexane-EtOAc (1:1) gave 
the N-Tosyl amide 122 as an oily residue (9 mg, 32%). RF 0.39; Dm /cm 1 (film, IR 
card) 3470br (OH), 1332, 1162 (S02-N), 1094 (C-O); 8H (250 MHz, DMSO) 1.75 
(3H, d, J 6.5, CHMe), 2.38 (3H, s, Me-aryl), 3.05-3.10 (1H, br.m, CHMe), 3.64 
(2H, s, CH2OBn), 3.95-4.00 (4H, m, CH2CH2), 4.26 (1H, t, J 5.0, CHOH), 4.61 
(2H, s, CH2Ph), 5.68 (1H, d, J 5.0, OH), 7.28-7.39 (7H, m, Ph and aryl), 7.63 
(1H, d, J 7.0, NH) .and 7.71 (2H, d, J 8.0, aryl); ö, (62.9 MHz, DMSO) 14.5 (CH31 
CHMe), 21.1 (CH3, Me-aryl), 53.0 (CH, CHMe), 64.8, 64.9 (CH2 and CH, 
CH2CH2 and CHOH), 72.8, 73.0 (2xCH21 CH2Ph and CH20Bn), 81.7, 83.7 (2xC, 
C-acetylene), 101.6 (C, C-ketal), 126.6, 127.6, 128.3, 129.7 (CH, Ph and aryl), 
138.3, 138.5 (C, Ph and aryl) and 142.6 (C, aryl); m/.z (F.A.B.) 446 [(MH), 3.5%1, 
198 (35), 155 (52), 91(63), 57 (100); [Found: (MH), 446.16379. C23H28N06S 
requires MH, 446.16374]. 
5.3.14 (2S, 3SR)-2-acetamido-3-acetyloxy-7-benzyloxy-6,6-ethylenedioxy-hept-4-
yne 123 
0 0 	 0 




OH 	 OAc 
118a/b 	 123 
The 13-amino alcohol 118a/b (60 mg, 0.15 mmol) was treated with trifluoroacetic acid 
(99%, 1 ml) at 0°C fOr 1 hour, whereafter water (1 ml) and DCM (1 ml) were added 
and the solvents removed under reduced pressure. The residue was taken up in DCM 
(5 ml), washed with sat. aq. NaHCO3 (5 ml) and brine (5 ml), dried over anhydrous 
Na2SO4 and concentrated in vacuo. A portion of this residue (18 mg) was taken up in 
anhydrous acetic anhydride (0.5 ml) and pyridine (0.5 ml) and stirred under a nitrogen 
atmosphere for 20 hours. After addition of dilute HC1 (5 ml) and EtOAc (5 ml), the 
organic layer was dried with anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue eluting with EtOAc yielded the N-acetyl amide 123 as 
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an oil (10 mg, 18%). RF 0.46; 	/cm' (film, JR card) 1739 (C=O, ester), 1657 
(C=O, amide), 1373 (CMe3), 1224 and 1027(C-0); H (250 MHz, CDC13) 1.19 (3H, 
d, J 6.5, CHMe), 1.85, 2.07 (6H, s, 2xMeCO), 3.68 (2H, s, CH2OBn), 3.70-4.09 
(4H, m, CH2CH2), 4.3-4.5 (11-I, br.m, CHMe), 4.67 (211, s, CH2Ph), 5.39-5.41 
(1H, m, CHOAc diastereomers), 5.60 (1H, br.d, NH diastereomers) and 7.25-7.35 
(5H, m, Ph); 5c (62.9 MHz, CDC13) 15.9 (CH31 CHMe), 20.6, 23.0 (2xCH31 
MeCO), 46.7 (CH, CHMe), 65.2 (CH2, CH2CH2), 66.5 (CH, CHOAc), 73.2, 73.8 
(2xCH21 CH2Ph and CH20Bn), 79.3, 79.7, 82.8 (RC, 2xC-acetylene and OCMe3)1 
101.8 (C, C-ketal), 127.7, 127.8 (CH, Ph), 128.3 (C, Ph), 169.3 and 169.6 (2xC, 
C=O); m/z (F.A.B.) 376 [(MH), 100%], 332 (7), 91(30), 86 (48), 43 (37); [Found: 
(MH), 376.17765. C20H26N06 requires 376.17601]. N.B The precursor amino 
alcohol 118 used for this reaction was of low diastereomeric ratio hence the acetylated 
compound 123 contained both diastereomers. 
5.3.15 (2S, 3S)-N-(tert-butoxycarbonyl)-2-amino-3-benzoyloxy- 7-benzyloxy-6, 6-
ethylenedioxyhept-4-yne 124 
0 	 0 
Me 	 OBn 	 Me 	 OBn 
J--'~BocHN 	 BocHN 
OH 	 OBz 
118a 	 124 
Triethylamine (190 .tl, 1.35 mmol) was added dropwise to an ice cold stirred solution 
of the n-amino alcohol 118a (427 mg, 1.09 mmol) in DCM (10 ml) under an argon 
atmosphere and stirring was continued for 10 minutes. Benzoyl chloride (152 .tl, 1.30 
mmol) was added slowly and the mixture stirred for a further 30 minutes at 0°C then at 
room temperature for 12 hours. The solvent was removed in vacuo and the resultant 
oily residue subjected to column chromatography eluting with hexane-EtOAc (2:1) to 
give the benzoate ester 124 (491 mg, 90%) as an oil. RF 0.50; (Found: C, 67.61; H, 
6.77; N, 2.66; C28H33N07 requires C, 67.86; H, 6.71; N, 2.83%); lJmjcm (film, JR 
card) 171Obr (C=O), 1518 (aryl), 1258, 1107 (C-O); H (250 MHz, CDC13) 1.29 (311, 
d, J 6.5, CHMe), 1.37 (9H, s, OCMe3), 3.69 (311, s, CH2OBn and NH), 4.00-4.12 
(10H, m, CH2CH2 and CHMe), 4.68 (2H, s, CH2Ph), 5.46 (1H, br.m, CHOBz) and 
7.24-8.04 (511, m, Ph); Sc (62.9 MHz, CDC13) 16.4 (CH31 CHMe), 28.1 (CH31 
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OCMe3), 48.4 (CH, CHMe), 65.1 (CH21 CH2CH2), 66.4 (CH, CHOBz), 72.8, 73.7 
(2xCH2, CH2Ph and CH20Bn), 79.5, 79.8, 83.0 (RC, 2xC-acetylene and OCMe3), 
101.7 (C, C-ketal), 127.5, 128.2, 19.8, 133.2 (CH, Ph), 129.2, 137.6 (2xC, Ph), 
154.7 (C, C=O urethane) and 164.9 (C, G=O benzoate); m/z (F.A.B.) 496 [(MH), 
1.1%], 318 (10), 274 (11), 57 (100); [Found; (MH), 496.23250. C28H34N07 
requires MH, 496.23353]. 
5.3.16 Attempted preparation of (2S, 3S)-2-amino-3-benzoyloxy-7-benzyloxy-6,6-
ethylenedioxyhept-4-yne 126 
0 Me 	 OBn 
)~ 
 )-'~ Ph N 






' 	 Me 	 ..OBn 
ÔBz 126 
A solution of the benzoyl ester 124 (55 mg, 0.11 mmol) in DCM (1 ml) was treated 
with trifluoroacetic acid (99%, 1 ml) at room temperature and stirred for 1 hour. Water 
(2 ml) and DCM (2 ml) were added and the organic liquors washed with sat. aq. 
NaHC01 (5 ml), brine (5 ml) and dried over anhydrous Na2SO4. Column 
chromatography of the, residue eluting with EtOAc-MeOH (20:1) gave two separate 
products, the benzpyl amide 125 and the amine 126. 
(25, 3S)2-benzamido-7-benzyloxy-6,6-ethy1enedioxy-3-hythoxy-hept-4-yne 125: RF 
(hexane-EtOAc 2:1) 0.36; ujcrn' (film, JR card) 3345br (OH), 1638 (C=O), 1538 
(aryl), 1,104 (C-O); ö (250 MHz, CDC13) 1.33 (3H, d, J 6.5, CHMe), 1.60-2.00 
(1H, br.s, OH), 3.65 (2H, s, CH2OBn), 3.93-4.07 (4H, m, CH2CH2),. 4.32-4.41 
(1H, rn, CHMe),, 4.54 (1H, d, J 5.0, CHOH), 4.62 (2H, s, CH2Ph), 6.41 (1H, d, J 
8.5, NH), and 7.24-7.76 (10H, m, Ph); Sc (62.9 MHz, CDC13) 15.6 (CH31 CHMe), 
49.7 (CH, CHMe), 65.1 (CH2, CH2CH2), 73.1, 73.7, (2xCH21 CH2Ph and 
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CH20Bn), 82.2, 83.5 (2xC, C-acetylene), 101.8 (C, C-ketal), 126.9, 127.0, 127.7, 
128.3, 128.4, 131.5 (CH, Ph), 134.1, 137.5 (2xC, Ph) and 167.6 (C, C=O); m/Z 
(F.A.B.) 396 [(MH)', 47.7%1, 178 (10), 148 (40), 105 (100), 77 (29); [Found: 
(MH), 396.18185. C23H26N05 requires MH, 396.18110]. 
(2S, 3S)-2-amino-3-benzoyloxy-7-benzyloxy-6,6-ethylenedioxyhept-4-yne 126: RF 
(EtOAc) 0.30; SH  (250 MHz, CDC13) 1.42 (3H, d, J 6.5, CHMe), 3.63 (3H, br.s, 
CH2OBn and CHMe), 3.90-4.08 (4H, m, CH2CH2), 4.62 (2H, s, CH2Ph), 5.77 (1H, 
br.d, J 5.5, CHOBz) and 7.25-8.08 (12H, m, Ph and NH2); 8c (62.9 MHz, CDC13) 
14.5 (CH3, CHMe), 19.8 (CH, CHMe), 64.7 (CH, CHOBz), 65.2 (CH21  CH2CH2)1  
72.9, 73.8 (2xCH2, CH2Ph and CH20Bn), 77.7, 85.2 (2xC, C-acetylene), 101.5 (C, 
C-ketal), 127.8, 128.3, 129.9, 133.7 (CH, Ph) 137.2 (C, Ph) and 164.8 (C, C=O); 
mlz (F.A.B.) 396 [(MH), 100%], 91(22), 77 (31); [Found: (MH), 396.18253. 
C23H26N05 requires MH, 396.181101. 
5.3.17 (2S, 3S)-2-acetamido-3-benzoyloxy- 7-benz yloxy-6, 6-ethylenedioxyhept-4-
yne 127 
Me 	 OBn 








Trifluoroacetic acid (99%, 1 ml) was added dropwise to the benzoyl ester 124 (66 
mg, 0.13 mmol) in DCM (0.5 ml) at 0°C and the mixture stirred for 1 hour at room 
temperature. Water (5 ml) and DCIvI (5 ml) were added and the organic layer washed 
with sat. aq. NaHCO3 (5 ml) and brine (5 ml), dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to give an oil (64mg). The residue was taken up 
in pyridine (1 ml) and acetic anhydride (1 ml) and stirred for 15 hours under a nitrogen 
atmosphere. Dilute HC1 (2 ml) and EtOAc (2 ml) were added and the organic phase 
dried over anhydrous Na2SO4 and concentrated in vacuo. Column chromatogrpahy 
(EtOAc) yielded the N-acetarnide 127 (37 mg, 66%). RF  0.42; o./cm-1 (film, IR 
card) 1722 (C=O, benzoate), 1655 (C=O, acetate), 1265, 1103 (C-O); 8H  (250 MHz, 
CDC13) 1.29 (3H, d, J 6.5 CHMe), 1.83 (3H, s, MeCO), 3.70 (2H, s, CH2OBn), 
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3.97-4.12 (4H, m, CH2CH2), 4.43-4.51 (1H, m, CHMe), 4.67 (3H, s, CH2Ph), 
5.63 (1H, d, J 5.5, CHOBz), 5.70 (1H, br.d, J 9.0, NH) and 7.22-8.03 (10H, m, 
Ph); 5c (62.9 MHz, CDC13) 16.0 (CH31 CHMe), 23.0 (CH31 MeCO), 46.8 (CH, 
CHMe), 65.1 (2xCH2, CH2CH2), 65.8 (CH, CHCHMe), 73.2, 73.8 (2xCH21 CH2Ph 
and CH20Bn), 79.8, 83.1 (2xC, C-acetylene), 101.8 (C, C-ketal), 127.7, 128.3, 
129.7, 133.3 (CH, Ph), 129.1, 137.5 (C, Ph), 164.9 (C, C=O benzoate) and 169.4 
(C, C=O acetate); m/z (F.A.B.) 438 [(MH), 84.1%], 105 (83), 86 (46), 77 (23), 44 
(100). 
5.3.18 Attempted preparation of (2S, .3S)-N-(4-methylphenylsulfonyl)-2-amino-3-
benzoyloxy- 7-benzyloxy-6, 6-ethylenedioxyhept-4yne 128 
0 
Me 	 OBn 
z~o  







The benzoyl ester 124 (193 mg, 0.39 mmol) was treated with trifluoroacetic acid 
(99%, 3 ml) for 40 minutes at room temperature and then concentrated under reduced 
pressure. A cooled (0°C) stirred solution of the residue in DCM (2 ml) and 1,4-
dioxane (2 ml) was treated with triethylamine (220 pl, 0.56 mmol) and tosyl chloride 
(81 mg, 0.43 mmol) and stirring continued for 30 minutes at low temperature and then 
at room temperature for 4 hours. Water (5 ml) and EtOAc (5 nil) were added and the 
organic layer washed with brine (5 ml), dried over anhydrous Na 	and 
concentrated. Column chromatography of the residue eluting with hexane-EtOAc (2:1) 
gave the trifluoroacetamide 129 (33 mg) and the N-Tosyl amide 128 (82 mg, 40%). 
(2S, 35)-3-benzoyloxy-7-benzyloxy-6,6-ethylenedioxy-2-trifluoroacetamidohept-4-
yne 129: RF 0.33; ./cm' (film, JR card) 1728 (C=0), 1265 (C-0), 1179 (C-F), 
1095 (C-0); 6H (250 MHz, CDC13) 1.36 (311, d, J 6.5, CHMe), 3.68 (2H, s, 
I 	\ 






CH2OBn), 4.01-4.11 (4H, m, CH2CH2), 4.50-4.54 (1H, m, CHMe), 4.67 (2H, s, 
CH2Ph), 5.71 (1H, d, J 5.5, CHOBz), 6.66 (1H, br.d, J 9.0, NH) and 7.25-8.04 
(1 OH, m, Ph); 8c (62•9  MHz, CDC13) 15.8 (CH31  CHMe), 48.1 (CH, CHMe), 65. 1, 
65.2 (CH2 and CH, CH2CH2 and CHOBz), 72.9, 73.7 (2xCH21  CH2Ph and 
CH20Bn), 78.7, 84.1 (2xC, C-acetylene), 101.7 (C, C-ketal), 117.8 (C, CF3)1  
127.6, 127.8, 128.2, 128.4, 129.8, 133.5 (CH, Ph), 128.6, 137.5 (C, Ph), 156.3 
(C, C=O amide) and 164.9 (C, C=O ester); F(235 MHz, CDC13) -76.2 (F, CF3); m/z 
(F.A.B.) 492 [(MH), 0.6%1, 370 (5), 193 (7), 105 (100), 91(78); [Found: (MH), 
492.16485. C25H25N06F3 requires MH, 492.16340]. 
(2S, 3S)-N-(4-methylphenylsulfonyl)-2-amino-3-benzoyl-7-benzyl-6,6-ethylenedioxy 
hept-4-yne 128: RF  0.20; 1)max/cm'  (film, JR card) 1726 (C=O), 1261 (C-O), 1162 
(S02-N), 1093 (C-O); oH  (250 MHz, CDC13) 1.22 (3H, d, J 6.5, CHMe), 2.36 (3H, 
s, Me-aryl), 3.67 (2H, s, CH2OBn), 3.67-3.90 (1H, br.m, CHMe), 4.00-4.09 (4H, 
m, CH2CH2), 4.69 (2H, s, CH2Ph), 4.98 (111, d, J 9.5, NH), 5.56 (1H, d, J 6.0, 
CHOBz), and 7.18-7.95 (14H, rn, Ph); O (62.9 MHz, CDC13) 16.9 (CH31  CHMe), 
21.3 (CH3, Me-aryl), 51.2 (CH, CHMe), 65.1 (CH2, CH2CH2), 66.1 (CH, CHOBz), 
72.9, 73.7 (2xCH2, CH2Ph and CH20Bn), 79.0, 83.9 (2xC, C-acetylene), 101.7 (C, 
C-ketal), 126.8, 127.6, 129.5, 129.7, 133.3, 137.8 (CH, Ph and aryl), 128.9, 143.2 
(C, Ph and aryl) and 164.7 (C, C=O); rn1z (C.I.) 567 [(M+NH4)], 198, 193, 91; 
[Found: (M+NH4), 567.21650. C30H35N207S requires (M+NH4), 567.21649]. 
5.3.19 Attempted benzylation to give (2S, 3S)-N-(tert-butoxycarbonyl)-2-amino-3, 7-
dibenzyloxy-6, 6-ethylenedioxyhept-4-yne 130 
Method]. BnBr. AO, ether:- 
Me 	 Me 




OH 118a 	 OBn 130 
To a solution of -amino alcohol 118a (74 mg, 0.19 mmol) in ether (4 ml) was added 
silver (I) oxide (48 mg, 0.20 mmol) and benzyl bromide (30 j.il, 0.25 mmol) and the 
black suspension heated under reflux for 10 hours. The reaction mixture was filtered 
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through a plug of Celite, washed with ether (2 x 5 ml), and the combined organic 
liquors dried over anhydrous Na2SO4 and concentrated in vacuo. Column 
chromatography of the residue eluting with hexane-EtOAc (2:1) gave the benzyl ether 
130 (7 mg, 8%) and unreacted 13-amino alcohol 118a (68 mg, 92%). 
Method 2. BnBr, NaH, DMF:- 
Me 	 OBn 
BocHN OH 
liSa 
Me 	 OBn 
BocHN 	 130 
OBn 
+ 	o 
Me 	 OBn 
Ph 	N 	 132 
Sodium hydride (60% dispersion in oil, 7 mg, 0.18 mmol) was added to a stirred 
solution of the 13-amino alcohol 118a (52 mg, 0.13 mmol) in DMF (3 ml) at 0°C and 
stirring continued for 30 minutes under a nitrogen atmosphere. Benzyl bromide (19 j.tl, 
0.16 mmol) was added dropwise and the reaction stirred at room temperature for 18 
hours. Water (5 ml) and ether (5 ml) were added and the combined organic fraction 
washed with brine (5 ml), dried over anhydrous Na2504 and concentrated in vacuo. 
Column chromatography of the residue eluting with hexane-EtOAc (2:1) gave the 
benzyl ether 130 (11 mg, 17%) and the oxazolidinone 132 (48 mg). 
(2S, 3S)-N-(tert-butoxycarbonyl)-2-amino-3,7-dibenzyloxy-6,6-ethylenedioxyhept-4-
yne 130: RF O.48; 3maxIcm1  (film, JR card) 1713 (C=O), 1498 (aryl), 1058, 1106 (C-
0); H  (250 MHz, CDC13) 1.19 (3H, d, J 6.5, CHMe), 1.42 (9H, s, OCMe3), 3.71 
(2H, s, CH2OBn), 3.90-4.11 (5H, m, CH2CH2 and CHMe), 4.19 (1H, d, J 4.0, 
CHOBn), 4.47 (1H, d, J 11.5, CHOCH2Ph), 4.70 (2H, s, CH20CH2Ph), 4.75 (1H, 
d, J 11.5, CHOCH2Ph) and 7.25-7.35 (10H, m, Ph); Sc (62.9 MHz, CDC13) 16.3 
(CH3, CHMe), 28.2 (CH3, OCMe3), 48.8 (CH, CHMe), 65.0 (CH21  CH2CH2), 70.8 
(CH2, CH2Ph), 71.3 (CH, CHOBn), 73.0, 73.7 (2xCH2, CH2Ph and CH20Bn), 
79.2, 81.4, 83.4 (RC, 2xC-acetylene and OCMe3), 101.8 (C, C-ketal), 127.5, 
127.6, 127.7, 128.2 (CH, Ph), 137.3, 137.7 (2xC, Ph) and 155.0 (C, C=0); m/z 
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(F.A.B.) 482 [(MH), 1.8%], 91 (100), 59 (82); [Found: (MH), 482.25493. 
C28H36N06 requires MH, 482.254261. 
(4S, 5S)-N-benzyl-4-methyl-5-[4-benzyloxy-3,3-ethylenedioxybut- 1 -yn- 1 -yl]oxazol 
idin-2-one 132: RF (DCM) 0.2; um/cm1 (film, JR card) 1759 (C=O), 1105, 1027 (C-
0); 8H (250 MHz, CDC13) 1.21 (3H, d, J 6.0, CHIVIe), 3.57-3.68 (3H, m, CH2OBn 
and CHMe), 4.03-4.13 (5H, m, CH2CH2 and CH-O), 4.60-4.77 (4H, m, OCH2Ph 
and NCH2Ph) and 7.25-7.30 (10H, m, OCH2Ph and NCH2Ph); 8c (62.9 MHz, 
CDC13) 17.0 (CH31 CHMe), 45.8 (CH2, NCH2Ph), 57.0 (CH, CHMe), 65.2 (CH21 
CH2CH2), 69.5 (CH, CH-0), 72.6, 73.7 (2xCH21 OCH2Ph and CH20Bn), 79.3, 
84.4 (2xC, C-acetylene), 101.7 (C, C-ketal), 127.5, 127.8, 128.2, 128.7 (CH, Ph), 
127.6, 135.3 (C, Ph) and 155.6 (C, C=0); m/z (F.A.B.) 408 [(MH), 100%], 318 
(8), 300 (1), 91 (27); [Found: (MH), 408.18 159. C24H26N05 requires MH, 
408.18110]. 
5.3.20 (2S, 3S)-N-(tert-butoxycarbonyl)-2 -amino- 7-benzyloxy-6, 6-ethylenedioxy-3-
methoxymethyloxyhept-4-yne 133 
d~0~~O 	 0 
Me~OBn 	 Me 
lo~l 
~>~OBn 
- 10 "k~ - 
BocHN2 	 BocHN 
OH 	 OMOM 
118a 	 133 
DirnethOxymethane (2 ml). and phosphorous pentoxide (670 mg) were added to a 
solution of the -amino alcohol 118a (90 mg, 0.23 mmol) in CHCI3 (3 ml) and the 
mixture stirred for 30 minutes under an atmosphere of nitrogen. The reaction mixture 
was poured into ice cold sat. aq. NaHCO3 (3 ml), the aqueous layer extracted with 
EtOAc (2 x 5 ml) and the combined organic liqours were washed with brine (5 ml), 
dried over anhydrous Na2SO4 and concentrated in vacuo. Column chromatography of 
the residue eluting with hexane-EtOAc (2:1) gave the MOM ether 133 as an oil (55 
mg, 55%). RF 0.28; iinax/crn1 (film, JR card) 1712 (C=0), 1366 (CMe3), 1163, 1032 
(C-0); 8H (250 MHz, CDC13) 1.19 (3H, d, J 6.5, CHMe), 1.41 (9H, s, OCMe3), 3.35 
(3H, s, CH20Me), 3.67 (2H, s, CH2OBn), 3.8-4.11 (5H, br.m, CH2CH2 and 
CHMe), 4.41 (1H, d, J 40, CHOMOM), 4.56 (1H, d, J 6.5, CH2OMe), 4.67 (2H, 
s, CH2Ph), 4.85 (1H, d, J 6.5, CH2OMe) and 7.25-7.34 (5H, m, Ph); 8c (62.9 MHz, 
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CDC13) 16.1 (CH31  CHMe), 28.2 (CH31  OCMe3), 48.7 (CH, CHMe), 55.6 (CH31  
CH20Me), 65.0 (CH2, CH2CH2), 68.2 (CH, CHOMOM), 72.9, 73.7 (2xCH21  
CH2Ph and CH20Bn), 79.3, 80.0, 82.9 (3xC, 2xC-acetylene and OCMe3)1  94.3 
(CH2, CH20Me), 101.8 (C, C-ketal), 127.5, 127.6, 128.2 (CH, Ph), 137.7 (C, Ph) 
and 154.5 (C, C=O); m/z (F.A.B.) 436 [(MH), 5.2%], 193 (43), 91(73), 57 (100), 
45 (63); [Found: (MH), 436.23504. C23H34N04 requires MH, 436.25353]. 










To a stirred solution of the acetylene 128 (43 mg, 0.08 mmol) in EtOAc-hexane (2:1, 
3 ml) was added Lindlar catalyst (5% palladium on CaCO3, 30 mg) and the 
deoxygenated mixture stirred for 17 hours under an atmosphere of hydrogen. The 
catalyst was removed by filtration through a plug of Celite and washed with EtOAc (2 
x 2 ml) before concentration of the combined filtrates in vacuo. Column 
chromatography of the residue eluting with hexane-EtOAc (2:1) gave the Z-alkene 134 
(28 mg, 68%) and recovered acetylene 128 (8 mg). RF  0.20; Dmax/Cffl'  (film, JR card) 
1719 (C=O), 1327 (SO2), 1266 (C-O), 1162 (S02-N) 1094 (C-O); H  (250 MHz, 
CDC13) 1.16 (3H, d, J 6.5, CHMe), 2.34 (3H, s, Me-aryl), 3.58 (2H, s, CH2OBn), 
3.58-3.67 (1H, m, CHMe), 3.94-4.01 (4H, m, CH2CH2), 4.60 (1H, d, J 12.0, 
CH2Ph), 4.67 (1H, d, J 12.0, CH2Ph), 5.49-5.61 (3H, m, CHOBz, NH and 
CHCHCHOBz), 6.08 (1H, dd, J 8.0, 4.0, CHCHOBz) and 7.15-7.96 (14H, m, Ph 
and aryT); 8c (62.9 MHz, CDC13) 18.5 (CH31  CHMe), 21.3 (CH3, Me-aryl), 53.2 
(CH, CHMe), 65.0 (CH2, CH2CH2), 72.4 (CH, CHOBz), 72.7, 73.6 (2xCH21  
CH2Ph and CHOBn), 108.0 (C, C-ketal), 126.9, 127.5, 127.6, 127.7, 128.8, 
129.3, 129.5 (CH, Ph and aryl), 132.5, 132.9, 133.0 (3xCH, 2xCH-alkene and Ph), 
137.8, 138.0 (C, Ph and aryl) and 165.3 (C=O); m/z (C.I.) 569 [(M+NH4)]; [Found: 







5.3.22 Attempted preparation of (2S, 3S)-N-(4-methylphenylsulfonyl)-2-amino-3-




Method 1. Use of PPh1  and cBr- 
A solution of triphenyiphosphine (16 mg, 0.06 mmol) in DCM (0.5 ml) was added 
dropwise to an ice cold stirred solution of the 1,3-dioxolane 134 (17 mg, 0.03 mmol) 
and carbon tetrabromide (20 mg, 0.06 mmol) in DCM (1 ml) under an atmosphere of 
argon. The mixture was stirred for 30 minutes at 0°C then allowed to warm to room 
temperature for 2 hours. The mixture was filtered through a pad of silica, concentrated 
in vacuo and subjected to column chromatogaphy eluting with hexane-EtOAc (2:1) to 
give the E-alkene, (2S, 3S)-N-(4-methylphenylsulfonyl)-2-amino-3-benzoyloxy..7. 
benzyloxy-6-oxo-(E)-hept-4-ene 138 (6 mg, 20%). RF 0.22; ./cm' (film, JR card) 
1723br (C=O), 1268, 1093 (C-0); SH  (360 MHz, CDC13) 1.15 (3H, J 6.5, CHMe), 
2.37 (3H, s, Me-aryl), 3.68-3.72 (1H, m, CHMe), 4.16 (2H, s, CH2OBn), 4.56 
(2H, ov.d, J 1.0, CH2Ph), 4.65 (1H, d, J 8.0, NH), 5.60 (1H, ov.ddd, J 5.0, 5.0, 
1.5, CHOBz), 6.42 (1H, dd, J 16.0, 1.5, CHCOCH2), 6.77 (1H, dd, J 16.0, 5.0, 
CHCHOBz) and 7.42-7.98 (14H, m, Ph and aryl); 3 (90.6 MHz, CDC13) 18.4 (CH31  
CHMe), 21.4 (CH3, Me-aryl), 52.0 (CH, CHMe), 73.3, 74.2 (2xCH2, CH2Ph and 
CH20Bn), 74.8 (CH, CHOBz), 124.9, 126.9, 127.8, 128.4, 128.59 128.9, 129.7 
(CH, Ph and aryl), 127.3, 127.9 (2xCH, CH-alkene), 136.9, 137.3, 143.6 (C, Ph 
and aryl) and 165.0 (C, C=O benzoate); m/z (C.I.) 525 [(M+NH4)], 198, 105, 91; 
[Found: (M+NH4), 525.20600. C28H33N206S requires (M+NH4), 525.205931. 
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Method 2. Use of Acetic acid:- 
The 1,3-dioxolane 134 (11 mg, 0.02 mmol) was treated with 80% acetic acid (2.5 ml) 
at 65°C for 18 hours. The reaction was quenched by careful addition to ice cold sat. 
aq. NaHCO3 (20 ml) and extracted with ether (2 x 20 ml). The combined organic 
fractions were dried over anhydrous Na2SO4, concentrated in vacuo and subjected to 
column chromatography eluting with hexane-EtOAc (2:1) to give the E-alkene 138 (5 
mg, 51%). 
Method 3, Use of Montinorrillonite K1O:- 
A stirred solution of the 1,3-dioxolane 133 (28 mg, 0.05 mmol) in DCM (1 ml) was 
treated with montmorillonite K10 (150 mg) and the mixture heated under reflux for 24 
hours. The mixture was cooled to room temperature, filtered through a plug of Celite 
and concentrated under reduced pressure. Column chromatography of the residue 
eluting with hexane-EtOAc (2:1) gave the E-alkene 138 (12 mg, 48%). 









A stirred solution of the a,3-acetyIenic ketal 128 (45 mg, 0.08 mmol) in DCM (1.5 
ml) was treated with montmorrillonite K10 (200 mg) and the mixture was heated under 
reflux for 18 hours. The cooled mixture was filtered through a plug of Celite to remove 
the clay and the Celite washed with DCM (2 x 4 ml). Removal of the solvent under 
reduced pressure followed by column chromatography of the residue eluting with 
hexane-EtOAc (2:1) gave the aj3-acetylenic ketone 139 (16 mg, 40%). RF 0.30; 
Dmaxkffl ' (film, JR card) 1728 (C=0 ester), 1698 (C=0 ketone), 1338, 1164 (S02-N), 
1271, 1092 (C-0); 6H (250 MHz, CDC13) 1.26 (3H, d, J 6.5, CHMe), 2.38 (3H, s, 
Me-aryl), 3:79-3.87 (1H, br.m, CHMe), 4.15 (2H, s, CH2OBn), 4.62 (2H, 5, 
CH2Ph), 5.00 (1H, d, J9.0, NH), 5.68 (1H, d, J5.5, CHOBz) and 7.22-7.97 (14H, 
in, Ph and aryl); & (62.9 MHz, CDC13) 17.2 (CH31 CHMe), 21.4 (CH3, Me-aryl), 
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51.1 (CH, CHMe), 66.1 (CH, CHOBz), 73.4, 75.4 (2xCH21  CH2Ph and CH20Bn), 
82.9, 88.1 (2xC, C-acetylene), 126.8, 127.9, 128.0, 128.4, 129.7, 133.6 (CH, Ph 
and aryl), 128.3, 136.5, 137.4, 143.7 (C, Ph and aryl), 164.5 (C, C=O ester) and 
183.9 (C, C=O ketone). 
5.3.24 Attempted Lindlar catalysed hydrogenation to yield (2S, 3S)-N-(4-







A solution of a,-acetylenic ketone 139 (15 mg, 0.03 mmol) in EtOAc-hexane (3 ml, 
2:1) was treated with the Lindlar catalyst (Pd on CaCO3, 20mg). The flask was 
evacuated several times and the mixture stirred under an atmosphere of hydrogen for 
18 hours. The mixture was filtered through a plug of Celite to remove the catalyst and 
washed with EtOAc (2 x 2 ml). The combined organic extracts were concentrated in 
vacuo and the residue subjected to column chromatography eluting with EtOAc-hexane 
(2:1) to give the fully saturated derivative 140 (15 mg, quantitative) as an oily residue. 
RF 0.26; D,,,/cm 1 (film, JR card) 1716 (C=0), 1330, 1161 (S02-N); 8H (250 MHz, 
CDC13) 1.05 (3H, d, J 6.5, CHMe), 1.95 (2H, m, CH2CHOBz), 2.24 (3H, s, Me-
aryl), 2.24 (2H, m, CH2CO), 3.54-3.67 (1H, br.m, CHMe), 3.97 (2H, s, CH2OBn), 
4.50 (2H, s, CH2Ph), 4.75 (1H, d, J 9.0, NH), 5.03 (1H, m, CHOBz) and 7.16-
7.93 (14H, m, Ph and aryl); 8c (62.9 MHz, CDC13) 18.9 (CH31  CHMe), 21.4 (CH31  
Me-aryl), 24.6 (CH21  CH2CHOBz), 34.4 (CH, CH2CO), 52.3 (CH, CHMe), 73.2, 
74.8 (2xCH2, CH2Ph and CH20Bn), 75.6 (CH, CHOBz), 126.8, 127.8, 128.4, 
129.6, 133.3 (CH, Ph and aryl), 127.8, 137.0, 137.7, 143.3 (C, Ph and aryl), 166.1 
(C, C=O benzoate) and 207.4 (C, C=0 ketone); m/z (C.J.) 527 [(M+NH4)], 509. 
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5.3.25 (2S, 3S)-N-(4-methylphenylsulfonyl)-2-amino-3-benzoyloxy-6, 6-ethylenedi 
oxyheptan-7-ol 141 
F~ 0 0, 
Me )0Bn Me
OH 
T '>< TsHN 	 sHN 
OBz 	 OBz 
128 141 
To the cx4-acetylenic ketal 128 (44 mg, 0.08 mmol) in ethanol (2 ml) was added 
palladium (10% on C, 35 mg) and the mixture stirred under an atmosphere of 
hydrogen for 20 hours. The catalyst was removed by filtration through a plug of 
Celite, washed with DCM (2 x 2 ml) and the combined filtrates concentrated in vacuo. 
The residue was subjected to column chromatography eluting with EtOAc-hexane (2:1) 
to give the saturated ketal 141 (19 mg, 51%). RF 0.48; um/cm' (film, JR card) 
3272br (OH), 1716 (C=0), 1329, 1159 (S02-N), 1273, 1092 (C-O); 8H (250 MHz, 
CDC13) 1.04 (3H, d, J 6.5, CHMe), 1.60-1.95 (5H, m, CHCH2CH2 and CHOH), 
2.34 (3H, s, Me-aryl), 3.43 (2H, br.s, CH20H), 3.52-3.71 (1H, m, CHMe), 3.91-
4.12 (4H, m, CH2CH2), 4.90 (1H, br.d, J 8.5, NH), 5.05 (1H, m, CHOBz), 7.16-
7.95 (9H, m, Ph and aryl); 6 (62.9 MHz, CDC13) 18.9 (CH1, CHMe), 21.3 (CH31 
Me-aryl), 24.9, 30.0 (2xCH2, CHCH2CIH2), 52.1 (CH, CHMe), 65.3, 65.4 (2xCH21 
CH2CH2 and CH20H), 77.1 (CH, CHOBz), 109.6 (C, C-ketal), 126.7, 126.8, 
128.2, 129.5, 129.6, 133.1 (CH, Ph and aryl), 129.5, 137.8, 143.2 (C, Ph and aryl) 
and 166.1 (C, C=O); m/z (C.I.) 481 [(M+NH4)], 198, 105; [Found: (M+NH4), 
481.20080. C23H33N207S requires (M+NH4), 481.20085]. 
5.3.26 (2S, 3S)-N-(4-methylphenylsulfonyl)-2-amino-3-benzoyloxy-6-oxoheptan- 7-
ol 142 
Me 
JI'~~  TsHN 0T 	 TsHN 0 






A stirred solution of the ketal 141 (17 mg, 0.04 mmol) in DCM (2 ml) was treated 
with montmorrillonite K10 (100 mg) and the mixture was heated under reflux for 24 
hours. The cooled mixture was filtered through a plug of Celite to remove the clay and 
the Celite washed with DCM (2 x 2 ml). The combined organic extracts were 
concentrated in vacuo and subjected to column chromatography eluting with EtOAc-
hexane (2:1) to yield a oily residue (5 mg, 29%). 
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